- Hardware, Equipment & Parts
- Technology
Teledyne Technologies Incorporated
TDY · US ·
NYSE
400.36
USD
-10.18
(2.54%)
-
18.61
EPS
-
21.51
P/E
-
18.7B
MARKET CAP
-
0.00%
DIV YIELD
Executives
Name | Title | Pay |
---|---|---|
Dr. Robert Mehrabian | Executive Chairman | 4.29M |
Mr. Carl W. Adams | Vice President & Chief Audit Executive | -- |
Mr. Scott Hudson | Vice President & Chief Information Officer | -- |
Mr. Jason W. Connell | Vice President of Human Resources & Associate General Counsel | -- |
Mr. Jason VanWees | Vice Chairman | 1.2M |
Mr. Kevin Prusso | President and GM of Test & Measurement Instrumentation | -- |
Dr. Edwin Roks B.Sc., M.Sc., Ph.D. | Chief Executive Officer | 1.4M |
Mr. George C. Bobb III | President & Chief Operating Officer | 1.22M |
Mr. Stephen Finis Blackwood | Chief Financial Officer and Senior Vice President of Strategic Sourcing & Tax | 855K |
Ms. Melanie Susan Cibik | Executive Vice President, General Counsel, Secretary & Chief Compliance Officer | 919K |
Insider Transactions
Date | Name | Title | Acquisition Or Disposition | Stock / Options | # of Shares | Price |
---|---|---|---|---|---|---|
2024-07-29 | MEHRABIAN ROBERT | Executive Chairman | D - G-Gift | Common Stock | 24000 | 0 |
2024-04-24 | VON SCHACK WESLEY W | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | SMITH MICHAEL T | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | Singleton Denise R | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | Sherburne Jane Cecile | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | Morales Vincent J | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | Malone Robert A | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | LORNE SIMON M | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | Kumbier Michelle | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | DAHLBERG KENNETH C | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-24 | CROCKER CHARLES | director | A - A-Award | Common Stock | 468 | 0 |
2024-04-25 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 1300 | 123.38 |
2024-04-25 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1300 | 123.38 |
2024-03-08 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 139 | 64.9 |
2024-03-08 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 95 | 63.01 |
2024-03-08 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 142 | 63.51 |
2024-03-08 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 1225 | 65.31 |
2024-03-08 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 48 | 62.82 |
2024-03-08 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 140 | 64.33 |
2024-03-08 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 4000 | 94.24 |
2024-03-08 | LORNE SIMON M | director | D - S-Sale | Common Stock | 2200 | 426.7015 |
2024-03-08 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 4000 | 94.24 |
2024-03-08 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 140 | 64.33 |
2024-03-08 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 48 | 62.82 |
2024-03-08 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 1225 | 65.31 |
2024-03-08 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 142 | 63.51 |
2024-03-08 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 95 | 63.01 |
2024-03-08 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 139 | 64.9 |
2024-03-05 | CROCKER CHARLES | director | A - M-Exempt | Common Stock | 4000 | 94.24 |
2024-03-05 | CROCKER CHARLES | director | D - S-Sale | Common Stock | 4000 | 422.4616 |
2024-03-05 | CROCKER CHARLES | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 94.24 |
2024-02-02 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 4000 | 94.24 |
2024-02-02 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 3300 | 432.771 |
2024-02-02 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 700 | 433.5466 |
2024-02-02 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 4000 | 94.24 |
2024-02-02 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 3677 | 94.24 |
2024-02-02 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 612 | 65.31 |
2024-02-02 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 139 | 64.9 |
2024-02-02 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 142 | 63.51 |
2024-02-02 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 95 | 63.01 |
2024-02-02 | SMITH MICHAEL T | director | D - S-Sale | Common Stock | 4665 | 431.0083 |
2024-02-02 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 95 | 63.01 |
2024-02-02 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 142 | 63.51 |
2024-02-02 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 139 | 64.9 |
2024-02-02 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 612 | 65.31 |
2024-02-02 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 3677 | 94.24 |
2024-01-30 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 323 | 94.24 |
2024-01-30 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 48 | 62.82 |
2024-01-30 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 140 | 64.33 |
2024-01-30 | SMITH MICHAEL T | director | D - S-Sale | Common Stock | 511 | 431 |
2024-01-30 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 323 | 94.24 |
2024-01-30 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 48 | 62.82 |
2024-01-30 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 140 | 64.33 |
2024-01-26 | Roks Edwin | Chief Executive Officer | A - M-Exempt | Common Stock | 324 | 0 |
2024-01-26 | Roks Edwin | Chief Executive Officer | A - M-Exempt | Restricted Stock Units | 362 | 0 |
2024-01-26 | MEHRABIAN ROBERT | Executive Chairman | D - D-Return | Common Stock | 250 | 0 |
2024-01-26 | Blackwood Stephen Finis | Senior VP and CFO | D - D-Return | Common Stock | 30 | 0 |
2024-01-26 | Cibik Melanie Susan | EVP, GenCounsel, CCO & Sec. | D - D-Return | Common Stock | 54 | 0 |
2024-01-26 | VanWees Jason | Vice Chairman | D - D-Return | Common Stock | 56 | 0 |
2024-01-26 | Belak Cynthia Y | Vice President and Controller | D - D-Return | Common Stock | 29 | 0 |
2024-01-26 | Bobb George C III | President and COO | D - D-Return | Common Stock | 35 | 0 |
2024-01-23 | VanWees Jason | Vice Chairman | A - A-Award | Stock Option (right to buy) | 3362 | 441.98 |
2024-01-23 | VanWees Jason | Vice Chairman | A - A-Award | Restricted Stock Units | 1316 | 0 |
2024-01-23 | Blackwood Stephen Finis | Senior VP and CFO | A - A-Award | Stock Option (right to buy) | 2432 | 441.98 |
2024-01-23 | Blackwood Stephen Finis | Senior VP and CFO | A - A-Award | Restricted Stock Units | 952 | 0 |
2024-01-23 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Stock Option (right to buy) | 1561 | 441.98 |
2024-01-23 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Restricted Stock Units | 611 | 0 |
2024-01-23 | Bobb George C III | President and COO | A - A-Award | Stock Option (right to buy) | 3742 | 441.98 |
2024-01-23 | Bobb George C III | President and COO | A - A-Award | Restricted Stock Units | 1465 | 0 |
2024-01-23 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Stock Option (right to buy) | 6431 | 441.98 |
2024-01-23 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Restricted Stock Units | 2517 | 0 |
2024-01-23 | Roks Edwin | Chief Executive Officer | A - A-Award | Stock Option (right to buy) | 6314 | 441.98 |
2024-01-23 | Roks Edwin | Chief Executive Officer | A - A-Award | Restricted Stock Units | 2472 | 0 |
2024-01-23 | Cibik Melanie Susan | EVP, GenCounsel, CCO & Sec. | A - A-Award | Stock Option (right to buy) | 2596 | 441.98 |
2024-01-23 | Cibik Melanie Susan | EVP, GenCounsel, CCO & Sec. | A - A-Award | Restricted Stock Units | 1016 | 0 |
2024-01-02 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 95 | 63.2 |
2024-01-02 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 143 | 62.93 |
2024-01-02 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 1333 | 60.03 |
2024-01-02 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 1333 | 60.03 |
2024-01-02 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 143 | 62.93 |
2024-01-02 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 95 | 63.2 |
2023-12-12 | MAIN SUE | Former Senior VP & CFO | A - M-Exempt | Common Stock | 9461 | 192 |
2023-12-12 | MAIN SUE | Former Senior VP & CFO | D - S-Sale | Common Stock | 4121 | 421.0618 |
2023-12-12 | MAIN SUE | Former Senior VP & CFO | D - S-Sale | Common Stock | 5340 | 421.5485 |
2023-12-12 | MAIN SUE | Former Senior VP & CFO | D - M-Exempt | Stock Option right-to-buy | 9461 | 192 |
2023-12-12 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 3700 | 123.38 |
2023-12-12 | VanWees Jason | Vice Chairman | D - S-Sale | Common Stock | 3700 | 420.2889 |
2023-12-12 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option (right-to-buy) | 3700 | 123.38 |
2023-12-08 | Belak Cynthia Y | Vice President and Controller | A - M-Exempt | Common Stock | 5389 | 217.39 |
2023-12-08 | Belak Cynthia Y | Vice President and Controller | D - S-Sale | Common Stock | 5389 | 409.5189 |
2023-12-08 | Belak Cynthia Y | Vice President and Controller | D - M-Exempt | Stock Option right-to-buy | 5389 | 217.39 |
2023-12-11 | MEHRABIAN ROBERT | Chairman, President and CEO | A - M-Exempt | Common Stock | 50000 | 78.4 |
2023-12-11 | MEHRABIAN ROBERT | Chairman, President and CEO | D - S-Sale | Common Stock | 50000 | 410.75 |
2023-12-11 | MEHRABIAN ROBERT | Chairman, President and CEO | D - M-Exempt | Stock Option right-to-buy | 50000 | 78.4 |
2023-12-08 | VON SCHACK WESLEY W | director | D - S-Sale | Common Stock | 1145 | 410.0578 |
2023-11-15 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 95 | 63.2 |
2023-11-15 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 143 | 62.93 |
2023-11-15 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 833 | 60.03 |
2023-11-15 | SMITH MICHAEL T | director | D - S-Sale | Common Stock | 1071 | 395 |
2023-11-15 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 833 | 60.03 |
2023-11-15 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 143 | 62.93 |
2023-11-15 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right--to-buy) | 95 | 63.2 |
2023-10-27 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 1300 | 123.38 |
2023-10-27 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1300 | 123.38 |
2023-09-14 | VON SCHACK WESLEY W | director | D - S-Sale | Common Stock | 376 | 412.3011 |
2023-09-12 | Sherburne Jane Cecile | director | A - M-Exempt | Common Stock | 2000 | 91.2 |
2023-09-12 | Sherburne Jane Cecile | director | D - S-Sale | Common Stock | 2000 | 406.7701 |
2023-09-12 | Sherburne Jane Cecile | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 2000 | 91.2 |
2023-09-01 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - M-Exempt | Common Stock | 13000 | 123.38 |
2023-09-01 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - S-Sale | Common Stock | 13000 | 422.4042 |
2023-09-01 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - M-Exempt | Stock Option right-to-buy | 13000 | 123.38 |
2023-09-01 | MAIN SUE | Senior VP & CFO | A - M-Exempt | Common Stock | 770 | 123.38 |
2023-08-31 | MAIN SUE | Senior VP & CFO | A - M-Exempt | Common Stock | 9230 | 123.38 |
2023-08-31 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 9230 | 420.1211 |
2023-09-01 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 770 | 420.28 |
2023-08-31 | MAIN SUE | Senior VP & CFO | D - M-Exempt | Stock Option right-to-buy | 9230 | 123.38 |
2023-09-01 | MAIN SUE | Senior VP & CFO | D - M-Exempt | Stock Option right-to-buy | 770 | 123.38 |
2023-08-29 | MEHRABIAN ROBERT | Chairman, President and CEO | A - M-Exempt | Common Stock | 45500 | 94.24 |
2023-08-29 | MEHRABIAN ROBERT | Chairman, President and CEO | D - S-Sale | Common Stock | 45500 | 416.13 |
2023-08-29 | MEHRABIAN ROBERT | Chairman, President and CEO | D - M-Exempt | Stock Option right-to-buy | 45500 | 94.24 |
2023-05-26 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 151 | 59.78 |
2023-05-26 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 101 | 59.61 |
2023-05-26 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 57 | 52.39 |
2023-05-26 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 111 | 54.17 |
2023-05-26 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 1545 | 51.77 |
2023-05-26 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 111 | 54.17 |
2023-05-26 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 1545 | 51.77 |
2023-05-26 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 57 | 52.39 |
2023-05-26 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 101 | 59.61 |
2023-05-26 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 151 | 59.78 |
2023-05-15 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - M-Exempt | Common Stock | 2000 | 123.38 |
2023-05-15 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - S-Sale | Common Stock | 2000 | 413 |
2023-05-15 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - M-Exempt | Stock Option right-to-buy | 2000 | 123.38 |
2023-04-26 | VON SCHACK WESLEY W | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | CROCKER CHARLES | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | SMITH MICHAEL T | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | Singleton Denise R | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | Sherburne Jane Cecile | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | Morales Vincent J | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | Malone Robert A | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | LORNE SIMON M | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | Kumbier Michelle | director | A - A-Award | Common Stock | 419 | 0 |
2023-04-26 | DAHLBERG KENNETH C | director | A - A-Award | Common Stock | 419 | 0 |
2023-03-06 | MEHRABIAN ROBERT | Chairman, President and CEO | A - M-Exempt | Common Stock | 3400 | 94.24 |
2023-03-07 | MEHRABIAN ROBERT | Chairman, President and CEO | A - M-Exempt | Common Stock | 1100 | 94.24 |
2023-03-07 | MEHRABIAN ROBERT | Chairman, President and CEO | D - S-Sale | Common Stock | 1000 | 439.0225 |
2023-03-06 | MEHRABIAN ROBERT | Chairman, President and CEO | D - S-Sale | Common Stock | 3400 | 440.1717 |
2023-03-07 | MEHRABIAN ROBERT | Chairman, President and CEO | D - S-Sale | Common Stock | 100 | 439.62 |
2023-03-06 | MEHRABIAN ROBERT | Chairman, President and CEO | D - M-Exempt | Stock Option right-to-buy | 3400 | 94.24 |
2023-03-07 | MEHRABIAN ROBERT | Chairman, President and CEO | D - M-Exempt | Stock Option right-to-buy | 1100 | 94.24 |
2023-02-13 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 5400 | 78.4 |
2023-02-13 | VanWees Jason | Vice Chairman | D - S-Sale | Common Stock | 5400 | 441.8312 |
2023-02-13 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 5400 | 78.4 |
2023-02-02 | Blackwood Stephen Finis | Senior VP & Treasurer | A - M-Exempt | Common Stock | 3333 | 123.38 |
2023-02-02 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 3333 | 434 |
2023-02-02 | Blackwood Stephen Finis | Senior VP & Treasurer | D - M-Exempt | Stock Option right-to-buy | 3333 | 123.38 |
2023-02-02 | Bobb George C III | Senior Vice President | A - M-Exempt | Common Stock | 10000 | 123.38 |
2023-02-02 | Bobb George C III | Senior Vice President | D - S-Sale | Common Stock | 3500 | 431.5867 |
2023-02-02 | Bobb George C III | Senior Vice President | D - S-Sale | Common Stock | 600 | 432.1867 |
2023-02-02 | Bobb George C III | Senior Vice President | D - S-Sale | Common Stock | 3200 | 433.7044 |
2023-02-02 | Bobb George C III | Senior Vice President | D - S-Sale | Common Stock | 2700 | 434.64 |
2023-02-02 | Bobb George C III | Senior Vice President | D - M-Exempt | Stock Option right-to-buy | 10000 | 123.38 |
2023-01-27 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 167 | 422.05 |
2023-01-27 | Roks Edwin | EVP & Pres. Digital Imaging | A - A-Award | Common Stock | 506 | 422.04 |
2023-01-27 | Bobb George C III | Senior Vice President | A - A-Award | Common Stock | 41 | 422.04 |
2023-01-27 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 187 | 422.04 |
2023-01-27 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 186 | 422.04 |
2023-01-27 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 117 | 422.04 |
2023-01-27 | VanWees Jason | Vice Chairman | A - A-Award | Common Stock | 742 | 422.04 |
2023-01-27 | MEHRABIAN ROBERT | Chairman, President and CEO | A - A-Award | Common Stock | 786 | 422.04 |
2023-01-30 | CROCKER CHARLES | director | A - M-Exempt | Common Stock | 3477 | 75.13 |
2023-01-27 | CROCKER CHARLES | director | A - M-Exempt | Common Stock | 523 | 75.13 |
2023-01-27 | CROCKER CHARLES | director | D - S-Sale | Common Stock | 523 | 425 |
2023-01-30 | CROCKER CHARLES | director | D - S-Sale | Common Stock | 3477 | 422 |
2023-01-27 | CROCKER CHARLES | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 523 | 0 |
2023-01-30 | CROCKER CHARLES | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 3477 | 0 |
2023-01-27 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 4000 | 75.13 |
2023-01-27 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 4000 | 421.62 |
2023-01-27 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 0 |
2023-01-24 | Roks Edwin | EVP & Pres. Digital Imaging | A - M-Exempt | Common Stock | 377 | 0 |
2023-01-24 | Roks Edwin | EVP & Pres. Digital Imaging | A - A-Award | Restricted Stock Units | 817 | 404.16 |
2023-01-24 | Roks Edwin | EVP & Pres. Digital Imaging | D - M-Exempt | Restricted Stock Units | 385 | 0 |
2023-01-24 | MEHRABIAN ROBERT | Chairman, President and CEO | A - A-Award | Common Stock | 4355 | 404.16 |
2023-01-24 | MEHRABIAN ROBERT | Chairman, President and CEO | D - D-Return | Common Stock | 52 | 0 |
2023-01-24 | Bobb George C III | Senior Vice President | A - A-Award | Common Stock | 772 | 404.16 |
2023-01-24 | Bobb George C III | Senior Vice President | D - D-Return | Common Stock | 7 | 0 |
2023-01-24 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 445 | 404.16 |
2023-01-24 | Blackwood Stephen Finis | Senior VP & Treasurer | D - D-Return | Common Stock | 6 | 0 |
2023-01-24 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 423 | 404.16 |
2023-01-24 | Belak Cynthia Y | Vice President and Controller | D - D-Return | Common Stock | 6 | 0 |
2023-01-24 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 591 | 404.16 |
2023-01-24 | MAIN SUE | Senior VP & CFO | D - D-Return | Common Stock | 12 | 0 |
2023-01-24 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 534 | 404.16 |
2023-01-24 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - D-Return | Common Stock | 11 | 0 |
2023-01-24 | VanWees Jason | Vice Chairman | A - A-Award | Common Stock | 596 | 404.16 |
2023-01-24 | VanWees Jason | Vice Chairman | D - D-Return | Common Stock | 11 | 0 |
2022-12-13 | MAIN SUE | Senior VP & CFO | A - M-Exempt | Common Stock | 5000 | 123.38 |
2022-12-13 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 4000 | 420 |
2022-12-13 | MAIN SUE | Senior VP & CFO | A - M-Exempt | Common Stock | 4000 | 78.4 |
2022-12-13 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 5000 | 420.0548 |
2022-12-13 | MAIN SUE | Senior VP & CFO | D - M-Exempt | Stock Option right-to-buy | 5000 | 0 |
2022-12-13 | MAIN SUE | Senior VP & CFO | D - M-Exempt | Stock Option right-to-buy | 4000 | 0 |
2022-12-01 | VON SCHACK WESLEY W | director | D - S-Sale | Common Stock | 1459 | 423.988 |
2022-11-14 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 4000 | 75.13 |
2022-11-14 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 60 | 50.08 |
2022-11-14 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 182 | 49.36 |
2022-11-14 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 0 |
2022-11-10 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 4000 | 75.13 |
2022-11-10 | SMITH MICHAEL T | director | D - S-Sale | Common Stock | 3775 | 419.4455 |
2022-11-10 | SMITH MICHAEL T | director | D - S-Sale | Common Stock | 225 | 420.2502 |
2022-11-10 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 0 |
2022-11-08 | Belak Cynthia Y | Vice President and Controller | A - M-Exempt | Common Stock | 5046 | 192 |
2022-11-08 | Belak Cynthia Y | Vice President and Controller | D - S-Sale | Common Stock | 2100 | 411.6103 |
2022-11-08 | Belak Cynthia Y | Vice President and Controller | D - S-Sale | Common Stock | 2946 | 412.3562 |
2022-11-08 | Belak Cynthia Y | Vice President and Controller | D - M-Exempt | Stock Option right-to-buy | 5046 | 0 |
2022-10-25 | Bobb George C III | Senior Vice President | A - A-Award | Stock Option right-to-buy | 4821 | 0 |
2022-10-25 | Roks Edwin | EVP & Pres. Digital Imaging | A - A-Award | Stock Option right-to-buy | 7072 | 0 |
2022-10-25 | MAIN SUE | Senior VP & CFO | A - A-Award | Stock Option right-to-buy | 6429 | 0 |
2022-10-25 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Stock Option right-to-buy | 4018 | 0 |
2022-10-25 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Stock Option right-to-buy | 3214 | 0 |
2022-10-25 | MEHRABIAN ROBERT | Chairman, President and CEO | A - A-Award | Stock Option right-to-buy | 14143 | 0 |
2022-10-25 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Stock Option right-to-buy | 5839 | 0 |
2022-10-25 | VanWees Jason | Vice Chairman | A - A-Award | Stock Option right-to-buy | 6429 | 0 |
2022-06-14 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 1000 | 78.4 |
2022-06-14 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1000 | 0 |
2022-06-14 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1000 | 78.4 |
2022-05-12 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 1000 | 78.4 |
2022-05-12 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1000 | 78.4 |
2022-05-06 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 1500 | 78.4 |
2022-05-06 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1500 | 78.4 |
2022-05-06 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1500 | 0 |
2022-04-27 | VON SCHACK WESLEY W | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | SMITH MICHAEL T | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | Sherburne Jane Cecile | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | Morales Vincent J | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | Malone Robert A | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | LORNE SIMON M | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | Kumbier Michelle | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | DAHLBERG KENNETH C | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | Singleton Denise R | A - A-Award | Common Stock | 376 | 0 | |
2022-04-27 | CROCKER CHARLES | A - A-Award | Common Stock | 376 | 0 | |
2022-03-01 | CROCKER CHARLES | director | A - M-Exempt | Common Stock | 4000 | 64.73 |
2022-03-01 | CROCKER CHARLES | director | D - S-Sale | Common Stock | 4000 | 428 |
2022-03-01 | CROCKER CHARLES | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 64.73 |
2021-12-31 | PICHELLI ALDO | officer | - | 0 | 0 | |
2022-02-09 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 4000 | 64.73 |
2022-02-09 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 572 | 430.56 |
2022-02-09 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 219 | 431.8787 |
2022-02-09 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 74 | 430.58 |
2022-02-09 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 70 | 430.78 |
2022-02-09 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 1954 | 430.5693 |
2022-02-09 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 210 | 42.89 |
2022-02-09 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 144 | 41.57 |
2022-02-09 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 219 | 41.04 |
2022-02-09 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 74 | 40.7 |
2022-02-09 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 70 | 43.15 |
2022-02-09 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 218 | 41.36 |
2022-02-09 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 2046 | 431.4925 |
2022-02-09 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 218 | 41.36 |
2022-02-09 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 70 | 43.15 |
2022-02-09 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 74 | 40.7 |
2022-02-09 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 219 | 41.04 |
2022-02-09 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 144 | 41.57 |
2022-02-09 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 210 | 42.89 |
2022-02-09 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 64.73 |
2022-01-31 | MEHRABIAN ROBERT | Chairman, President and CEO | A - A-Award | Common Stock | 779 | 415.12 |
2022-01-31 | VanWees Jason | Vice Chairman | A - A-Award | Common Stock | 796 | 415.12 |
2022-01-31 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 697 | 415.12 |
2022-01-31 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 272 | 415.12 |
2022-01-31 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 213 | 415.12 |
2022-01-31 | Roks Edwin | EVP & Pres. Digital Imaging | A - A-Award | Common Stock | 489 | 415.12 |
2022-01-31 | Bobb George C III | Senior Vice President | A - A-Award | Common Stock | 37 | 415.12 |
2022-01-31 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 118 | 415.12 |
2022-01-25 | Bobb George C III | Senior Vice President | A - A-Award | Common Stock | 516 | 427.51 |
2022-01-25 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 558 | 427.51 |
2022-01-25 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 400 | 427.51 |
2022-01-25 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 421 | 427.51 |
2022-01-27 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 4000 | 64.73 |
2022-01-27 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 64.73 |
2022-01-25 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 505 | 427.51 |
2022-01-25 | VanWees Jason | Vice Chairman | A - A-Award | Common Stock | 563 | 427.51 |
2022-01-25 | MEHRABIAN ROBERT | Chairman, President and CEO | A - A-Award | Common Stock | 7017 | 427.51 |
2022-01-25 | MEHRABIAN ROBERT | Chairman, President and CEO | A - A-Award | Common Stock | 4117 | 427.51 |
2022-01-25 | Roks Edwin | EVP & Pres. Digital Imaging | A - M-Exempt | Common Stock | 651 | 0 |
2022-01-25 | Roks Edwin | EVP & Pres. Digital Imaging | A - A-Award | Restricted Stock Units | 772 | 427.51 |
2022-01-24 | Roks Edwin | EVP & Pres. Digital Imaging | D - M-Exempt | Restricted Stock Units | 651 | 0 |
2021-12-03 | VanWees Jason | Vice Chairman | A - M-Exempt | Common Stock | 1300 | 78.4 |
2021-12-03 | VanWees Jason | Vice Chairman | D - M-Exempt | Stock Option right-to-buy | 1300 | 78.4 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 125 | 47.82 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 193 | 46.52 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 1800 | 44.44 |
2021-11-24 | LORNE SIMON M | director | D - S-Sale | Common Stock | 1714 | 435.6863 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 210 | 42.89 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 217 | 41.57 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 219 | 41.04 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 1936 | 41.33 |
2021-11-24 | LORNE SIMON M | director | D - S-Sale | Common Stock | 1800 | 435.6659 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 74 | 40.7 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 70 | 43.15 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 218 | 41.36 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 149 | 40.25 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 239 | 37.66 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 4000 | 64.73 |
2021-11-24 | LORNE SIMON M | director | D - S-Sale | Common Stock | 1936 | 435.7403 |
2021-11-24 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 2150 | 37.21 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 1800 | 44.44 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 193 | 46.52 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 125 | 47.82 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 2150 | 37.21 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 64.73 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 239 | 37.66 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 149 | 40.25 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 218 | 41.36 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 70 | 43.15 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 74 | 40.7 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 1936 | 41.33 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 219 | 41.04 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 217 | 41.57 |
2021-11-24 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 210 | 42.89 |
2021-11-16 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - M-Exempt | Common Stock | 2000 | 94.24 |
2021-11-16 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - S-Sale | Common Stock | 2000 | 450 |
2021-11-16 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - M-Exempt | Stock Option right-to-buy | 2000 | 94.24 |
2021-11-01 | Morales Vincent J | director | A - A-Award | Common Stock | 144 | 0 |
2021-11-01 | Morales Vincent J | - | 0 | 0 | ||
2021-10-15 | MEHRABIAN ROBERT | Chairman, President and CEO | A - A-Award | Stock Option right-to-buy | 6484 | 429.39 |
2021-10-15 | MAIN SUE | Senior VP & CFO | A - A-Award | Stock Option right-to-buy | 554 | 429.39 |
2021-10-15 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Stock Option right-to-buy | 94 | 429.39 |
2021-10-15 | Bobb George C III | Senior Vice President | A - A-Award | Stock Option right-to-buy | 566 | 429.39 |
2021-10-15 | VanWees Jason | Vice Chairman | A - A-Award | Stock Option right-to-buy | 554 | 429.39 |
2021-10-15 | Roks Edwin | EVP & Pres. Digital Imaging | A - A-Award | Stock Option right-to-buy | 604 | 429.39 |
2021-09-21 | PICHELLI ALDO | President and CEO | A - M-Exempt | Common Stock | 13052 | 75.13 |
2021-09-22 | PICHELLI ALDO | President and CEO | A - M-Exempt | Common Stock | 6948 | 75.13 |
2021-09-21 | PICHELLI ALDO | President and CEO | D - S-Sale | Common Stock | 3748 | 419.5344 |
2021-09-22 | PICHELLI ALDO | President and CEO | D - S-Sale | Common Stock | 4074 | 419.0035 |
2021-09-21 | PICHELLI ALDO | President and CEO | D - S-Sale | Common Stock | 1733 | 420.6999 |
2021-09-21 | PICHELLI ALDO | President and CEO | D - S-Sale | Common Stock | 2168 | 421.8884 |
2021-09-21 | PICHELLI ALDO | President and CEO | D - M-Exempt | Stock Option right-to-buy | 13052 | 75.13 |
2021-09-22 | PICHELLI ALDO | President and CEO | D - M-Exempt | Stock Option right-to-buy | 6948 | 75.13 |
2021-09-13 | VanWees Jason | Executive Vice President | A - P-Purchase | Common Stock | 1500 | 425.9969 |
2021-08-12 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 242 | 37.14 |
2021-08-12 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 161 | 37.32 |
2021-08-12 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 242 | 37.14 |
2021-08-12 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 161 | 37.32 |
2021-07-27 | MAIN SUE | Senior VP & CFO | A - A-Award | Stock Option right-to-buy | 5328 | 441.51 |
2021-07-27 | VanWees Jason | Executive Vice President | A - A-Award | Stock Option right-to-buy | 5328 | 441.51 |
2021-07-27 | Bobb George C III | VP & President A&D Electronics | A - A-Award | Stock Option right-to-buy | 3850 | 441.51 |
2021-07-27 | Roks Edwin | EVP & Pres. Digital Imaging | A - A-Award | Stock Option right-to-buy | 5866 | 441.51 |
2021-07-27 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Stock Option right-to-buy | 5328 | 441.51 |
2021-07-27 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Stock Option right-to-buy | 3667 | 441.51 |
2021-07-27 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Stock Option right-to-buy | 2843 | 441.51 |
2021-07-27 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Stock Option right-to-buy | 6600 | 441.51 |
2021-05-14 | SMITH MICHAEL T | director | A - A-Award | Common Stock | 10392 | 0 |
2021-04-28 | VON SCHACK WESLEY W | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | SMITH MICHAEL T | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | Sherburne Jane Cecile | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | Malone Robert A | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | LORNE SIMON M | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | Kumbier Michelle | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | CROCKER CHARLES | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | Cade Denise R | director | A - A-Award | Common Stock | 288 | 0 |
2021-04-28 | DAHLBERG KENNETH C | director | A - A-Award | Common Stock | 288 | 0 |
2021-03-05 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 177 | 33.9 |
2021-03-05 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 2355 | 33.98 |
2021-03-05 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 4000 | 49.51 |
2021-03-05 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 91 | 33 |
2021-03-05 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 284 | 31.64 |
2021-03-05 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 91 | 33 |
2021-03-05 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 284 | 31.64 |
2021-03-05 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 49.51 |
2021-03-05 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 2355 | 33.98 |
2021-03-05 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 177 | 33.9 |
2021-03-04 | VanWees Jason | Executive Vice President | A - P-Purchase | Common Stock | 2090 | 357.701 |
2021-03-04 | VanWees Jason | Executive Vice President | A - P-Purchase | Common Stock | 910 | 356.958 |
2021-03-04 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 1300 | 365.76 |
2021-03-04 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 1282 | 364.59 |
2021-03-04 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 918 | 363.94 |
2021-03-04 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 1531 | 360.49 |
2021-03-04 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 4969 | 359.53 |
2021-02-23 | Kumbier Michelle | director | A - P-Purchase | Common Stock | 127 | 387 |
2021-02-22 | Kumbier Michelle | director | A - P-Purchase | Common Stock | 68 | 405.5 |
2021-02-22 | Kumbier Michelle | director | A - P-Purchase | Common Stock | 193 | 404.9126 |
2021-01-29 | Roks Edwin | VP & Pres. Digital Imaging | A - A-Award | Common Stock | 530 | 361.65 |
2021-01-29 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 211 | 361.65 |
2021-01-29 | Bobb George C III | VP & President A&D Electronics | A - A-Award | Common Stock | 5 | 361.65 |
2021-01-29 | VanWees Jason | Executive Vice President | A - A-Award | Common Stock | 796 | 361.65 |
2021-01-29 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 82 | 361.65 |
2021-01-29 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 152 | 361.65 |
2021-01-29 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 137 | 361.65 |
2021-01-29 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Common Stock | 680 | 361.65 |
2021-01-29 | PICHELLI ALDO | President and CEO | A - A-Award | Common Stock | 1981 | 361.65 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 224 | 40.25 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 239 | 37.66 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 242 | 37.14 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 161 | 37.32 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 266 | 33.9 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 4000 | 49.51 |
2021-01-29 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 1507 | 368.05 |
2021-01-29 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 2986 | 365.7204 |
2021-01-29 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 314 | 366.5809 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 91 | 33 |
2021-01-29 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 284 | 31.64 |
2021-01-29 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 600 | 367.7967 |
2021-01-29 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 100 | 368.63 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 242 | 37.14 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 239 | 37.66 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 224 | 40.25 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 266 | 33.9 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 284 | 31.64 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 91 | 33 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 49.51 |
2021-01-29 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 161 | 37.32 |
2021-01-29 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 200 | 368.79 |
2021-01-29 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 1000 | 367.84 |
2021-01-29 | MEHRABIAN ROBERT | Executive Chairman | A - P-Purchase | Common Stock | 8800 | 365.78 |
2021-01-26 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 289 | 380.59 |
2021-01-26 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 566 | 380.59 |
2021-01-26 | Roks Edwin | VP & Pres. Digital Imaging | A - M-Exempt | Common Stock | 643 | 0 |
2021-01-26 | Roks Edwin | VP & Pres. Digital Imaging | A - A-Award | Restricted Stock Units | 362 | 380.59 |
2021-01-26 | Roks Edwin | VP & Pres. Digital Imaging | D - M-Exempt | Restricted Stock Units | 643 | 0 |
2021-01-26 | Bobb George C III | VP & President A&D Electronics | A - A-Award | Common Stock | 338 | 380.59 |
2021-01-26 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 280 | 380.59 |
2021-01-26 | VanWees Jason | Executive Vice President | A - A-Award | Common Stock | 531 | 380.59 |
2021-01-26 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 517 | 380.59 |
2021-01-26 | PICHELLI ALDO | President and CEO | A - A-Award | Common Stock | 2102 | 380.59 |
2021-01-26 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Common Stock | 2365 | 380.59 |
2020-12-15 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 175 | 34.2 |
2020-12-15 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 288 | 31.24 |
2020-12-15 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 2675 | 29.91 |
2020-12-15 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 288 | 31.24 |
2020-12-15 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 2675 | 29.91 |
2020-12-15 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 175 | 34.2 |
2020-10-20 | Kumbier Michelle | director | A - A-Award | Common Stock | 162 | 0 |
2020-10-20 | Kumbier Michelle | - | 0 | 0 | ||
2020-08-04 | SMITH MICHAEL T | director | A - M-Exempt | Common Stock | 4000 | 49.51 |
2020-08-04 | SMITH MICHAEL T | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 49.51 |
2020-07-28 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 306 | 29.43 |
2020-07-28 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 219 | 27.42 |
2020-07-28 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 219 | 27.42 |
2020-07-28 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 306 | 29.43 |
2020-07-27 | VanWees Jason | Executive Vice President | A - M-Exempt | Common Stock | 1800 | 78.4 |
2020-07-27 | VanWees Jason | Executive Vice President | D - M-Exempt | Stock Option right-to-buy | 1800 | 78.4 |
2020-06-05 | AUSTIN ROXANNE S | director | D - S-Sale | Common Stock | 1266 | 383.47 |
2020-05-28 | Bobb George C III | VP & President A&D Electronics | A - M-Exempt | Common Stock | 10000 | 78.4 |
2020-05-28 | Bobb George C III | VP & President A&D Electronics | D - S-Sale | Common Stock | 10000 | 368.3469 |
2020-05-28 | Bobb George C III | VP & President A&D Electronics | D - M-Exempt | Stock Option right-to-buy | 10000 | 78.4 |
2020-05-28 | VanWees Jason | Executive Vice President | D - S-Sale | Common Stock | 2214 | 366.5675 |
2020-05-27 | Blackwood Stephen Finis | Senior VP & Treasurer | A - M-Exempt | Common Stock | 3000 | 64.73 |
2020-05-27 | Blackwood Stephen Finis | Senior VP & Treasurer | A - M-Exempt | Common Stock | 2000 | 123.38 |
2020-05-27 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 355.859 |
2020-05-27 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 3000 | 353.6 |
2020-05-27 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 355.7059 |
2020-05-27 | Blackwood Stephen Finis | Senior VP & Treasurer | D - M-Exempt | Stock Option right-to-buy | 2000 | 123.38 |
2020-05-27 | Blackwood Stephen Finis | Senior VP & Treasurer | D - M-Exempt | Stock Option right-to-buy | 3000 | 64.73 |
2020-05-27 | AUSTIN ROXANNE S | director | A - M-Exempt | Common Stock | 4000 | 64.73 |
2020-05-27 | AUSTIN ROXANNE S | director | D - S-Sale | Common Stock | 1250 | 356.74 |
2020-05-27 | AUSTIN ROXANNE S | director | D - S-Sale | Common Stock | 4000 | 357.75 |
2020-05-27 | AUSTIN ROXANNE S | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 64.73 |
2020-05-26 | VON SCHACK WESLEY W | director | A - M-Exempt | Common Stock | 1000 | 94.24 |
2020-05-26 | VON SCHACK WESLEY W | director | D - S-Sale | Common Stock | 1000 | 349.49 |
2020-05-26 | VON SCHACK WESLEY W | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 1000 | 94.24 |
2020-05-21 | VON SCHACK WESLEY W | director | A - M-Exempt | Common Stock | 1000 | 94.24 |
2020-05-21 | VON SCHACK WESLEY W | director | D - S-Sale | Common Stock | 80 | 337.47 |
2020-05-21 | VON SCHACK WESLEY W | director | D - S-Sale | Common Stock | 920 | 337.775 |
2020-05-21 | VON SCHACK WESLEY W | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 1000 | 94.24 |
2020-05-21 | CROCKER CHARLES | director | A - M-Exempt | Common Stock | 2000 | 49.51 |
2020-05-21 | CROCKER CHARLES | director | D - S-Sale | Common Stock | 1900 | 335.25 |
2020-05-21 | CROCKER CHARLES | director | D - S-Sale | Common Stock | 100 | 336.025 |
2020-05-21 | CROCKER CHARLES | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 2000 | 49.51 |
2020-05-12 | Belak Cynthia Y | Vice President and Controller | A - M-Exempt | Common Stock | 8000 | 123.38 |
2020-05-12 | Belak Cynthia Y | Vice President and Controller | D - S-Sale | Common Stock | 7465 | 330 |
2020-05-12 | Belak Cynthia Y | Vice President and Controller | D - S-Sale | Common Stock | 535 | 332.66 |
2020-05-12 | Belak Cynthia Y | Vice President and Controller | D - M-Exempt | Stock Option right-to-buy | 8000 | 123.38 |
2020-05-08 | PICHELLI ALDO | President and CEO | A - M-Exempt | Common Stock | 5000 | 64.73 |
2020-05-08 | PICHELLI ALDO | President and CEO | D - S-Sale | Common Stock | 3100 | 331.6781 |
2020-05-08 | PICHELLI ALDO | President and CEO | D - S-Sale | Common Stock | 1000 | 332.531 |
2020-05-08 | PICHELLI ALDO | President and CEO | D - S-Sale | Common Stock | 900 | 333.4394 |
2020-05-08 | PICHELLI ALDO | President and CEO | D - M-Exempt | Stock Option right-to-buy | 5000 | 64.73 |
2020-05-08 | MAIN SUE | Senior VP & CFO | A - M-Exempt | Common Stock | 8000 | 78.4 |
2020-05-08 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 1371 | 330.6519 |
2020-05-08 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 4816 | 331.426 |
2020-05-08 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 1404 | 332.3974 |
2020-05-08 | MAIN SUE | Senior VP & CFO | D - S-Sale | Common Stock | 409 | 333.4322 |
2020-05-08 | MAIN SUE | Senior VP & CFO | D - M-Exempt | Stock Option right-to-buy | 8000 | 78.4 |
2020-05-04 | MILLER PAUL DAVID | director | A - M-Exempt | Common Stock | 386 | 51.77 |
2020-05-04 | MILLER PAUL DAVID | director | A - M-Exempt | Common Stock | 4000 | 75.13 |
2020-05-04 | MILLER PAUL DAVID | director | D - S-Sale | Common Stock | 450 | 316.7941 |
2020-05-04 | MILLER PAUL DAVID | director | A - M-Exempt | Common Stock | 450 | 44.44 |
2020-05-04 | MILLER PAUL DAVID | director | D - S-Sale | Common Stock | 4000 | 316.1018 |
2020-05-04 | MILLER PAUL DAVID | director | D - S-Sale | Common Stock | 386 | 315.83 |
2020-05-04 | MILLER PAUL DAVID | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 450 | 44.44 |
2020-05-04 | MILLER PAUL DAVID | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 75.13 |
2020-05-04 | MILLER PAUL DAVID | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 386 | 51.77 |
2020-04-29 | MEHRABIAN ROBERT | Executive Chairman | A - M-Exempt | Common Stock | 15000 | 75.13 |
2020-04-29 | MEHRABIAN ROBERT | Executive Chairman | D - S-Sale | Common Stock | 1000 | 339.116 |
2020-04-29 | MEHRABIAN ROBERT | Executive Chairman | D - S-Sale | Common Stock | 14000 | 339.59 |
2020-04-29 | MEHRABIAN ROBERT | Executive Chairman | D - M-Exempt | Stock Option right-to-buy | 15000 | 75.13 |
2020-04-29 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - M-Exempt | Common Stock | 10000 | 94.24 |
2020-04-29 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - S-Sale | Common Stock | 10000 | 336.0354 |
2020-04-29 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | D - M-Exempt | Stock Option right-to-buy | 10000 | 94.24 |
2020-04-29 | VanWees Jason | Executive Vice President | A - M-Exempt | Common Stock | 6000 | 94.24 |
2020-04-29 | VanWees Jason | Executive Vice President | D - S-Sale | Common Stock | 6000 | 335.8235 |
2020-04-29 | VanWees Jason | Executive Vice President | D - M-Exempt | Stock Option right-to-buy | 6000 | 94.24 |
2020-04-29 | AUSTIN ROXANNE S | director | A - M-Exempt | Common Stock | 4000 | 49.51 |
2020-04-29 | AUSTIN ROXANNE S | director | D - S-Sale | Common Stock | 4000 | 330 |
2020-04-29 | AUSTIN ROXANNE S | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 49.51 |
2020-04-28 | CROCKER CHARLES | director | A - M-Exempt | Common Stock | 2000 | 49.51 |
2020-04-28 | CROCKER CHARLES | director | D - S-Sale | Common Stock | 2000 | 326.6105 |
2020-04-28 | CROCKER CHARLES | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 2000 | 49.51 |
2020-04-24 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 263 | 34.2 |
2020-04-24 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 288 | 31.24 |
2020-04-24 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 456 | 312.65 |
2020-04-24 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 306 | 29.43 |
2020-04-24 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 219 | 312.17 |
2020-04-24 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 219 | 27.42 |
2020-04-24 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 306 | 312.9432 |
2020-04-24 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 107 | 28.12 |
2020-04-24 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 349 | 25.79 |
2020-04-24 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 288 | 312.8641 |
2020-04-24 | DAHLBERG KENNETH C | director | D - S-Sale | Common Stock | 263 | 312.9162 |
2020-04-24 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 349 | 25.79 |
2020-04-24 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 107 | 28.12 |
2020-04-24 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 219 | 27.42 |
2020-04-24 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 306 | 29.43 |
2020-04-24 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 288 | 31.24 |
2020-04-24 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 263 | 34.2 |
2020-04-22 | VON SCHACK WESLEY W | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | SMITH MICHAEL T | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | Sherburne Jane Cecile | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | MILLER PAUL DAVID | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | Malone Robert A | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | LORNE SIMON M | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | DAHLBERG KENNETH C | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | CROCKER CHARLES | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | Cade Denise R | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-22 | AUSTIN ROXANNE S | director | A - A-Award | Common Stock | 353 | 0 |
2020-04-02 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 4000 | 43.32 |
2020-04-02 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 104 | 28.88 |
2020-04-02 | DAHLBERG KENNETH C | director | A - M-Exempt | Common Stock | 211 | 28.5 |
2020-04-02 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 211 | 28.5 |
2020-04-02 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 104 | 28.88 |
2020-04-02 | DAHLBERG KENNETH C | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 43.32 |
2020-03-18 | VanWees Jason | Executive Vice President | A - M-Exempt | Common Stock | 2000 | 94.24 |
2020-03-18 | VanWees Jason | Executive Vice President | D - M-Exempt | Stock Option right-to-buy | 2000 | 94.24 |
2020-02-27 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 349 | 25.79 |
2020-02-27 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 1570 | 25.46 |
2020-02-27 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 4000 | 43.32 |
2020-02-27 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 104 | 28.88 |
2020-02-27 | LORNE SIMON M | director | A - M-Exempt | Common Stock | 316 | 28.5 |
2020-02-27 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 104 | 28.88 |
2020-02-27 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 316 | 28.5 |
2020-02-27 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 4000 | 43.32 |
2020-02-27 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 1570 | 25.46 |
2020-02-27 | LORNE SIMON M | director | D - M-Exempt | Non-Employee Director Stock Option (right-to-buy) | 349 | 25.79 |
2020-01-24 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 105 | 364.98 |
2020-01-24 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 151 | 364.98 |
2020-01-24 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 287 | 364.98 |
2020-01-24 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 259 | 364.98 |
2020-01-24 | Roks Edwin | VP & Pres. Digital Imaging | A - A-Award | Common Stock | 156 | 364.98 |
2020-01-24 | VanWees Jason | Executive Vice President | A - A-Award | Common Stock | 567 | 364.98 |
2020-01-24 | PICHELLI ALDO | President and CEO | A - A-Award | Common Stock | 364 | 364.98 |
2020-01-24 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Common Stock | 784 | 364.98 |
2020-01-24 | Roks Edwin | VP & Pres. Digital Imaging | A - M-Exempt | Common Stock | 759 | 0 |
2020-01-24 | Roks Edwin | VP & Pres. Digital Imaging | D - M-Exempt | Restricted Stock Units | 759 | 0 |
2020-01-21 | Roks Edwin | VP & Pres. Digital Imaging | A - A-Award | Stock Option right-to-buy | 6751 | 383.33 |
2020-01-21 | Roks Edwin | VP & Pres. Digital Imaging | A - A-Award | Restricted Stock Units | 385 | 357.69 |
2020-01-21 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Common Stock | 308 | 357.69 |
2020-01-21 | Blackwood Stephen Finis | Senior VP & Treasurer | A - A-Award | Stock Option right-to-buy | 4646 | 383.33 |
2020-01-21 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Common Stock | 550 | 357.69 |
2020-01-21 | Cibik Melanie Susan | Sr.VP, GenCounsel, CCO & Sec. | A - A-Award | Stock Option right-to-buy | 6751 | 383.33 |
2020-01-21 | Bobb George C III | VP & President A&D Electronics | A - A-Award | Common Stock | 359 | 357.69 |
2020-01-21 | Bobb George C III | VP & President A&D Electronics | A - A-Award | Stock Option right-to-buy | 4878 | 383.33 |
2020-01-21 | MAIN SUE | Senior VP & CFO | A - A-Award | Common Stock | 603 | 357.69 |
2020-01-21 | MAIN SUE | Senior VP & CFO | A - A-Award | Stock Option right-to-buy | 6751 | 383.33 |
2020-01-21 | PICHELLI ALDO | President and CEO | A - A-Award | Common Stock | 2237 | 357.69 |
2020-01-21 | PICHELLI ALDO | President and CEO | A - A-Award | Stock Option right-to-buy | 7433 | 383.33 |
2020-01-21 | VanWees Jason | Executive Vice President | A - A-Award | Common Stock | 565 | 357.69 |
2020-01-21 | VanWees Jason | Executive Vice President | A - A-Award | Stock Option right-to-buy | 6751 | 383.33 |
2020-01-21 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Stock Option right-to-buy | 3601 | 383.33 |
2020-01-21 | Belak Cynthia Y | Vice President and Controller | A - A-Award | Common Stock | 298 | 357.69 |
2020-01-21 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Common Stock | 2516 | 357.69 |
2020-01-21 | MEHRABIAN ROBERT | Executive Chairman | A - A-Award | Stock Option right-to-buy | 8362 | 383.33 |
2019-12-20 | MEHRABIAN ROBERT | Executive Chairman | A - M-Exempt | Common Stock | 5348 | 0 |
2019-12-20 | MEHRABIAN ROBERT | Executive Chairman | D - F-InKind | Common Stock | 2651 | 342.28 |
2019-12-20 | MEHRABIAN ROBERT | Executive Chairman | A - M-Exempt | Restricted Stock Units | 5348 | 0 |
2019-12-10 | Bobb George C III | VP & President A&D Electronics | A - M-Exempt | Common Stock | 2000 | 94.24 |
2019-12-10 | Bobb George C III | VP & President A&D Electronics | D - S-Sale | Common Stock | 1880 | 344.5 |
2019-12-10 | Bobb George C III | VP & President A&D Electronics | D - S-Sale | Common Stock | 120 | 344.99 |
2019-12-10 | Bobb George C III | VP & President A&D Electronics | D - M-Exempt | Stock Option right-to-buy | 2000 | 94.24 |
2019-11-22 | Blackwood Stephen Finis | Senior VP & Treasurer | A - M-Exempt | Common Stock | 2500 | 78.4 |
2019-11-22 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 348.55 |
2019-11-22 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 349.75 |
2019-11-22 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 500 | 349.85 |
2019-11-22 | Blackwood Stephen Finis | Senior VP & Treasurer | D - M-Exempt | Stock Option right-to-buy | 2500 | 78.4 |
2019-11-19 | Blackwood Stephen Finis | Senior VP & Treasurer | A - M-Exempt | Common Stock | 5000 | 78.4 |
2019-11-19 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 346.1 |
2019-11-19 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 346.25 |
2019-11-19 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 347 |
2019-11-19 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 347.1 |
2019-11-19 | Blackwood Stephen Finis | Senior VP & Treasurer | D - S-Sale | Common Stock | 1000 | 347.2 |
2019-11-19 | Blackwood Stephen Finis | Senior VP & Treasurer | D - M-Exempt | Stock Option right-to-buy | 5000 | 78.4 |
Transcripts
Operator:
Ladies and gentlemen, thank you for standing by and welcome to Teledyne's Second Quarter Earnings Call. [Operator Instructions] And as a reminder, this conference call is being recorded. At this time, I'd like to turn the conference call over to your host, Jason VanWees. Please go ahead, sir.Jason VanWees:
Good morning, everyone. I'm Jason, VanWees, Vice Chairman. I'd like to welcome everyone to Teledyne's second quarter 2024 earnings release conference call. We released our earnings earlier this morning before the market opened. Joining me today are Teledyne's Executive Chairman, Robert Mehrabian; CEO, Edwin Roks; Senior Vice President and CFO, Steve Blackwood; and Melanie Cibik, EVP, General Counsel, Chief Compliance Officer and Secretary. President and COO, George Bobb would have joined us, but after getting stuck in airports late last week in the weekend, George came back with COVID and is being isolated. Anyway, after remarks by Robert, Edwin and Steve, we will ask your questions. However, before we get started, our attorneys have reminded me to tell you that all forward-looking statements made this morning are subject to various discussions with some caveats as noted in the earnings release and our periodic SEC filings. And of course, actual results may differ materially. In order to avoid potential selective disclosures, this call is simultaneously being webcast and a replay, both via webcast and dial-in will be available for about one month. Here is Robert.Robert Mehrabian:
Thank you, Jason, and good morning, and thank you for joining our earnings call. In the second quarter, Teledyne achieved all-time record free cash flow allowing us to deploy approximately $852 million through July on debt repayment, acquisitions and stock repurchases. Non-GAAP operating margin increased from last year and increased in each of our three largest segments. Total sales and earnings increased sequentially and exceeded our most recent expectations, although year-over-year comparisons remain especially difficult in certain commercial markets, such as industrial automation and electronic test and measurement. Nevertheless, strong defense-related sales at Teledyne FLIR and our own legacy space based infrared imaging business partially offset the expected declines in industrial imaging systems. Furthermore, despite the anticipated year-over-year decline in certain instrumentation product lines, total instrumentation sales were a second quarter record due to exceptional performance of our marine instrumentation businesses. Primarily driven by our aerospace and defense businesses, orders were greater than sales for the third consecutive quarter and we ended the period with record backlog. Therefore, we're reasonably confident that quarterly sales will again increase sequentially and with a return to year-over-year sales growth in the second half of 2024. Finally, even with the significant capital deployment in the second quarter, our quarter end leverage remained at 1.7 and we plan to continue stock repurchases in the balance of 2024 as well as pursue acquisitions. I would now turn the call to Edwin who will further comment on the performance of our four segments.Edwin Roks:
Thank you, Robert. This is Edwin and I will report on the - first report on the digital imaging segment, which represents 54% of Teledyne's portfolio. And like Teledyne as a whole, this segment is a mix of longer cycle businesses such as defense, space and healthcare combined with shorter cycle markets, including industrial automation, semiconductor inspection and infrared components and cameras for applications ranging from factory condition monitoring to maritime navigation. Second quarter 2024 sales declined 6.8% compared with last year. As expected, sales to industrial machine vision markets declined approximately 30% year-over-year. However, this was partially offset by increased sales from FLIR defense and from generalized space-based infrared imaging detectors. Furthermore, for the fourth consecutive quarter, healthy margins across the entire FLIR business portfolio helped us protect overall operating margin even given the significant year-over-year production in sales of our typically highest contribution margin product lines. I will now report on the other three segments, which represent the remaining 46% of Teledyne. The instrumentation segment consists of marine, environmental and test and measurement businesses which contributed a little over 24% of sales. For the total segment, overall second quarter sales increased 1.6% versus last year. Sales of marine instruments increased 60% in the quarter, primarily due to strong offshore energy and subsea defense. Sales of environmental instruments decreased 1.6% with greater sales of drugs discovery and laboratory instruments, offset by lower sales of processed gas, emission monitoring systems and gas flame safety analyzers. Sales of electronics and measurement systems which include oscilloscopes, digitizers and protocol analyzers decreased 50.8% year-over-year on a tough quarterly comparison versus 2023. Overall instrumentation segment operating profit increased in the second quarter with GAAP operating margins increasing on a 36 basis points to 26.1% and 134 basis points on a non-GAAP basis to 27.2%. In the Aerospace and Defense Electronics segment which represents 14% of Teledyne sales, second quarter sales increased 4.5% driven by the growth of commercial aerospace and defense microwave products. GAAP and non-GAAP segment operating profits increased year-over-year with segment margin increasing approximately 77 basis points. For the engineered system segment which contributes 8% to overall sales, second quarter revenue decreased 8.7% and operating profit was impacted by lower sales and unfavorable program mix. I will now pass the call back to Robert.Robert Mehrabian:
Thank you, Edwin. In conclusion, our second quarter performance was a testament to the strength of our balanced business portfolio. We also continued our proven strategy of increasing margin in those businesses which are growing while reasonably protecting margins in businesses with more challenging markets. Our current full year earnings outlook is identical to the last quarter with some markets such as industrial automation and electronic test and measurement remaining difficult, although year-over-year comparisons are easier in the second half while the outlook for our global defense, energy and aerospace businesses remain strong and is supported by our record backlog. Finally, we continue to review acquisition opportunities, but given the strength of our balance sheet and cash flow, we also plan to continue purchasing our own stock under our current $1.25 billion authorization. I will now turn the call over to Steve.Stephen Blackwood:
Thank you, Robert, and good morning. I will first discuss some additional financials for the quarter not covered by Robert and then I will discuss our third quarter and full year 2024 outlook. In the second quarter, cash flow from operating activities was $318.7 million compared with $190.5 million in 2023. Free cash flow that is cash from operating activities less capital expenditures was $301 million in the second quarter of 2024 compared with $163.2 million in 2023. Cash flow increased in the second quarter due to stronger working capital performance. Capital expenditures were $17.7 million in the second quarter of 2024 compared with $27.3 million in 2023. Depreciation and amortization expense was $77.8 million for the second quarter of 2024 compared with $80 million in 2023. We ended the quarter with approximately $2.35 billion of net debt that is approximately $2.8 billion of debt less cash of $443.2 million. Now, turning to our outlook. Management currently believes the GAAP earnings per share in the third quarter of 2024 will be in the range of $4.02 to $4.16 with non-GAAP earnings in the range of $4.90 to $5 and for the full year 2024, our GAAP earnings per share outlook is $15.87 to $16.13 and we are affirming our prior non-GAAP outlook of $19.25 to $19.45. I will now pass the call back to Robert.Robert Mehrabian:
We would like to take your questions. John, if you're ready to proceed with the questions and answers, please go ahead.Operator:
[Operator Instructions] Our first question is going to come from Jim Ricchiuti with Needham and Company. Please go ahead.Jim Ricchiuti:
Hi. Thank you. Good morning. I was hoping to get a little bit more color on the bookings, the book-to-bill. It sounds like the positive book-to-bill was largely driven by the aerospace and defense business, but I wonder if you could just elaborate on what you saw from an order standpoint in the quarter.Robert Mehrabian:
Thank you, Jim. First, you're correct in generally overall, but I think our overall book-to-bill was 1.07. It was -- digital imaging was close to 1, like 0.98. Instrumentation was just over 1 at 1.04. But as you said, aerospace and defense was very strong at 1.41 and engineered systems also strong at 1.25 resulting in a combined book-to-bill of 1.07 for the complete company.Jim Ricchiuti:
Got it. That's helpful, Robert. If we think about the backlog, but the longer cycle backlog and as it converts into the second half to revenue, is that mainly defense converting? I'm wondering what other areas of the longer cycle business might drive growth in the second half? And maybe related, what kind of expectations do you have for the short cycle business in the back half? Thank you.Robert Mehrabian:
Let me start with the first part. It's defense is obviously as you said very important and is the long cycle business that's doing really well. The second area is energy and that's our marine instruments businesses. They've done exceptionally well for the year and will continue to do so. And then the third area is aerospace. Both aerospace from the computers that we have on commercial aircraft through aerospace and the aerospace from our imaging sensor businesses. Now going back to the commercial shorter cycle businesses, what we're seeing is we think that digital imaging as a whole, total digital imaging should be relatively flat in the second half of the year. That's year-over-year flat, which is good because it declined in the first half of the year. Some of the recovery that we're seeing is early signs that come from our MEMS, microelectronic mechanical systems, which are kind of like the canaries in the mine. We are seeing some uptick in orders there, which is encouraging especially from semiconductor industry. And then we also have some indications that our machine vision systems as example have stabilized and book-to-bill has reached 1 or a little better, which is encouraging. We're hoping that these trends will continue with semiconductor coming back and inspection businesses that we have picking up and some of our high end thermal cameras also doing better than they have. So I think overall, we're positively inclined towards the second half of the year.Jim Ricchiuti:
Got it. That's helpful, Robert. Thank you.Robert Mehrabian:
Thank you, Jim.Operator:
Our next question comes from Andrew Buscaglia with BNP. Please go ahead.Andrew Buscaglia:
Hi, good morning, guys.Robert Mehrabian:
Good morning, Andrew.Andrew Buscaglia:
Yes. So long that line of questioning. Can you talk a little bit about your test to measurement has been a tough market, a little bit weaker in Q2, but in line I think with what you guys were suggesting. How do you see that playing out? Do you still feel like your expectations for down 10% for the year are valid?Robert Mehrabian:
Yes. About that. Not to be picky, but we have 9.9%, which is very close to your 10%. But that's also tailored to cities there. In our test and measurement as you know, Andrew, we have two businesses. One is the oscilloscope business and the other one is our protocol business, which are basically rules for communication between devices and devices on the cloud. That business, the protocol business is coming back faster and is doing better, a little bit better. It's the oscilloscope business which is lagging. Having said that, we took cost out in that business. And fortunately for us, we took the cost out very early and the margins of instruments have remained pretty well. We anticipate, for example, about almost 94 basis points improvement in our total instrument portfolio even with part of CNM being weak, partially because our marine is very strong and our environmental businesses are doing okay. So I don't know whether that answers your question fully or not.Andrew Buscaglia:
Yes. No, that's helpful. Maybe sticking with instrumentation. Yes, marine has been really strong. Presumably you have good visibility there. Can you parse out what's driving that exactly and the confidence that, that continues into the second half? How should we think about that for the full year?Robert Mehrabian:
Two areas. First is the offshore oil production and discovery. We have -- as you know, we have instruments that are deployed in streamers to look down at acoustic signals that bounce from the ocean floor and determine whether there's oil and gas there. That's a strong business and continues to be. The other part is, of course, our connector businesses. They are doing really well. Actually, we're almost at capacity in that business. And then the second part of the marine business is the defense part of the business. As you know, we have defense unmanned vehicles, underwater vehicles. We also provide connectors for submarines. That business is doing really well and our underwater vehicle businesses are doing really well. So it's a combination of offshore oil production and discovery and defense and security.Andrew Buscaglia:
Okay. Thank you.Robert Mehrabian:
For sure.Operator:
Next is Conor Walters with Jefferies. Go ahead, please.Conor Walters:
Hi, guys. Thanks so much for taking my questions. Just to start off, any updates of the free cash flow guidance for the year despite somewhat constrained top line in the first half? Free cash flow is tracking well ahead of your $1 billion target. What do you expect for the year and what are some of the drivers just given such a strong start in the first half?Robert Mehrabian:
That's a good question, Conor. I don't want to be effervescent about that because in the first two quarters, we've generated $576 million of free cash flow. I think in the second half, we have some bond payments coming due. We have some taxes coming due. So I think it's going to be less. We are hoping that our free cash flow would be above $900 million. That's where we're sitting right now with the front end being heavily loaded. But having said that, we're confident enough in our cash position to continue our purchases of our own stock.Conor Walters:
Okay, got it. That's very clear. And maybe just jumping over into defense a little bit. More. We've seen a lot of technology announcements for Teledyne, some new wins in areas such as loitering munitions. Just given this, how are you thinking about defense going forward? And any divergence within the exposure and A&D electronics and engineered versus where you are in digital imaging?Robert Mehrabian:
No. I think let's just look at the major programs that announcements that keep coming out. There's a whole slew of them. The most important one, I would say, that's new is our loitering unmanned aerial vehicle, which now is weaponized, what we call Rogue 1 and we already have our first order for over 100 systems for that and it competes very well against the competition, both in terms of precision, but also with the fact that you can send these vehicles to target. And if you decide to bring them back, you can do that easily. That's a distinguishing feature and of course, the other part is the accuracy. The next example as you may know is again staying with vehicles are very small mini drones. We saw the whole bunch of them over the years, what we call Black Hornet streets, which are about 6 inches in size. Black Hornet 4 was introduced this year and we got the first production order for about almost 1,000 systems recently. We expect that, that program will continue and be a very strong contributor to our defense businesses and these orders are from the U.S. government right now. Then we have -- as I mentioned, we have the inserts for the Virginia ore connectors for the Virginia and Colombia class submarines. Those businesses have really good backlogs and are doing well. We also have drones that come out of our Canadian operations, the R70 and R80. We have orders for those and we also have countered UAV systems that are being deployed in Europe. And finally, that's just an example. We have a very lightweight uncooled target recognition system, what we call the FWS family of weapons systems. We have the development order for it and we have the first production order for it. Those two combined over $70 million and expect about $500 million in IDIQ contracts. Those are just examples. I think our defense business especially FLIR defense has picked up the pace very well and we're very excited about that.Conor Walters:
Great. That's super helpful. I'll leave it there.Robert Mehrabian:
Thank you.Operator:
Next question is from Joe Giordano with TD Cowen. Please go ahead.Joe Giordano:
Hi. Good morning. Robert, you said you're seeing some stability in the machine vision business, which is good to hear. I think you mentioned it was down 30 year-on-year. What was that compared to 2Q and what's the expectation for, like, 3Q and 4Q. What was that versus 1Q and what's the expectation in 3Q, 4Q versus the second quarter?Robert Mehrabian:
Well, I think basically, they were down 30 in Q1 and Q2 as Edwin indicated. I think that's now going to be about 10 and 10 in Q3 and Q4. So for the year would be about 20. So it's going to improve, partially it's improving partially because comps are getting easier to be frank and very straightforward about it. That market began softening last year in Q3, so the comps are going to get easier. But also we're seeing as I indicated before, we're seeing some uptick in certain areas and as you know, semiconductor industry is coming back and coming back strong and our products are used in the inspection systems all over the world.Joe Giordano:
Just to be clear, like are the dollars for that business in 2Q higher than 1Q and will they be higher in like the second half dollars versus one half dollars?Robert Mehrabian:
I think our expectations right now are that they'd be relatively flat, maybe a little better in the second half. I don't want to be -- certainly, in Q4, we expect it to be stronger. But right now, we have to be very careful not to drink our own bath water because while things are looking well, good, we have both the vision systems, which are visual systems as well as our infrared systems. So we have -- we're looking at the combo there and I think flat would be a good word with Q4 picking up.Joe Giordano:
Okay. We're also hearing some people talk about like Boeing finally telling suppliers to cool off a little bit. I know that their production has gone down. But they've been still receiving components from suppliers at the same pace. And are you seeing any of that where they're pushing back a little bit?Robert Mehrabian:
We're not seeing that as much. There's some rotation going on there in our OEM products. But we're not only supplying OEMs, we're also the aftermarket business there is very important to us and we're doing okay there. I think overall, our aerospace business is pretty healthy.Joe Giordano:
Good. I'll get back in queue. Thanks, guys.Operator:
Next question is from Guy Hardwick with Freedom Capital Markets. Go ahead, please.Guy Hardwick:
Hi. Good morning.Robert Mehrabian:
Good morning, Guy.Guy Hardwick:
Going back to the free cash flow issue, what's your sense for when you look back on this year, where you would have deployed the free cash flow in terms of acquisition, share repurchases and debt repayments?Robert Mehrabian:
Well, Guy, we think because our free cash flow was so strong in the first two quarters and you have to also keep in mind our liabilities which is our debt, our debt is set up pretty well. It's fixed. It's -- only we will pay -- have to pay like $150 million in October time frame. Other than that, our payments start in 2026. And if you roll everything that we owe over the years, our interest payments are about 2.35%. Now for the year, we think that we will continue buying our stock, maybe, depends on the stock price, right? We bought back quite a bit in the first half of the year. We expect to continue to do that, but we're also looking at acquisitions at the same time. So we're balancing the two as we go forward right now because of our very serious efforts in 80/20 and ability to generate cash. We think that we're in a really good situation. We just renewed our line of credit for another five years. We haven't touched it. We have about $1.2 billion untouched. So with no debt payments, big ones coming due, our interest rates being 2.35% over the many years, we feel good that we can do whatever we want. Right now, focused on buying back stock and looking at the acquisitions as well.Guy Hardwick:
Okay. Thank you. And just so as a follow up, would you mind updating us on your margin expectations by segment or has nothing changed since the last quarter?Robert Mehrabian:
No. I can do it if you wish, I can do it for the full year. We think that for the full year in instruments as an example, it should be up about 90 to 100 basis points. It's pretty healthy for us. It'll go from what was last year at 26.6% to 27.5% plus. In digital imaging, we think that margins for the year may go down a little bit even though I mentioned the headwind that we have there. But if you look at the whole portfolio while margins went down in our DALSA 2B businesses, they went up significantly in our FLIR businesses. So we think they might go down modestly, maybe 30 basis points for the year, maybe 20. Aerospace and defense, I think we're doing really well, maybe over 100 basis points and engineered systems which is our smallest segment, I think margins are going to be going down primarily because of the first half. And overall, we think the segment margins should be about 14, 15 basis points up from last year considering all the headwinds that we have. That's pretty good.Guy Hardwick:
Okay. Thank you.Robert Mehrabian:
Thank you.Operator:
Next question is from Rob Jamieson with Vertical Research Partners. Go ahead, please.Rob Jamieson:
Hi. Thanks, guys. I guess, just real quick one clarification just with digital imaging. Should we -- in the next two quarters, 3Q, 4Q, is there much differential between the quarters on margin to kind of get to that down 20, 30 basis points?Robert Mehrabian:
Well, let me see if I can answer that well. I think in the first half if you look at Q1, the margins were about 21.8% overall in digital imaging. You look at Q2, they dropped about 20 basis points to 21.6%. We think in Q3, it will pick up to over 22%, 22.2% maybe and then go as high as 23% in Q4. So we should end the year at 22.2% even with a weak first half. So I think margins are going to keep improving both because of the cost action that Edwin and his people have taken, but also because some of the markets are coming back.Rob Jamieson:
Perfect. That's helpful. I was actually going to ask about that next. And look, I know this is a pretty small part of your business, but I just wanted to ask a little bit more on the oscilloscope within instrumentation and test and measurement. Just one of your competitors this morning cutting their outlook on delayed R&D spend and government and China related spend. Just curious if there's anything in the end markets that you're seeing within test and measurement on the oscilloscope side that's maybe weaker or starting to improve more or is it just all kind of a little bit soft and lagging the protocols business? Any additional color there would be great.Robert Mehrabian:
Yes. I think you've explained it very well. I think people are hesitant to spend discretionary CapEx. So in the high end oscilloscope where you make really good money is slowed down. We expect the whole business to be down about 10% year-over-year. But having said that, as with many other years, we were probably the first one out of the box early in the year in April to warn. And subsequently, you see everybody else, of course, having to do the same. The advantage that we had in doing that was that knowing that the market was going to soften, we took cost out late in Q4 and early in Q1. And as a consequence, the margins in that business have been exceptionally healthy.Rob Jamieson:
Absolutely. No, thank you for that. I appreciate you all taking my questions.Robert Mehrabian:
Of course. Thank you.Operator:
We have one more in queue. [Operator Instructions] We're going now to Jordan Lyonnais from Bank of America. Go ahead, please.Jordan Lyonnais:
Good morning and thanks for taking the question. How should we think about if the U.S. puts more restrictions on to ASML and Tokyo electron, what would that impact be for the digital imaging segment?Robert Mehrabian:
I don't see that impacting as much. We supply product to their customers. I don't want to mention the name, but this is a large customer and this is a U.S. customer and they use ASML equipment, which uses a critical part that we make in our MEMS factories. We don't expect to see a change in that because we're frankly supplying the customers of ASML and it's not a huge business, maybe $20 million, $25 million business, but very profitable.Jordan Lyonnais:
Got it. Thank you.Robert Mehrabian:
For sure.Operator:
At this time, we have no additional callers in queue.Robert Mehrabian:
Thank you very much, John. I'll now ask Jason to conclude the conference call.Jason VanWees:
Thanks, Robert, and thanks, everyone, for joining us this morning. If you have follow-up questions, of course, feel free to email me or call me on the number on the earnings release. All our earnings releases are available on our website as this is webcast. And John, if you could conclude the call and give the replay information, it'd be much appreciated. Thank you.Operator:
Absolutely, ladies and gentlemen. A recorded replay of this conference call be available from today at 10:00 a.m. Pacific through August 24 of this year 2024 at midnight. To access the replay from domestic areas call 866-207-1041. Enter the access code 562-3764. International callers use 402-970-0847 and the same access code, 562-3764. Once again replay available from 10:00 a.m. Pacific today through August 24. Domestic callers use 866-207-1041. International callers use 402-970-0847 and the access code for either is 562-3764. That does conclude your conference call for today. We do thank you for your participation and for using AT&T Event Conferencing. You may now disconnect.Operator:
Ladies and gentlemen, thank you for standing by, and welcome to the Teledyne Q1 2024 Earnings Call. [Operator Instructions] And as a reminder, this conference call is being recorded.Jason VanWees:
All right. Thank you, and good morning, everyone. This is Jason VanWees, Vice Chairman. I'd like to welcome everyone to Teledyne's First Quarter 2024 Earnings Release Conference Call. We released our earnings earlier this morning before the market opening. Joining me today are Teledyne's Executive Chairman, Robert Mehrabian; CEO, Edwin Roks; President and COO, George Bobb; SVP and CFO, Stephen Blackwood; and Melanie Cibik, EVP General Counsel, Chief Compliance Officer and Secretary.Robert Mehrabian:
Thank you, Jason. Good morning, everyone, and thank you for joining our earnings call. Today, we reported record first quarter non-GAAP operating margin, record adjusted earnings per share and record free cash flow. While overall orders remained strong, sales were impacted by deterioration in some of our short cycle imaging and instrumentation market. We have previously assumed no full year sales growth in industrial automation as well as test and measurement market. However, those markets weakened more than planned in the first quarter, and we now forecast full year sales in those product families to decline meaningfully in 2024.Edwin Roks:
Thank you, Robert. This is Edwin, and I will report on the Digital Imaging segment, which represents 55% of Teledyne's portfolio. And like Teledyne as a whole, this segment is a mix of local cycle businesses, such as defense, space and healthcare, combined with shorter cycle markets, including industrial automation, semiconductor inspection and infrared components and cameras for applications ranging from factory condition monitoring to maritime navigation.George Bobb:
Thanks, Edwin. The instrumentation segment consists of our marine, environmental and test and measurement businesses, which contributed a little over 24% of sales. So the total segment, overall first quarter sales decreased 0.9% versus last year. Sales of marine instruments increased 15.3% in the quarter, primarily due to both strong offshore energy and subsea defense sales. Sales of environmental instruments decreased 5.8% with greater sales of processed gas emission monitoring systems. In gas and flame safety analyzers, more than offset by lower sales of drug discovery and laboratory [indiscernible].Robert Mehrabian:
Thanks, George. In conclusion, orders have been strong for two consecutive quarters with the increase almost entirely due to our longer cycle businesses such as defense and energy. However, given the nature of these businesses, converting much of the greater backlog to sales will not begin until the second half of 2024. At the same time, the pace of orders in our short-cycle instrumentation and imaging businesses did have a near-term sales impact in the first quarter and likely will continue to impact total sales in the second quarter of 2024.Stephen Blackwood:
Robert, and good morning. I'll first discuss some additional financials for the quarter not covered by Robert, and then I will discuss our second quarter and full year 2024 outlook. In the first quarter, cash flow from operating activities was $291 million compared with $203 million in 2023. Free cash flow, that is cash from operating activities less capital expenditures was $275.1 million in the first quarter 2024 compared with $178.6 million in 2023.Robert Mehrabian:
We would now like to take your questions. Operator, if you're ready to proceed with the questions and answers, please go ahead.Operator:
[Operator Instructions]James Ricchiuti:
First question, just given the weakness that you're seeing in some of the higher-margin areas of the short-cycle business. I wonder how you're thinking about gross margins over the next couple of quarters.Robert Mehrabian:
In terms of the gross margin, we're looking at relatively flat gross margins of somewhere around 43%. Yes.James Ricchiuti:
All right. Robert, with the shift in and capital allocation. I'm wondering what does this really imply just in terms of the M&A pipeline? Are you still seeing more opportunities for the smaller deals as opposed to the larger M&A. Is that a fair way to characterize the environment right now?Robert Mehrabian:
Jim, kind of, but let me just start with some numbers that are significant. Our debt-to-EBITDA is at 1.7x now. We have one acquisition in the pipeline. Once we make that, we would spend up over $300 million since we bought FLIR in acquisitions. If we don't do anything else, by the end of the year, our debt-to-EBITDA ratio would be closer to 1.3x where it is at 1.7x today. So we think that it's an appropriate time, first, to look at our stock and repurchase some shares because since we bought FLIR, our shares have increased by almost 700,000 shares because of option exercises and restricted stock awards.James Ricchiuti:
It helps. I mean, in the past, it was more recently, you've talked about valuations still being a bit on the risk side, do you see -- as you look at the pipeline for some of the larger M&A, have you seen any change in terms of the prices out there that it's going to take to do some of these larger deals?Robert Mehrabian:
Not yet. On the other hand, I have to tell you, Jim, they haven't done come out with their earnings. And in this market, kind of a bifurcated market, I expect that some of those will come down, and there will be -- just like it did before. Interestingly, enough history does repeat itself. It doesn't repeat itself on the time scale that we always expect, but repeat it.Operator:
Our next question is going to come from Greg Konrad with Jefferies.Greg Konrad:
This is a bit of an unusual question, but one I've been getting from investors and in light of the uncharacteristic guidance cut, which there hasn't really been many over the past 20 years. Is Teledyne different today than what has made it so successful thinking back over the past 20 years? Or what's really changed just given some of these uncharacteristic items? Or is this just you think about it as part of the normal cycle?Robert Mehrabian:
Well, two things. First, in the 25 years or so -- we've only had this occasion in 4 earnings call -- So almost 100 earnings calls and releases. We've experienced this 4x, 4%. So it's not something that happens very frequently. The flip side of it is that the economy and the markets are not quite predictable. Some parts of the economy are doing well. Like our marine businesses are devising the ball out of the park.Greg Konrad:
And then -- I appreciate that. And maybe just kind of a follow-up to that. I mean, just thinking back to what Teledyne did out of the oil and gas downturn and there was the sequester before that and impacted Defense. I mean if I remember back, I mean you took pretty aggressive actions, and we saw with margins and growth out of those two downturns. I mean is there similar actions that you're undertaking on the short cycle side, does that offer opportunity maybe to examine the margins where you have an even better kind of trajectory coming out of market recovery?Robert Mehrabian:
Yes. First, if you look at the FLIR businesses, year-over-year, the margins are up almost 200 basis points year-over-year. And the reason that happened is very simple. We took about $52 million worth of cost out last year, and we're taking additional $10 million to $15 million cost of this year early on. So that is affecting the margin. If you look at the DALSA e2v, which is our traditional businesses, our estimates are that by the end of second quarter, we have taken another $40 million out of that, altogether, we're talking about almost $100 million in cost.Operator:
Our next question comes from Joe Giordano with TD Cowen.Joseph Giordano:
Maybe I'll start on [indiscernible] as well. Just curious on the timing of this, right? Because if you look at some of the pure players within vision they had huge declines last year and you guys did okay relative to them last year. And now this year, it seems like we may yet to report largely, but it sounds like they're going to be sequentially improving offload levels starting right now. And it seems like now is when you guys are starting to see declines. So I'm just curious your thoughts on that timing mismatch is because it's pretty short cycle stuff.Robert Mehrabian:
It is. We know a couple of businesses that took a pretty good hit, but their quarters are kind of a little different and the yields are a little different from ours. They took a pretty big hit and lower their numbers significantly. So now they're coming up from the bottom, slightly better. We didn't take a hit because we didn't have short-cycle declines of the magnitude. So we anticipated it would happen, but it happened fast. And we took the cost off.Joseph Giordano:
And then just a follow-up on the question earlier about is Teledyne different today. I think what you guys have been known for so long is being very good estimators of your own businesses with high precision. And when you think about all the M&A companies you've done, does that become just inherently more challenging today versus a decade ago just because you have so many more businesses. And is there maybe -- does there need to be a tinkering of the process with how you communicate upwards from the businesses towards management to fine-tune the budgeting process in light of some of these being caught off guard here?Robert Mehrabian:
Well, I mean you're right in one respect. And I'll kind of paraphrase, but it is that the estimating the short cycle businesses actually always been inherently challenging. The flip side is the part that you mentioned, we have a lot of businesses, et cetera. That part is actually a help to us rather than a hindrance because it opens up the platform from which you can make acquisitions. And that is true and it will remain true. So we will accelerate that. The only we don't want to do is make stupid acquisitions with very high prices that are not going to be accretive. But the acquisitions we will do -- we had a larger platform to do that with.Operator:
Our next question comes from Andrew Buscaglia with BNP.Andrew Buscaglia:
So I wanted to get a sense of how much this guidance is really derisked. Maybe number one, are you assuming buybacks in the guidance. And then secondly, why should we have confidence given the low visibility that there's not another step down here in some of the shorter-cycle areas?Robert Mehrabian:
A very good question, Andrew. First, No. The buybacks are not built into the numbers primarily because we buy back, it's really going to affect next year's EPS not this year's. So that's fairly neutral for this year, depending on, of course, how much we bought. So I would put that aside. The second part of the question, we've struggled with that mildly over the last 10 days and with our Board in the last 2 days, trying to decide how conservative we should be or how aggressive we should be. We've ended up being somewhere in between the two.Andrew Buscaglia:
Yes. Okay. Okay. Just -- I think some investors are also somewhat confused by the small portion of the sales, it seems like a small portion of digital imaging is driving sort of the profound declines. Can you kind of walk through within digital imaging. We know machine vision is weak, but that's probably only low double digits as a percentage of that segment. Can you walk through the other items beyond just machine vision and tell us how much that is as a percentage of that segment sales. So that we could [indiscernible] around what's affecting the overall decline?Robert Mehrabian:
Sure. First, let's start with the machine vision specifically. Approximately $600 million in 2023. We projecting a decline of about $120 million of debt. So -- the reason it's affecting other things is that the highest margin businesses that we have in digital imaging. And overall, there are -- when you put the two parts together, which is DALSA e2v, [indiscernible] and FLIR, our total revenue there is going to be down about by year-end, about 1.5%. So it's not a big number, right? 1.5% but that's 1.5% with something like over $2.1 billion. So It's meaningful only because the top line $2.1 billion is significant. And it's our highest margin business. By year-end, we're projecting that basically, the declines would be 1.5% overall. With FlIR up and DALSA e2v down because of that. I don't know if that answers your question. The numbers when you look at them look large, but in retrospect, it's not huge, it's 1.5% of the total.Andrew Buscaglia:
Yes. Okay. And beyond machine vision or what other areas or short cycle that are out of favor?Robert Mehrabian:
Well, the only other one that I would say is out of favor. I wouldn't call it out of favor. I would say it's decline. It's test and measurement. Test and measurement is the oscilloscopes and protocol solutions that we have. Last year, we had $340 million of revenue there. We expect right now that in January, we thought it remained flat. Now we expecting it to go down about 10%. So that's $30 million in revenue.Operator:
[Operator Instructions]Unknown Analyst:
This is Gaby on for Kristine. So I was just wondering if you can provide some -- a little bit of color if you've been seeing improvements in the supply chain and your expectations for the supply chain going forward and how that's going to impact throughout the year?Robert Mehrabian:
Thank you very much. Great question. The supply chain improved in 2023 significantly versus 2022. It has improved further this year. Just to give you exact number, we -- when we buy from brokers, we pay higher percentages of price. Last year in the first quarter, we bought about $10 billion for electronic buyers broker. This year, first quarter, we only bought a little over $2 million. So I think there's been significant improvement.Operator:
Our next question is going to come from Noah Poponak from Goldman Sachs.Noah Poponak:
Robert, you have the second quarter revenue to be about flat from the first the year-over-year rate of decline would need to accelerate. Is that right? Is that what you're anticipating?Robert Mehrabian:
Right now, we're anticipating that it will be flat only because -- the answer is yes, only because we don't think our -- where we have really good backlog, it's got to kick in until the third quarter. The decline about, 4.5% from last year year-over-year in second quarter, yes.Noah Poponak:
Okay. Yes. And then I guess that would imply kind of mid-single-digit organic revenue growth year-over-year in the back half. I was going to ask -- you just alluded to it, but I was going to ask how much of that is kind of purely visibility from longer cycle things in the backlog versus what's the assumption embedded in that on the short cycle side?Robert Mehrabian:
I think primarily, it's what we have in the long cycle, the majority of that recovery is in what we have in our back maybe 3.5% to 4% improvement in revenue in the second half. There is a little bit of positivity in some of our short type of businesses only because our larger customers or platforms on which we serve like semiconductors. The data shows that it's better than it was last year and improving its up. So we have a little of that in mind. That -- so I think that's there but we're not counting on industrial automation, other things to improve significantly because frankly, we have no visibility.Noah Poponak:
Okay. What are the pieces of the Engineered Systems margin in the quarter? Is there -- I assume there's some kind of cumulative catch-up adjustment mark-to-market write-down in that?Robert Mehrabian:
Yes. What happens in that business is that, as you well know, we're obligated to do [indiscernible] accounting. As you estimate your cost and completion timing. When went back and looked pretty hard, we saw that some of the costs were higher than we had anticipated.Noah Poponak:
Do you know the size of in front of you guys there on how much of a markdown you took in the quarter?Robert Mehrabian:
Well, we took in Q1, we took about a $7 million EBIT hit, which was basically $0.10 to $0.11. So if that happened, we would have made our earnings.Noah Poponak:
Okay.Robert Mehrabian:
Despite the downturn in a short cycle imaging. We'll fix that.Noah Poponak:
Got it. That's helpful. That's helpful. Last one, I guess, given how much you've now delevered balance sheet, net debt-to-EBITDA post FLIR integration. You're still going to have pretty healthy free cash flow despite tweaks you're making here today. If you're coming out with a share repurchase, I guess the number you're talking about is kind of small relative to your forward annual free cash flow generation, how much balance sheet firepower you have if you were to take leverage a little higher, a little bit of like if you're going to layup, layup type of thing.Robert Mehrabian:
Well, two ways. First, we'll put out the case about our authorization. And if you look at that, we have authorization to go from what we said was $200 million to $250 million to $300 million. We can go up to $1.25 billion in buybacks.Operator:
And at this time, there are no additional questions in queue.Robert Mehrabian:
Thank you very much. We would like now to conclude the conference operator, I will now ask Jason to do so.Jason VanWees:
Thank you, John, and thanks, everyone, for joining the earnings call this morning. Again, all the earnings release are on our website. The reply is available. And for those on the call, please feel free to [indiscernible] talk further. So thank you, everyone.Operator:
As we mentioned, this conference has been recorded for replay, which will be available for one month starting at 10:00 a.m. Pacific Time today and ending May 24, 2024 midnight. To access and listen to the replay at any time, you can call (866) 207-1041 and use access code 832-7266 International callers, you can use the number (402) 970-0847 and again, for domestic, that is (866) 207-1041 and international (402) 970-0847 and the access code to use is 832-7266. And that does conclude your conference call for today. We do thank you for your participation and for using AT&T Event Conferencing. You may now disconnect.Operator:
Ladies and gentlemen, good morning, thank you for standing by. Welcome to the Teledyne Fourth Quarter Earnings Call. [Operator Instructions]. As a reminder, today's conference is being recorded. At this time, it's my pleasure to turn the conference over to our host, Mr. Jason VanWees. Please go ahead.Jason VanWees :
Thanks, Tom, and thanks, everyone. This is Jason VanWees, Vice Chairman. I would like to welcome everyone to Teledyne's Fourth Quarter and full year 2013 (sic) [2023] earnings release conference call. We released our earnings earlier this morning. Joining me today are Teledyne's Executive Chairman, Robert Mehrabian and our new but familiar management team, CEO, Edwin Roks, President and COO, George Bobb, Senior Vice President and CFO, Steve Blackwood, and also Melanie Cibik, EVP and General Counsel, Chief Compliance Officer and Secretary. After remarks by Robert, Edwin, George and Steve, we will ask for your questions. Of course, so before we get started, Tony's have reminded me to tell you that all forward-looking statements made this morning are subject to various assumptions, risks and caveats as noted in the earnings release and our periodic SEC filings. And of course, actual results may differ materially. In order to avoid potential selective disclosures, this call is simultaneously being webcast and a replay, both via webcast and dial-in, will be available for approximately 1 month. Here is Robert.Robert Mehrabian :
Thank you, Jason, and good morning, and thank you for joining our earnings call. In the fourth quarter, we achieved all-time record sales and GAAP and non-GAAP earnings per share. Sales increased primarily due to the performance of our Marine medical and aerospace businesses, which were more than able to compensate for the previously announced headwind in the industrial automation and laboratory instrumentation market. Furthermore, Overall, record orders exceeded sales in every business segment but were particularly strong in our Marine and Defense businesses. Leverage declined further to 1.9% and our balance sheet remains healthy. Finally, we continue to acquire complementary businesses, as shown by the acquisition of Zeno Networks in the fourth quarter. Compared with last year, fourth quarter and full year non-GAAP operating margin increased 27 and 57 basis points, respectively. Our broad-based strength in orders was encouraging, especially in the uncertain global macro environment today. Nevertheless, it's worth noting that most of the increase in orders was in our backlog-driven longer-cycle businesses. So converting the orders to sales will take a little time. In terms of 2024 outlook, we, therefore, think the quarterly sales and earnings ramp will be a bit greater than in recent years. So while we see annual 2024 sales growth of about 4%, we believe that typically seasonally low first quarter will be slightly under $1.4 billion or roughly flat with last year. I will now turn the call over to Edwin and George, who will further comment on the performance of our 4 business segments.Edwin Roks :
Thank you, Robert. This is Edwin and I will report on the Digital Imaging segment, which is 56% of Teledyne's portfolio. And like Teledyne as a whole, this segment is a mix of longer-cycle businesses such as defense, space and health care, combined with shorter cycle markets, including industrial automation, semiconductor inspection and infrared components and cameras for application ranging from factory condition monitoring and maritime navigation. Fourth quarter 2023 sales was slightly lower compared to last year. Double-digit sales growth in each of X-ray products, FLIR surveillance systems and space-based infrared imaging detectors offset a significant year-over-year decline in sales of industrial imaging systems and Micro Electro Mechanical Systems, or MEMS. Fourth quarter sales of unmanned systems were at the greatest level in 2023 and but declined year-over-year due to a tough comparison. For the second quarter in a row, the FLIR business collective fleet were positive contributors to overall segment margin. In addition, FLIR quarterly sales increased year-over-year and were at the highest level in the last 2 years. George will now report on the other 3 segments, which will represent the remaining 44% of Teledyne.George Bobb :
Thanks, Evan. The instrumentation segment consists of our Marine, test and measurement and environmental businesses, which contributed a little over 23% of sales. For the total segment, overall fourth quarter sales increased 2.8% versus last year. Sales of marine instruments increased 14.7% in the quarter, primarily due to strong offshore energy sales, but also continued growth in global defense and ocean science markets. Sales of electronic test and measurement systems, which include oscilloscopes, digitizers and protocol analyzers were flat year-over-year. We continue to see some softness in sales of analyzers for electronic storage and data center applications. But this was largely offset by continued strong sales of oscilloscopes and a small amount of incremental sales from the Zeno acquisition. Sales of environmental instruments decreased 7.3% and with greater sales of air quality and gas and flame safety analyzers more than offset by lower sales of drug discovery and laboratory instruments. Overall, Instrumentation segment operating profit increased over 14% in the fourth quarter, with GAAP operating margin increasing 284 basis points to 27.1%, and 278 basis points on a non-GAAP basis to 28.1%, both all-time records for the segments. In the Aerospace and Defense Electronics segment, which represents 13% of Teledyne sales, Fourth quarter sales increased 3.4%, primarily driven by growth of commercial aerospace products. GAAP and non-GAAP segment operating profit decreased approximately 5% year-over-year primarily due to a tough comparison with last year's all-time record segment margin. For the Engineered Systems segment, which contributes 8% to overall sales, fourth quarter revenue decreased 3.8%. But operating profit increased with margin up 325 basis points. I will now pass the call back to Robert.Robert Mehrabian :
Thank you, George. In conclusion, we were pleased with our record performance in 2023. In the near term, we will continue to focus on growth in those businesses with favorable markets while cutting costs and protecting margins in businesses which are more challenged. And at the same time, we'll be acquiring and integrating complementary businesses. When certain markets like laboratory instrumentation, industrial automation or electronic test measurement recover, we will keep our cost structure in check and benefit handsomely. But if there are global or macroeconomic shocks in 2024, we will do what we've done in the past, execute well, generate record cash flow and complete some of our base and potentially larger acquisitions. I will now turn the call over to Steve.Steve Blackwood :
Thank you, Robert, and good morning. I will first discuss some additional financials for the quarter not covered by Robert, and then I will discuss our first quarter and full year 2024 outlook. In the fourth quarter, cash flow from operating activities was $164.4 million compared with $237.7 million in 2022. Free cash flow, that is cash from operating activities less capital expenditures was $124.2 million in the fourth quarter of 2023 compared with $203.6 million in 2022. Cash flow declined in the fourth quarter since we made $139 million of additional tax payments, which we were allowed to defer from the second and third quarter of 2023, due to IRS disaster relief. Without these catch-up tax payments, quarterly cash flow have been at an all-time record. Capital expenditures were $40.2 million in the fourth quarter of 2023 and compared with $34.1 million in 2022. Depreciation and amortization expense was $77.4 million for the fourth quarter of 2023, compared with $81.8 million in 2022. We ended the quarter with approximately $2.60 billion of net debt. That is approximately $3.24 billion of debt less cash of $48.3 million. Now turning to our outlook. Management currently believes that GAAP earnings per share in the first quarter of 2024 and will be in the range of $3.73 to $3.86 with non-GAAP earnings in the range of $4.55 to $4.65 per share. And for the full year of 2024, our GAAP earnings per share outlook is $17.15 to $17.53. And on a non-GAAP basis, $20.35 to $20.68. The 2024 full year estimated tax rate, excluding discrete items, is expected to be 22.5%. I will now pass the call back to Robert.Robert Mehrabian :
Thank you, Steve. We would now like to take your questions. Tom, if you're ready to proceed with the questions and answers, please go ahead.Operator:
[Operator Instructions] We'll begin today with a question from Jim Ricchiuti representing Needham & Company.Jim Ricchiuti:
I wanted to see if we could dig a little bit more into the way you see the year unfolding, it sounds like Q1 a little bit more seasonality. And I guess, with respect to the full year guidance, as you think about the balance of the year, are you making some assumptions of recovery in the shorter cycle business in the latter part of the year, particularly some of the areas that have been weaker, like the lab instrumentation and the industrial automation, machine vision area.Robert Mehrabian :
Alright. Yes. We're right now expecting uptick in those businesses in the second half of the year. We think that what will happen is that we will have a linear ramp in sales and earnings throughout the year with about average revenue increase of about 4% and earnings as we've outlined up to $20.68, which would reflect also an improvement in margin from this year to next year of another almost 50 to 60 basis points. So yes, we're anticipating that. On the other hand, we're also adjusting our cost structure and if necessary, we'll do more. So that our earnings remain healthy.Jim Ricchiuti:
With respect to the margin improvement that you're anticipating I'm wondering how should we think about margins by some of the major business units just directionally?Robert Mehrabian :
Sure. Jim, we are expecting margin improvement in every segment. A little lower in instruments, maybe 25 basis points. We already have very healthy margins there. On the other hand, in Digital Imaging, about 80 basis points. In Aerospace and Defense, we think we'll have 80 to 90 basis points. And engineered systems around 50 basis points. So overall, Jim, in the segment, we anticipate about 70 basis points margin improvement. And overall, for the company between 50 and 60 basis points. In a way, it's kind of similar to what we achieved this year. Which was about 60 basis points over last year.Operator:
Next, we'll go to the line of Greg Konrad with Jefferies.Greg Konrad:
Maybe just to follow up with the last question, but on the revenue side, given the commentary around book to bail, 4% growth for the year. Can you maybe talk about the assumptions between long and short cycle or from a segment basis for growth in 2024?Robert Mehrabian :
Yes, Greg, let me give you the segment first. And then I'll try and answer the first question. From a segment perspective, with the instrumentation, would grow about 3.5% this year over last year. We think Digital Imaging will -- going back to instrumentation, there's a difference between the different businesses that we have. The marine businesses with healthy background backlog, as George mentioned, would grow about 6% to 6.5%, whereas environmental would be just under 3%, and we're expecting T&M to basically hold. Going to Digital Imaging. We believe that the overall sales increase would be above 4%. Aerospace and Defense, about 5%. Engineered Systems, about 4%. And when you add all of that up, we expect an average of about 4% at this time.Greg Konrad:
And then maybe if we can just dig into digital imaging a little bit more. I mean the commentary and the release around product lines on the call was helpful. But is there any way just for Q4 in 2023 to kind of level set or put some numbers behind growth in space in health care versus maybe the declines you've seen in other parts of the portfolio?Robert Mehrabian :
Sure. Let me start with Q4, please, and then I'll go to some of the others. In health care, we had really nice Q4. Revenue increased about 13.5% to 14%. In Aerospace and Defense, it increased about 5%. This offset basically weakness in our industrial and scientific vision systems. The flip side, if you go over to our FLIR businesses, we have really robust growth in our surveillance system, about 16.5%, and some of our detection products Overall, in Q4, FLIR revenue defense increased about 4.8%. Now going forward, to the future. I'll make a little distinction between DALSA e2v and FLIR. We think that DALSA e2v would have a modest growth of about 3%, offset by about 4.5% in FLIR. As mentioned earlier, clear defense especially, is experiencing really good order intake -- and we expect the growth there to exceed that of the rest of the imaging. So I can give you more detail, but that's basically a summary of it.Operator:
We'll go to the line of Ron Epstein with Bank of America.Unidentified Analyst:
This is Jordan Lines on for Ron. I wanted to ask, so for the backlog growth in the defense wins that you guys are seeing, how are you guys thinking about the risk of the CR?Robert Mehrabian :
Well, Sure. Obviously, CR is always an unpleasant occurrence for us. The way we're looking at it is we're only right now considering the orders that we have in house. We're not really looking at future orders. So book-to-bill has been healthy. These are longer-term programs. And frankly, we have some exciting new products coming out, which are being now tested. For example, if you look at our Black Hornet, we -- Black Hornet 3, which is our nano drones. Black Hornet 3 had a really good run over the past 5, 6 years. We've introduced a Black Hornet 4, which is already getting traction. We also have some really nice programs in space development agency, tranche true tracking layer as well as our international sales in that domain are healthy. So in some ways, while CR would be not a pleasant thing to experience. We've done it in the past. We've had CRs in many years. Right now, we're looking at what we have in our backlog, which is healthy.Unidentified Analyst:
Got it. And then on the Unmanned Systems – Air systems that you guys cited as being lower for DI. Is that related to just sunsetting programs? Or what was driving that change?Robert Mehrabian :
I think basically, it’s tough comps rather than real declines. We think our drone businesses are healthy. We also have some businesses that our anti-drone or flame detection systems, which we’re selling in Europe, which are very healthy. So I think it’s just a matter of tough comps. Other than that, we feel very good about our drone businesses.Operator:
A question from the line of Joe Giordano with TD.Joe Giordano:
Close enough there. How are you doing?Robert Mehrabian :
Good, Joe. Good.Joe Giordano:
Can you -- I'll start on free cash flow. I think that at the end of the day, that probably came in a little lighter than you thought for the full year. Can you talk about how you think '24 shapes up and how working capital looks for the year?Robert Mehrabian :
Yes, you're right. It came in a little lighter, but we made some really good progress in the third quarter, and especially in the fourth quarter, from our managed working capital perspective, we had some significant improvement in our -- trying to reduce our inventory. The flip side is, we also did not -- we're always like most companies suffering from not being able to get cash for our R&D. So I'd say but that affected us maybe $75 million or $60 million to $75 million. Our cash, nevertheless, if you looked at it, we paid down $680 million of debt in 2023. Our debt-to-EBITDA ratio -- net debt-to-EBITDA ratio is about 1.9. So let me fast forward to 2024. We believe we'll do a little better in 2024 than we did in 2023. We'd like to think that we would have a 100% conversion, recognizing that there is always going to be this R&D headwind. Even though everybody in the Congress has agreed that the R&D program should be passed. I think nothing is passing in this Congress. So we're not -- we're assuming we don't get that. Nevertheless, we think will be somewhere between $900 million, $925 million and $1 billion. If we hit those numbers, which we think we will then our debt-to-EBITDA ratio should go down from 1.9 to closer to 1.1 to 1.2, which is -- which puts us in a really good position to be able to make both small and midsized acquisition.Joe Giordano:
That's really helpful color. My last one, we've kind of talked about the a lot, but I just want to -- maybe if you can frame for the full year of '23, like how much down was like the industrial and scientific vision? And what did that do to margins? And then how did FLIR margins for the full year look year-on-year?Robert Mehrabian :
Okay. Let me just pick the first part. Industrial and scientific vision, I'm going to say we're down about 2% year-over-year, larger declines in Q4 than that. In terms of the margins, FLIR margins actually improved significantly year-over-year. It went from 20.3% in 2022 to 22.1% in 2023, which was very healthy. As a consequence, we were able to hold the overall margins in Digital Imaging relatively flat.Joe Giordano:
And you'd expect FLIR to expand margins again in '24, correct? Just inherent in that margin commentary?Robert Mehrabian :
Yes. We think FLIR would have some margin expansion. But if you look at it as a whole segment that is our Digital Imaging segment, we expect margins to increase somewhere between 50 and 100 basis points in 2024.Operator:
Next, let's go to the line of Kristine Liwag representing Morgan Stanley.Kristine Liwag:
Robert, last year, you talked about some facility consolidation at Digital Imaging. And you're also talking about 80 basis points in margin expansion this year for the segment. How much of that is from this consolidation from before on the floor integration? And how much of that is on better price cost? And ultimately, could we expect to see higher margins there if you have additional cost takeout you could do this year?Robert Mehrabian :
Yes, Kristine, let me see if I can do this properly. We -- we are in the process, for example, now in terms of space consolidation. What we're doing is we're getting out of leased spaces and moving to owned spaces. For example, in Massachusetts, we have an own space in Bevrica, we're getting out of a lease space there, and that should be effective in March. That will help us say something of $500,000, $600,000, $700,000. The issue that we have whole consolidation overall is helpful. It's the growth of our businesses and the lower costs that we have put in place this year. that should be more helpful. So when Edwin thinks about or talks about margin improvement, he is looking at really a lower cost structure, which we've achieved maintaining that and getting some growth, especially from our longer-cycle businesses. So it's a combination of those. I would say, lower cost and growth trumping just space consolidation.Kristine Liwag:
Great color. And in terms of industrial automation and the laboratory instrumentation markets, you've talked about a rebound for the second half of the year. What metrics are you looking at? What indicators are you following to -- that you're watching out for this end market?Robert Mehrabian :
For industrial automation, really is it's a combination of things. We're seeing, for example, some improvement in the semi market now, projections for improved semi market recovery. We'll also seeing some pickup in smartphones now, which is our consumer-related businesses, which affects our Micro Electro Mechanical Systems MEMS programs, in the other markets, especially laboratory instrumentation, we don't have as much visibility, frankly, we haven't seen these kind of declines before. So we think those should come back. But we're not counting on them a lot. We think there's a flip side of our environmental businesses, which is -- that's a part of which is the air quality, water quality monitoring, which have been very healthy. We have a nice backlog and -- we think the combination of those 2 will help us in that part of our instrumentation business.Kristine Liwag:
And last question for me. I mean, your current leverage position gives you flexibility to pursue more sizable deals? I mean, you've recently closed the Zeno acquisition. But in terms of larger deals, are valuations starting to look more attractive? And how is the 2024 pipeline shaping up?Robert Mehrabian :
Yes. I have to tell you, valuations on the larger deals have not come down yet as much as we would like. We've looked at some of the prices that our competitors have paid for large ones, those are kind of out of our range of what we would consider. On the flip side, we see some opportunities in smaller bolt-on acquisitions, what we call single pearls, which are available, and we will be pursuing those. If you looked at our '68, '69 acquisitions over our history, the string of pearls are of '68, '69. And they are the easiest to integrate. We can fit them in and we can improve their margins as we go. The larger deals, we have to be a little more patient because right now, prices are still pretty high.Operator:
Here's a question from Andrew Buscaglia with BNP.Andrew Buscaglia:
Digital Imaging margin. So I wanted to ask on -- so you're going to start Q1 sounds like in a whole. First off is digital imaging margins, do you expect those down year-over-year and that effectively marks sort of a bottom for that segment as sales start to improve from there?Robert Mehrabian :
No. The answer is no. I don't expect Digital Imaging margins to go down. I think that should go up a little bit in Q1 and then pick up the rest of the year. As I mentioned before, Andrew, this -- we think Digital Imaging as a whole should have margin improvement in '24, somewhere between 50 basis points and 100 basis points. We'd probably more prejudice towards the higher number. But nevertheless, no, I don't think we're expecting to suffer there because as we've done before, when some of our markets soften up, we take cost out. And then that helps maintain our margins. And the markets come back -- we really enjoy the margin improvement. So no, I don't think digital imaging is going to go down.Andrew Buscaglia:
And you mean up year-over-year or up sequentially?Robert Mehrabian :
Well, I think year-over-year first, it's going to between 50 to 100 basis points. I think -- and I think what would happen is if there's sequentially -- it will be sequential improvement. I don't expect things to go down.Andrew Buscaglia:
Yes. Okay. And then in past quarters, you sort of broke out [indiscernible] book-to-bill versus legacy Teledyne book-to-bill. Do you have that? And then wondering your view on potential incremental defense awards as the year progresses?Robert Mehrabian :
Sure. If you look at instrumentation, which is all legacy Teledyne in some ways. Which is marine, environmental and test and measurement. The book-to-bill in Q4 was 1.12 which is very healthy, driven primarily by Marine, which was really good. Digital Imaging, we -- or excluding FLIR, I'm just answering your question precisely, it was just over 1. Aerospace and Defense, it was closer to 1.2. That's historical paradigm. And Engineered Systems was just over 1. And then if you look at FLIR, which is our big acquisition, obviously, it was just over 1. So all in all, whether it's our historical Teledyne or Teledyne Plus FLIR, if you look at Q4, our book-to-bill was over more closer to 1.07%.Andrew Buscaglia:
Okay. And then a question on you're feeling on incremental defense awards throughout the year. Is there still a lot you're tracking?Robert Mehrabian :
Yes. The answer is yes. We have a pretty good read on what's coming. We have some new products. I mentioned the Black Hornet 4. I mentioned the space Tranche 2. The primes that have gotten their awards in last week or we are up to all of them. And we feel good about that.Operator:
[Operator Instructions] And let's go to the line of Noah Poponak with Goldman Sachs.Noah Poponak:
Robert, your full year 2024 framework is assuming 4% full year organic revenue growth. Is that correct?Robert Mehrabian :
Yes, about 4%.Noah Poponak:
And can you just repeat what you said about the first quarter top line revenue dollars or organic revenue growth?Robert Mehrabian :
Yes. I think it'd be above 1.4 or a little under, if that's going to be our lowest quarter. And I'm saying that because of the short-cycle businesses that we're seeing. We have orders on long-cycle businesses. But we -- our short-cycle businesses -- we're assuming that will not recover much in Q1 and so it should be flat year-over-year in terms of revenue and then pick up.Noah Poponak:
Got it. Okay. Just -- yes, I wasn't clear, but now I am. And I guess in those short-cycle businesses, I mean this has sort of been asked and discussed, but just have you actually seen concrete evidence of when that will pick up? Or I know a short cycle, but orders for it to pick up? Or are you just kind of making an assumption based on everything you know about the business? And then I guess you'll also have easier compares.Robert Mehrabian :
That's very good. We look at our pipeline, as necessarily say that we have better orders at this time. But we're talking to our customers, we're looking at that inventory level, but they're sharing that with us. And we see that inventories are going down. As a consequence, we expect that we will start getting the orders. long cycle, of course, you understand that's much easier because we already have the orders, and we feel good about that. So the other thing that we do on the short cycle is we look at the generator trends that people are talking about in terms of what happened in the semi industry in the past number of quarters. And what's expected -- what people are projecting. We'd be thinking that environmental and test and measurement will eventually pick up. But we're also seeing some pickup in MEMS already in flame infrared as well as our maritime businesses. So that's what's encouraging. We see some lowering of inventories for our customers as well as some pickup in certain unique businesses of ours.Noah Poponak:
Okay. That makes sense, and that's helpful. If I go to the 4% organic for the year, and then I do what you said with the segment margins, I think most of the things between that and the EPS are pretty straightforward. I get something above your EPS guidance. Is it safe to assume that you've just embedded some degree of conservatism relative to the lack of visibility in short cycle in the EPS range?Robert Mehrabian :
Yes. You said it better than I could. We're always a little conservative. The other -- there's one other thing that I should mention. When we look at our segment, per se. And we look at increases in segment margins. We have to be cognizant of the fact that the new management, which is Edwin and George are now going to be their costs or their pay is going to reflect in the corporate portion. And we're also seeing a little higher medical and insurance premiums. So corporate, we expect would go up. That's why while the margins in the segment look much higher, the corporate margins are -- we're assuming they're going to be increasing about 50 to 60 basis points.Noah Poponak:
Last one, some of your commentary makes it sound like the M&A pipeline is pretty full and pretty active and you're pretty optimistic about what you see. Other things you've said suggests there's a bid-ask spread and maybe it's a little tougher. So I guess, can you put a finer point on it in terms of how likely we are to see deals this year?Robert Mehrabian :
Yes. Let me just say that the confusion may have reason because I was answering 2 questions at the same time. The first part was larger acquisitions because we -- our leverage ratio is obviously going down and it go down faster this year. The larger acquisitions right now that we look at are pretty expensive. People are paying prices that we are not going to. On the other hand, smaller acquisitions are available, and we expect to make some this year. So I think we'd be patient for the larger ones like we always have been and -- but we will make some smaller acquisitions this year. So we have a reasonable product line.Operator:
Next is the question from Robert Jamieson with UBS.Robert Jamieson:
Very helpful. Just one kind of smaller one on A&D electronics. Strong growth, like expected for next year and another 80 to 90 basis points of margin expansion. Just curious how you're thinking about the growth split within commercial aerospace between new builds and then MRO? And then how should we think about the puts and takes on margin there, maybe if like MRO is a little bit pressured next year?Robert Mehrabian :
Let's stay with aerospace first. A significant amount of our revenue in aerospace is in the aftermarket. Because we have a very large embedded base in aircraft of various kinds. So we think that is going to be very helpful for us. We also are -- obviously, in 737, we have a product line that's going into that. And we think that's going to help us regardless of the current issues with builds and so on. On the defense side, we are seeing some good programs in modernization, stockpile, replacement. And we think those would be helpful to us. And obviously, we believe it will be a balance of improvement, both in aerospace and in defense perhaps 5% to 6%. 5% to 6% in each domain.Robert Jamieson:
That's great. And then this is kind of more of a random question, but just -- we talked a little bit about capital allocation. You got a full funnel, probably going to look to do some smaller acquisitions. Absent anything large, and I know this would be a deviation for what we've seen over the last several years. But would you have any interest in buying back stock? And then I guess one other kind of thought or questions that random would be given like the float, would you ever consider a stock split to maybe make it a little bit easier to trade like tighten the bid-ask spread? And could that ever maybe make it easier for you to buy back stock?Robert Mehrabian :
Split, no. And the reason -- let me start there. And the reason I say that that's a pain for our investors. And 90-plus percent of our investors are institutional investors. We don't want to cause that kind of a problem for them. We have very small fraction of our investors that are retail investors. Going back to buyback. Right now, we think our investment returns are much better reflected in acquisitions than stock buyback. You don't want to say never because stock goes down a lot, then it becomes attractive. I'm hoping that doesn't happen. We do have open authorization if we wanted to do that. But right now, I don't see that as long as we have attractive acquisitions, even small ones, we'll do those. And there's nothing wrong also having some cash on the side in these days. with the interest rates that we're seeing. So we have to pay down about $600 million of debt this year. In some ways, it's unfortunate because it's fixed debt at less than 1%. But then we don't have to pay down debt going in 2026. So we'll have a lot of cash available to do things. So we think we'll be okay.Operator:
[Operator Instructions] We have a follow-up from Joe Giordano, he's representing TD Cohen.Joe Giordano:
Just wanted to ask on the pricing environment because I know you said before that maybe you took less -- I mean, price was so strong for kind of everyone for a long time here. But I think in some areas, maybe in some of the vision products, you took less price than you probably could have to kind of maintain share. And just curious how the pricing environment has evolved since you made those comments and what you're thinking how price is a part of your guidance for next year?Robert Mehrabian :
First point, backwards, in '23, we had some nice price increases. I'm going to say broadly 2% to 3%, let's say, 3%. We expect the same in '24. In some areas, obviously, we were able to increase price more than 3%. But in some areas like government contracts that are not peak [indiscernible] the cost plus then you can increase prices as such. So I think 2% to 3% is what we're looking at for '24.Operator:
And we have no other participants queuing up at this time.Steve Blackwood :
Thank you very much, Tom. I'll just have -- I'll ask Jason to please conclude our call.Jason VanWees :
Thanks, Robert. Again, thanks, everyone, for joining us this morning. And if you have follow-up questions, please feel free to call me at the number on the earnings release. And Tom, if you could give the replay information, just a conclusion, that would be the ideal.Operator:
One moment here. I pull that up -- sorry about that. Ladies and gentlemen, this will be available for replay, if you can make one moment. It will be available for replay in an hour, and it will run through February 24 at midnight. You may access the AT&T replay service at any time by dialing (866) 207-1041 866-207-1041 and entering the access code of (459-0647)45-90647. And we thank you for your participation and using the AT&T Event Services. You may now disconnect.Operator:
Ladies and gentlemen, thank you for standing by. Welcome to Teledyne's Third Quarter Earnings Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to your host, Mr. Jason VanWees. Please go ahead.Jason VanWees:
Thanks John and good morning everyone. This is Jason VanWees, Vice Chairman, and I'd like to welcome everyone to our third quarter 2023 earnings release conference call. We released our earnings earlier this morning before the market opened. Joining me today are Teledyne's Chairman, President and CEO, Robert Mehrabian’ and Senior Vice President and CFO, Sue Main. Also joining today are Steve Blackwood who will assume the role of SVP and CFO on December 1st; Melanie Cibik, currently Senior Vice President, General Counsel, Chief Compliance Officer and Secretary will be promoted to Executive Vice President on January 1st; and Edwin Roks and George Bobb, currently Executive VPs of Teledyne will assume the roles of CEO and President and COO, respectively, on January 1st. After remarks by Robert and Sue, we will ask for your questions. Of course, before we get started, our attorneys have reminded me to tell you that all forward-looking statements made this morning are subject to various assumptions, risks and caveats as noted in the earnings release and our periodic SEC filings and of course actual results may differ materially. In order to avoid potential selective disclosures, this call is simultaneously being webcast and a replay, both via webcast and dial-in, will be available for approximately one month. Here is Robert.Robert Mehrabian:
Thank you, Jason, and good morning and thank you for joining our earnings call. These are exciting times for Teledyne. We have new leadership coming in, but we also have continuity and resilience in our programs, in our operations and our ability to meet what we say we would do in our earnings. In the third quarter, as example, we achieved record operating margin and earnings per share. GAAP operating margin of 18.8% was a third quarter record. On a non-GAAP basis, the operating margin was 22.8%, which was an all time record for any quarter. Likewise, GAAP earnings per share of $14.15 (sic) [$4.15] was a third quarter record and non-GAAP earnings per share of $5.05 was an all-time record for Teledyne. Compared to last year, GAAP and non-GAAP operating margins increased 119 and 86 basis points, respectively, and both GAAP and non-GAAP earnings per share increased approximately 11%. Our overall third quarter performance was led by growth in our marine, medical, aerospace and certain defense businesses, coupled with vigilant cost control. There was, however, some deterioration in certain end markets such as industrial automation and laboratory instrumentation. Nevertheless, given our focus on operational excellence, operating margins increased, both sequentially and year-over-year in Digital Imaging and Instrumentation segments, helping generate record earnings. Given continued debt repayment through September, which totaled about $680 million year-to-date, our consolidated leverage ratio declined to just under 2 times. And finally, we're pleased to have added Xena Networks to our test and measurement businesses which also continued to perform very well in a challenging environment. In terms of our outlook, we now see total sales for 2023 growth of about 4% or a little less than the second half versus our July outlook with the fourth quarter sales being roughly $1.45 billion. Approximately half of this change in incremental -- is due to incremental currency translation headwind from July to now, and the balance being further deterioration in industrial automation and laboratory instrumentation markets mentioned earlier. However, given the strong margin and earnings achieved in the third quarter, we're raising our non-GAAP earnings outlook to $19.25 at the midpoint from a prior outlook of $19.10. I will now further comment on the performance of our four segments. Third quarter sales in our Digital Imaging segment were flat compared to last year. Sales of x-ray products, infrared imaging detectors and surveillance system increased year-over-year but were offset by lower sales of unmanned ground systems, and micro-electro-mechanical systems or MEMS. Sales of commercial marine hardware and software were flat, but declined organically. Finally, cameras and sensors for industrial automation declined compared to last year. Like Teledyne as a whole, the Digital Imaging business portfolio is exceptionally well balanced across market segments and geographies. With the help of bolt-on acquisitions and growth in our medical and defense markets, we were able to offset declines in industrial automation and its -- and the small portion of our overall portfolio that is associated with consumer discretionary spending. Despite of the flat revenue, margins performance improved considerably to record levels with the FLIR businesses collectively slightly higher than segment average margins. Turning to our Instrumentation businesses. This segment consists of marine instruments, test and measurement and environmental instruments. Overall, third quarter sales in Instrumentation segment increased 7.4% versus last year. Sales of marine instruments increased 20.5% in the quarter, primarily due to ongoing recovery in offshore energy markets and also greater sales of acoustic imaging systems. Sales of electronic test and measurement systems, which includes oscilloscopes, digitizers and protocol analyzers, collectively increased 2.5%. We continue to see some softness in sales of analyzers for electronic storage and data center application. But, this was more than offset by sales of devices for wireless and video protocols as well as continued strong sales of oscilloscopes. Demand for high-speed networking customers remains very healthy, and we see the Xena acquisition, enhancing our offerings in this market. Sales of environmental instruments decreased slightly compared to last year, with sales of air quality and gas and flame safety analyzers offsetting some decline in drug discovery and laboratory instruments. Overall, Instrumentation segment operating profit increased over 20% in the third quarter with GAAP operating margins increasing 277 basis points to 26% and 253 basis points on a non-GAAP basis to 27%. These were all-time records for this segment. Third quarter sales in our Aerospace and Defense Electronics segment increased 8.1%, driven by growth both in defense electronics and aerospace -- commercial aerospace products. GAAP and non-GAAP operating profit increased 11.5% with margins 81 basis points greater than last year. Finally, in the Engineering Systems segment, third quarter revenue increased 4.1%, but operating profit declined slightly, given an unfavorable product mix but also a tough comparison with the prior year period. So, in conclusion, we are pleased to continue to do what we know best, grow sales and margin in businesses with favorable markets, while cutting costs and protecting margins in those businesses where market trends are more challenging. At the same time, especially now that our leverage continues to decline, we should acquire and integrate complementary businesses. Before turning the call to Sue, I want to thank her for her more than 34 years of service to Teledyne, and I wish her very, very well-earned retirement. I will greatly miss her. And finally, I want to congratulate our other executives on their well-deserved promotions announced yesterday, and I and the entire Board are delighted that the same talented group of executives will continue to serve Teledyne's leadership. Sue?Sue Main:
Thank you, Robert, for the kind words, and good morning, everyone. I will first discuss some additional financials for the quarter not covered by Robert, and then I will discuss our fourth quarter and full year 2023 outlook. In the third quarter, cash flow from operating activities was $278.2 million. Free cash flow, that is cash from operating activities less capital expenditures, was $255.2 million in the third quarter of 2023 compared with $252.2 million in 2022. Capital expenditures were $23 million in the third quarter of 2023 compared with $16.7 million in 2022. Depreciation and amortization expense was $76.9 million for the third quarter of 2023 compared with $80.8 million. We ended the quarter with approximately $2.74 billion of net debt. That is approximately $3.24 billion of debt less cash of $508.6 million. Our stock-based compensation expense was $8 million in the third quarter of 2023 compared with $6.7 million in 2022. Turning to our outlook. Management currently believes that GAAP earnings per share in the fourth quarter of 2023 will be in the range of $4.07 to $4.21 per share with non-GAAP earnings in the range of $4.95 to $5.05. And for the full year 2023, our GAAP earnings per share outlook is now $15.82 and to $15.96. And on a non-GAAP basis, we are raising our outlook to $19.20 to $19.30. Both the fourth quarter and full year non-GAAP outlook excludes estimated pretax charges for further FLIR integration costs. The 2023 full year estimated tax rate, excluding discrete items, is expected to be 22.1%. I will now pass the call back to Robert.Robert Mehrabian:
Thank you, Sue. Operator, we'd now like to take questions. If you're ready to proceed with the questions and answers, please go ahead.Operator:
[Operator Instructions] And we'll go to our first question, it’s coming from Jim Ricchiuti with Needham & Company.Jim Ricchiuti:
Congratulations, Sue, and congratulations to everyone else, on the new appointments. Robert, maybe a question for you. You talked about the booking strength at FLIR last quarter. And I'm wondering how did that business fare Q3 from a booking standpoint? And what does the near-term outlook look like in the Teledyne FLIR business? And maybe as a follow-up, if you could provide a little bit more color on the overall level of bookings and the various bookings at the segment level. Thank you.Robert Mehrabian:
Thank you, Jim. I would say on the FLIR specific, we're moving up to 0.93, 0.95 at the present time with improvements in the Defense segment. And Defense is going to be over 1 actually for FLIR business. We had an inflection in the Defense businesses there in the second quarter and we have some really good new awards that makes us feel good about that domain. Going to the rest of overall book-to-bill, Jim, I will exclude Engineered Systems because sometimes it would -- big, lumpy orders might increase book-to-bill to 1.4, 1.5 or dropping to 0.6 depending on the quarter. So, if I exclude that, I think we will be over 0.9 at this time. But that is not a big concern at the present because where we have some softness in certain markets, we are gaining traction in markets like energy, defense, healthcare, and that's why our margins are improving. And we're projecting better earnings as we go forward.Jim Ricchiuti:
Got it. And can you give an update on the facilities realignment at FLIR and when do you expect to see the meaningful improvement on margins as it relates to these moves or maybe you're already starting to see some of those benefits?Robert Mehrabian:
Yes. Jim, we're already seeing those benefits. First of all, most everything will be done in the March to April time frame. The reductions in force, a majority of them have happened and the rest will happen in the Q4 time frame. The facility closures, transfer of one facility to another, that will happen in early next year. But having said that, coming back to the margins of -- FLIR margins have really improved this quarter, both because of the cost reduction, also because of the mix of businesses that we have and Digital Imaging as a whole, which includes DALSA and e2v. At the end of last quarter, we were looking at perhaps a little margin decrement of 15 basis points. That has not turned around. We expect for the year to be -- margins to be up 20 basis points. So about 35 basis points, 40 basis points improvement over a quarter because of the focus on cost.Operator:
Our next question comes from Ron Epstein with Bank of America.Unidentified Analyst:
This is Jordan on for Ron. I just had a quick question. Could you guys walk us through any of the exposure you guys have to the Israel-Palestine conflict? And if you're seeing any increase in heritage FLIR program interest or any changes coming from outlays?Robert Mehrabian:
We have some background. I think, basically, we expect in the long term to have some orders in our defense businesses from that. We have -- we are a supplier, obviously, and we think that the conflict -- unfortunately, the conflict is what it is. But I think I'm not at liberty to disclose, but we have contributed to some of the defense mechanisms that are used by Israel. The other part is that the first thing that will happen is that there'd be a refreshment of the stockpiles in the defense businesses, both because of the conflict in Israel, but also as well as the conflict in Europe. And these are present themselves as obviously long-term opportunities, both the FLIR defense program, but also our Aerospace and Defense segment that has a lot of components and subsystems that go into various products.Operator:
Next, we go to Joe Giordano with TD Cowen.Joe Giordano:
Just curious on the management changes that you articulated for January 1st. Is there any real like change in the org structure internally just in terms of how the businesses are going to roll up? You have a COO now. Like, just curious if there's any kind of like structural changes in how the business is going to report.Robert Mehrabian:
Yes. I think that's a good question, Joe. Two things. First, we have one subsegment, which is in the instruments businesses. You remember instruments consists of marine, environmental test and measurement. The marine already refers to George Bobb, the test and measurement and environmental reports to me. Those would begin reporting to George in January. Edwin has been running our biggest segment, which is our Digital Imaging segment. He will continue running that for a while. But as time goes on over the next 12 to 18 months, they will begin harmonizing, George learning more about the Digital Imaging businesses and Edwin learning more about the businesses that George is running at the present time. The resilience to all of this is that I'm not going anywhere. We'll continue to work together, the three of us, also, of course, with others like Jason and Steve Blackwood and Melanie, to make sure that all the assignments, changes happen slowly, orderly and don't offset any of our market leading products that we're focused on. So, I see this as a continuum but one in which both Edwin and George take more responsibility and I move to more to worrying about how to allocate capital with Jason, do more M&A and also improve our margins, which is something we have to do continuously.Joe Giordano:
I appreciate that color there. If I go over to DI margins, I mean, obviously, that's been a focus area for investors and for you guys. It was pretty substantially higher than maybe what people anticipated this quarter. Curious if there was any kind of one-off type benefits going on this quarter that maybe we have to consider reversing out? And then into next year, we have time before we get there, but I think you guys have been at conferences recently talking about maybe 23% is a good target for next year. Is it early target? You're kind of going to be there now. If you think this year is off of 20 bps, you're kind of going to be almost at 23 for this year. So, does that target not just become that much more conservative? How should we think about that?Robert Mehrabian:
That's a good one. Actually, you're right. The margins have improved. Right now, we're projecting for the full year '23 to be at 22.7%. So, it's very close to the 23% that you mentioned. Moving further up, of course, that's what we're going to strive for. We have to take a little more cost out in DALSA, e2v as we've done in FLIR, and we're doing that right now. And the other part that I think would affect it is that some of the markets that are declined like semiconductor, automation sensors in our vision systems, those are going to come back and then finally, we have some new markets for our Digital Imaging, for example, inspection of lithium-ion batteries. You remember now, most of that manufacturing is beginning to switch back to North America. And we do have some really good systems for quality control. And you can guess lithium-ion battery, a flaw can be catastrophic. So, these new cameras, new markets will offset some of the declines we have now, but I also think that the semi market will come back. So if all of that takes place, as I've just outlined, obviously, our margins should improve.Joe Giordano:
If I could just sneak in one last one. If I think about your oscilloscope business, I know that's growing very quickly now on delivery of backlog. But if you think about where orders have been all year, and let's say, we don't -- like absent an inflection in near term in orders, is that a business that likely declines just given where your backlog is and what you're delivering this year, if I think into ‘24?Robert Mehrabian:
No. I think -- we feel very good about our T&M business. First, remember, as you said, part of it is oscilloscope, part of it is digitizers and very fast-growing part has been our protocol analyzers where we've just made the acquisition, Xena acquisition. The book-to-bill in that business is between 0.94, 0.95 at this time. By the way, in protocols, we don't really see declines. What we see is a little push out because new standards are continuously evolving in our protocols are at the forefront of those standards. So, people will be adapting those. But while those have softened a little bit, oscilloscope, because we are also offering new products, are doing fine. I know that market may not look as exciting now that it has known before, but it is for us. It's very exciting.Operator:
We will go now to Greg Konrad with Jefferies.Greg Konrad:
Maybe just to level set the guidance for the year in terms of revenue. I mean, you mentioned industrial automation and laboratory instrumentation softening. But, can you just remind us where FX is the biggest headwind given you said that was half of the impact? Just kind of thinking about the segments for the rest of the year.Robert Mehrabian:
Yes. The FX that I mentioned is versus what we were looking at in July, and things have tightened and it's costing us about 1%. And it's mostly focused in our Digital Imaging and Instrumentation businesses. Having said that, overall, if you look at year-over-year, we do get a little tailwind. But it tightened significantly from our July meeting to today. We'll deal with it, like we deal with any market softening here and there. I mean, basically focus on getting products up where there's a good market, cut costs where we don't have the market, improve our margins, and if we can do what we just did, beat and raise.Greg Konrad:
And then, the operating discipline definitely comes through. Given those two markets that you did say were deteriorating, how does price play into this? Just thinking about maybe what you're able to capture does that kind of change the pricing equation at all thinking about into year-end?Robert Mehrabian:
Yes. I think what we have been able to do is increase prices successfully in businesses that are doing well, like on our Aerospace and Defense businesses or certain parts of our environmental. And for example, marine where we have a really strong market at the present time, we've increased prices. That offsets prices that we have not been able to increase in the environmental area. So, it changes across our portfolio up and down. But generally, we are successful in raising prices across the board, we have been this year versus let's say last year. And we think that sustainability that's happening for our businesses will allow us to increase prices but more modestly going forward than we have aspirations for. But if things turn around, we'll do it.Operator:
And next, we'll go to Andrew Buscaglia with BNP. Go ahead, please.Andrew Buscaglia:
So maybe -- you guys mentioned, or Robert, you mentioned your book-to-bill is just over 0.9, which is not too inspiring, heading into 2024. But you talked about some optimism in some areas, like Digital Imaging, some of those markets coming back. I'm wondering, can you comment on your expectations heading into the new year? Last quarter, you talked about backlog possibly or defense backlog converting into Q4. And you're sounding more optimistic around new awards as well materializing. So, I'm just wondering, can that book-to-bill change on us heading into the new year, or how are you feeling going into January, February?Robert Mehrabian:
Yes. I think, to cut to the chase, we still have over $3 billion of backlog, which is very healthy. There are some short-cycle businesses that there have obviously been short cycles, especially in the environmental area, as an example. 0.9, 0.93 does not bother me, only because we have also a slew of new products that are coming to market. For example, just take going back to FLIR Defense, we just introduced a new nano-drone called the Black Hornet 4, which can go twice as high as the one we have, which is Black Hornet 3, was only 10,000 feet. This can go up to 20,000 feet, last longer, be a lot more -- do a lot of other things. We also have new programs in counter-UAS. And the other thing that is exciting for us that we're just starting to get some traction on is understanding where we can bring our intelligence systems, if you want to call it, artificial intelligence, to bear. We have now about $250 million to $300 million of products that are benefiting from not just being sensors but being systems, cameras that provide intelligent information. So, it doesn't bother me, the slight decrement in backlog. It's primarily because certain parts of the market, like semiconductor is done. But all semiconductor inclusive across Teledyne is less than 10%. So, it doesn't bother me. I think the more important thing is, can we just keep bringing new products and make the acquisitions that we are now able to do because our leverage is down and do what we've always done, acquire, integrate and increase our earnings per share.Andrew Buscaglia:
Yes. Okay. Well, that dovetails into my next question around M&A. With your leverage now back below 2ish, what are you seeing in the pipeline for next year? And then, maybe if you don't see M&A materialize, what are your thoughts on share repurchase just given where your valuation is?Robert Mehrabian:
I'll answer the M&A question. Share repurchase is something that we haven't done. We've only purchased shares I'm going to say, 10, 12 years ago about $400 million, when you look at our market cap versus that very small fraction. I think our M&A opportunities are there. We're looking at smaller acquisitions at the present time with one or two what I'll call, midsize, several hundred million dollar acquisitions in the potential pipeline. The one thing we have to be careful about is there's some really outrageous prices that people are paying for some of the acquisitions we've looked at. multiples of sales going 15 times. And that's just not us. Well, we are looking at smaller acquisitions, both here and in Europe and they'll come along just like we've done before, what we call the string of pearls, and we will make those acquisitions. If we don't make any acquisitions on the flip side, by the end of next year, our leverage ratio would be 1, which was actually less than that before the FLIR acquisition. And cash also will help our earnings, but our primary focus is going to be acquisitions.Operator:
Next, we go to Rob Jamieson with UBS.Rob Jamieson:
Just a couple. Can we run through the segment -- each segment and what you're embedding for organic and margin expectations just for the rest of the year? And then also, just hit on your net leverage comment there. Is it safe to kind of assume that you guys are going to be able to produce above like maybe $1 billion in free cash flow in '24?Robert Mehrabian:
Let me answer the last question first. We're right in the middle of our planning cycle for our operating plan and made presentations to our Board yesterday, and the answer is yes. Let me now go back to the organic question that you asked for this year. Fundamentally, we're going to have -- organically, we're going to be relatively flat in our overall Digital Imaging business, maybe a little -- a percent down, but that's partly because we're also cleaning up some stuff that are not profitable. On the other hand, we will have organic growth of almost 6% in our Instrumentation businesses, which, as I said, is environmental, test and measurement, and marine. We're going to have similarly, over 6% in our Aerospace and Defense organic growth, and about 8% in our Engineered Systems. So, those are very healthy growths for this environment that we're all experiencing.Rob Jamieson:
And then, I guess, just one specific to test and measurement. You said you had a new protocol product that was coming to market in September. Just wondering what the uptake is and how customers are reacting to that? And is that -- could that be an incremental benefit to that sliver of instrumentation in fourth quarter?Robert Mehrabian:
Yes. The new protocol is the PCI Express Gen 7. The life cycle of that is usually a couple of years. I think we'll see some benefit from that next year, probably later next year. But the flip side is the protocol business that we just bought, Xena is fulfilling a gap that we had in our protocol businesses, which was the high-speed network protocols, and they fill that gap very well. So we love our protocol businesses and hope that we can buy more of them as time goes on.Operator:
Next, we go to Kristine Liwag with Morgan Stanley.Kristine Liwag:
Congratulations on the leadership changes. Robert, I hope that this change means you get some extra free time.Robert Mehrabian:
I hope so, too. I have my new leaders shaking their head, across the table from me, but I hope I will. Yes. Thank you, Kristine.Kristine Liwag:
Well, great, and it's been wonderful to follow your career and what you've done for Teledyne. So, maybe with the leadership changes, I mean, sometimes there's also a change in strategic focus. I mean, Teledyne is a much broader and bigger company than it was over 20 years ago. You mentioned earlier that M&A is still a priority over share buybacks. I guess, as we look out the next 5, 10 or even 20 years and maybe that question is a little too broad of a scope for this call, but how do we think about the strategic direction for Teledyne? Like where to from here?Robert Mehrabian:
Well, first, let me answer the first question. The way we operate in the current Teledyne is a lot of the M&A ideas come from our businesses. Now, we are proactive. At any one time, we have a large funnel of businesses that we're looking at. But that will not change because it comes from Digital Imaging, it comes from Instrumentation and marine and A&D. And these are areas that the two leaders that are taking over are responsible for. So I don't think in the short term, things will change. Also in the short term, at least, I'm still going to be here. And of course, Jason helps make a lot of the capital allocation decisions. But having said that, we will probably focus more on commercial businesses as we go forward. And we will get some defense businesses, but we don't want our defense businesses to grow beyond where they are today. We have a healthy balance of 25% defense, 75% commercial. Almost half or 47% of our commercial businesses are overseas. We're also expanding some defense business in the NATO countries and the Middle East. But having said that, I think my colleagues and I agree that we do not want to change our portfolio from what it is today to something that is not sustainable. If you're singularly focused on one market, when that market suffers, then it takes the whole company down. Our balanced portfolio is our resilience and our ability to tolerate changes. And as you can see, while we have some weakness in certain areas, we have strength in other areas. We have growth in instruments, in A&D, Engineered Systems. And so I don't think that will change. Now I'm talking about three years. If you go beyond that, then I can't predict, because the world is changing so much right now. I mean, it's such a difficult environment in some cases. It will depend on what happens and our strategies will evolve.Operator:
[Operator Instructions] We have one more in queue at this time. We're going now to Noah Poponak. Please go ahead.Noah Poponak:
Congratulations to everybody on the new seats or responsibilities. Robert, I just want to go back to the DI margin. You just printed a number that you previously said you would get to in two years. It sounds like you're saying the majority of the explanation for that is that you performed an incremental cost out. And so, if that's the driver, wouldn't that kind of sustain in the margin from here? And therefore, why would that margin pull back from the level that you just reported?Robert Mehrabian:
I mentioned the margin for the year of 22.7% in DI, which is 35 basis higher than it was what I quoted in Q2 -- at the end of Q2. What has happened is that the cost out is important because it's not just people, it's the consolidation of our facilities as well. We have not done that. We were all focused on, at first, fixing our export control issues, fixing our tax liabilities. We're still working on tax liabilities somewhat. But what's happening is that the defense business at Digital Imaging, specifically FLIR, are getting better. And machine vision, while it's getting worse at the present time, it sooner or later is going to have to come back. And so, I was a little cautious about for next year when I was asked about the margins, and I stayed with the 22.7%, maybe 22%. But over the long term, there's no reason that these margins in these businesses could not be like margins in our Aerospace and Defense, which we're predicting this year to be 27.6% or our instruments with our 26.1%. There's no reason that margins cannot improve and get there.Noah Poponak:
Okay. That's helpful context. I understood part of the challenge to be that there's been volatility in defense outlays compared to what's been authorized at the end market level. And so, with regard to your defense business inside of Digital Imaging, you were gearing up for higher defense revenue that then just kind of surprisingly didn't come through. And so, did that come through in the third quarter, or what was the growth rate, I guess, in the defense piece of Digital Imaging in the quarter?Robert Mehrabian:
We have several large programs that came through in the third quarter. And large -- for us things are below -- above $10 million, $20 million, for example. We got some counter unmanned vehicle systems that we partnered with Kongsberg. That was a nice win in Q3. We've also penetrated some of our nano-drones are now moving into India. We had a nice award from there. Also, our surveillance program, we had to straighten out some of the issues with our gimbals and vibration and products that we inherited. We straightened those out, and we have now a Navy award that's about $35 million. So surveillance grew in Q3. And I think with the many drones and our newer products, we think we’ll do fine. Our unmanned programs we expect to grow in Q4. Overall, what we've been able to do is really take the non-profitable stuff-up, consolidate facilities that shouldn't have been separate to begin with, focus on the things that we can deliver, unmanned systems using our own sensors. Other people have unmanned systems to various conflicts that use our sensors. So we're happy to send them our sensors, but we also can incorporate them in our system. So, we kind of think that the defense business there in DI has had an inflection point and is really turning positive now.Noah Poponak:
Okay. That's helpful. And then just one last one in DI. What do you now expect the rate of decline to be for the year in the machine vision piece? And do you have enough order book or visibility to have a sense for what that revenue does in '24, or is it too short cycle?Robert Mehrabian:
I think, overall, we're going to see an increase in revenue in DALSA, e2v part of DI, as much as 6% with some of it coming from acquisitions. In the other part of DI, which would be FLIR, we expect that we may have slight decline, let's say, to 1.839 -- 1.834 let’s say from 1.84 what was then 1.86 last year, which is very minor. And some of that comes from Raymarine, where we -- consumer products that are more discretionary at this time. But overall, I don't see a huge decline in Digital Imaging because DALSA, e2v has grown. And we are weathering the downturn in some of our other commercial products very well. And then we, of course, have some really good upside in things like healthcare, where markets, even in, let's say, in Q3, we had almost 12% increase in revenue in that area. So, it's balanced.Noah Poponak:
Sorry. Those comments are on total Digital Imaging revenue, you're saying?Robert Mehrabian:
Total Digital Imaging revenue. Yes.Noah Poponak:
Okay. I appreciate that. I just -- so it's clear. I was asking on just machine vision within Digital Imaging.Robert Mehrabian:
Just machine vision?Noah Poponak:
Yes.Robert Mehrabian:
Okay. There's different parts of it. There's a machine vision at DALSA, e2v and there's some machine vision in FLIR. I haven't added those two together. If I were to add those two together, I'd say, the full year might be down 2%. But again, could be a little higher, but it doesn't bother me that much, Noah, only because, as I mentioned before, we have new products like in battery inspection, and we're more emphasizing our ability to put some information and intelligence in our devices, cameras, a move up market. So, this market is going to turn. It's not going to stay where it is. Semiconductor is not going to stay down forever. And I think we're well positioned for growth once those turn a little bit.Noah Poponak:
Yes. That's interesting. It's much different than the peer set. So, yes, it seems well positioned. Okay. All right. Well, thanks again. Thanks for the time. I appreciate it.Robert Mehrabian:
Thank you very much, Noah.Operator:
And we have no additional questions in queue at this time.Robert Mehrabian:
Thank you, operator. I'll now ask Jason to conclude our conference call.Jason VanWees:
Thanks, Robert. And again, thanks everyone for joining us today. If you have any follow-up questions, please feel free to call me. Number is on the earnings release or of course, send me an e-mail. And all the press releases are available on our website as is the replay. John, if you could give the dial-in information for the replay at the end of this call that would be great.Operator:
Certainly. Ladies and gentlemen, this call has been recorded and will be available for replay from today at 10 am Pacific through midnight on November 25, 2023. To access the replay, dial 866-207-1041 and enter access code 6439556. International participants, dial 402-940-0847. Once again, those numbers are 866-207-1041 for domestic and for international it's 402-940-0847 and the access code again is 6439556. And that will conclude your conference call for today. Thank you for your participation and for using AT&T Event Conferencing. You may now disconnect.Operator:
Ladies and gentlemen, good morning. Thank you for standing by today's conference assembled [ph]. Welcome to the Teledyne Technologies Second Quarter Earnings Call. [Operator Instructions] At this time, it's my pleasure to turn the conference over to our host, Jason VanWees. Please go ahead.Jason VanWees:
Thank you, Dom. This is Jason VanWees, Vice Chairman. I'd like to welcome everyone to Teledyne's second quarter 2023 earnings release conference call. We released our earnings earlier this morning before the market opened. Joining me today are Teledyne's Chairman, President and CEO, Robert Mehrabian; Senior Vice President and CFO, Sue Main; and Senior Vice President and General Counsel, Chief Compliance Officer and Secretary, Melanie Cibik. Also joining is Edwin Roks, Executive VP. After remarks by Robert and Sue, we will ask for your questions. Of course, though, before we get started, our attorneys have reminded me to tell you that all forward-looking statements made this morning are subject to various assumptions, risks and caveats as noted in our earnings release and our periodic SEC filings. Actual results may differ materially. In order to avoid potential selective disclosures, this call is simultaneously being webcast and a replay, both via webcast and dial-in, will be available for approximately one month. Here is Robert.Robert Mehrabian:
Thank you, Jason and thank you for joining our earnings call. In the second quarter, we achieved all-time record quarterly sales, with overall sales increasing 5.1%. Furthermore, sales as well as GAAP and non-GAAP operating profit and operating margin increased year-over-year in every segment. For the total company, GAAP and non-GAAP operating margins increased 105 and 73 basis points, respectively. Excluding foreign currency headwind, which negatively impacted second quarter sales growth by approximately 40 basis points, growth in local currency would have been 5.5%. GAAP operating margin of 18% was a second quarter record and non-GAAP operating margin was 21.4%. Second quarter GAAP earnings per share were $3.87 and non-GAAP earnings of $4.67 were also second quarter records. And finally, including continued debt repayment through July, which totaled about $620 million year-to-date, our consolidated leverage ratio declined to 2.1x. I'll now comment a bit further on the performance of Teledyne flare and the announced cost reductions and the outlook for the balance of the year. In the 2 years, since we've owned FLIR, we've resolved the most significant legacy tax matters, exited the consent agreement with the Department of State, consolidated leadership in marketing and operations for the FLIR Defense portfolio and corrected some historical product quality issues. As part of this effort, we also took a much more focused view of the Defense business, aggressively pursuing those opportunities where we have truly differentiated technology. I am pleased to report that the order book and backlog of FLIR, specialty FLIR Defense, significantly inflected during the second quarter. For reference, the commercial business across digital imaging, both DALSA to FLIR grew organically in the second quarter. While FLIR Defense sales declined year-over-year, nearly all of this was lower revenue in unmanned ground systems as we achieved the milestone of shipping our 1,000th man transportable robotic system increment to, to the U.S. Army. Overall, orders at all of FLIR were 1.18x sales and 1.5x sales at FLIR Defense. Large orders not only included the recently announced Black Hornet Nano UAV to the U.S. Military but also additional UAVs for customers in Europe as well as counter UAV systems and missile systems utilizing both FLIR imaging, radar and AI-based software systems. Additionally, more surveillance imaging systems for the U.S. and foreign customers. Having stabilized the business, including achieving stronger backlog, it is not time to focus on execution and additional margin improvement. Thus, the charges announced this morning are for the further reduction in the FLIR operating footprint and related headcount. We are exciting the elimination of 3 lease sites, all of those activities will be relocated to other FLIR Defense facilities, most of which are locates. Today, we are reaffirming our prior 2023 full year sales and non-GAAP earnings outlook, including -- excluding the $10 million to $12 million charges that -- covered. Supply chain challenges have continued to improve and we were once again able to exceed our original second quarter sales and earnings outlook by pulling forward some revenue from the third quarter. On revenue specifically, we continue to see total 2023 growth of approximately 5% or sales of approximately $5.73 billion, with the third quarter being roughly $1.4 billion. We continue to see non-GAAP earnings of $19.10 at the midpoint of our guidance, excluding the charges referenced above. I will now further comment on the performance of the 4 business segments. Second quarter sales, in our Digital Imaging segment, increased 2.3% with greater sales of X-ray products, commercial infrared imaging components and solutions and industrial scientific cameras partially offset by lower sales of unmanned ground systems for Defense applications. GAAP segment operating margin increased 51 basis points to 15.7% and adjusted for reduced the intangible asset amortization non-GAAP segment margin was 28 basis points higher at 21.5%. Turning to our Instrumentation segment. Overall, second quarter sales increased 5.1% versus last year. Sales of Marine instruments increased a healthy 10.5% in the quarter, primarily due to ongoing recovery in offshore energy markets, also greater sales of autonomous underwater vehicles. Sales of electronic test and measurement systems, which include oscilloscopes, digitizers and protocol analyzers, collectively increased 4.9%. We encountered some softness in sales of analyzers for electronic storage and data center application but this was more than offset by [indiscernible] for wireless and video protocols as well as continued strong sales of oscilloscopes. Sales of environmental instruments were flat compared to last year with greater sales of air quality, process gas, safety analyzers offset by drug discovery and laboratory instruments. Overall, instrumentation segment operating profit increased 10.6% in the second quarter, with GAAP operating margin increasing 123 basis points to 24.8% and 80 basis points on a non-GAAP basis, excluding reduced intangible asset amortization to 25.9%. In the Aerospace and Defense Electronics segment, second quarter sales increased 10.2%, driven by growth of both Defense Electronics and Commercial Aerospace products. GAAP and non-GAAP segment operating profit increased over 20% with margins approximately 250 basis points greater than last year. In the Engineering Systems segment, second quarter revenue increased 18.5% and operating profit increased 33.7%, representing 112 basis points increase in margin from last year. In conclusion, our short-term, more economically sensitive businesses remained resilient in the second quarter, collectively growing year-over-year, although comparisons for some do become more difficult in the second half. In addition, our longer Cycle Medical, Aerospace, Defense and Marine businesses continued to perform very well. Quarterly operating margin in our Instrumentation segment was an all-time record. Operating margin in our Aerospace and Defense Electronics segment was the second quarter record and just slightly less than the fourth quarter of last year. And now through a combination of sales growth, operating leverage and the more aggressive cost actions mentioned earlier, I fully expect digital imaging margins to grow considerably over time. And now I'm going to turn the call over to Sue.Sue Main:
Thank you, Robert and good morning, everyone. I will first discuss some additional financials for the quarter not covered by Robert and then I will discuss our third quarter and full year 2023 outlook. In the second quarter, cash flow from operating activities was $190.5 million. Free cash flow, that is cash from operating activities less capital expenditures was $163.2 million in the second quarter of 2023 compared with $176.1 million in 2022. Capital expenditures were $27.3 million in the second quarter of 2023 compared with $20.8 million in 2022. Depreciation and amortization expense was $80 million for the second quarter of 2023 compared with $82.7 million. We ended the quarter with approximately $2.99 billion of net debt. That is approximately $3.35 billion of debt less cash of $364.2 million. Stock-based compensation expense was $8.4 million in the second quarter of 2023 compared with $6.4 million in 2022. Turning to our outlook. Management currently believes that GAAP earnings per share in the third quarter of 2023 will be in the range of $3.76 to $3.90 per share, with non-GAAP earnings in the range of $4.70 to $4.80. And for the full year 2023, our GAAP earnings per share outlook is $15.60 to $15.88. And on a non-GAAP basis, we are maintaining our prior outlook of $19 to $19.20. Both the third quarter and full year non-GAAP outlook excludes estimated pretax charges for further FLIR integration costs, the 2023 full year estimated tax rate, excluding discrete items, is expected to be 22.3%. I'll now pass the call back to Robert.Robert Mehrabian:
Thank you very much, Sue. We would now like to take your questions. Operator, if you're ready to proceed with the questions and answers, please go ahead.Operator:
[Operator Instructions] And our first question today will come from the line of Jim Ricchiuti.Jim Ricchiuti:
I wanted to talk a little bit, Robert, if I may, about digital imaging. If we exclude the acquisitions, it looks like your revenues were down year-on-year and sequentially. And some of this may be partly due to what you're seeing at FLIR. But I wonder if you could just expand on what you're seeing in digital imaging just because it's a large category that covers a lot of ground?Robert Mehrabian:
Well, thank you. I think what you're referring to is in the organic growth or decline year-over-year was a little over 1% decline -- 1.5% to be exact. We see several thingsJim Ricchiuti:
And follow-up question, I wonder if you could talk a little bit about -- just an update on the rate at which you may be burning through some of that higher cost component inventory that you had. And just in general, it sounds like supply chain has gotten better and how you're seeing that part of the business?Robert Mehrabian:
Yes. I think you're right. As I mentioned earlier, our supply chain issues have significantly moderated. We're still paying some premiums but perhaps as much as year-to-date, 65% to 70% lower than we did at the first quarter -- second quarter of last year. So that's a positive. But we're still paying some premium and our inventory remained fairly flat between first quarter and second quarter. But as these supply chain issues relax, we're going to reduce our inventory for the remainder of the year. So I feel good about how we've dealt with the supply chain. We really didn't lose a whole lot of revenue because of that.Jim Ricchiuti:
And if I could just slip one more in, apologies but you did talk about some pull-in from Q3. I wonder if you would size that for us.Robert Mehrabian:
I'm going to say approximately $10 million, not a whole lot. But when we have the opportunity and I hope we will have in the future we're going to try and do that. The flip side of that, Jim, is that a lot of our customers have also ordered a lot of inventory anticipating shortages. So -- resistent about letting us ship all the stock that they have ordered before but we're balancing that because, again, our balanced portfolio help us along in all of those directions.Operator:
Our next question will come from the line of Joe Giordano, representing TD Cowen.Joe Giordano:
I want to continue first on DI. I guess I'd say 90-plus percent of the questions I get from investors are about the margins there. So I mean, I think they -- over the last couple of quarters, they probably come in and the outlook has come in a little bit below what you thought. I know there's some elements, high-margin machine vision, probably market declines there. But can you talk about what's been slightly different than you thought on the margin side? And how should we really think about that business kind of into 2024, like what's realistic for like a baseline margin assumption is?Robert Mehrabian:
Let me start with second quarter margin. Actually, second quarter Digital Imaging margin is up about 28 basis points. That's a 30 basis points year-over-year. And we think for the year, it might -- it will be probably flat, maybe down about 10 or 15 basis points but relatively flat. I think what -- what's going to happen is that the flare margins are going to increase somewhat and the historic or legacy digital imaging, they're going to decline a little bit. Basically, we think year-over-year, it's going to be flat. We've had, as I mentioned before, we've had a slower revenue and lower revenue in Defense in the first half of the year. But as I mentioned earlier, that's turning around now. So I think that's going to help us for the rest of the year. That's about really all I can say about the margins. I think second quarter year-over-year, we saw an improvement of about 28 to 30 basis points. For the whole year, it might be flat or down maybe 15 basis points but not much. And again, the balanced portfolio is really going to help us. The flip side of it is, if you look at our Aerospace and Defense segment, there second quarter margins increased 247 basis points. And for the year, we're projecting 80 basis points expansion. So sometimes, when we look at Defense, yes, we differentiate Defense -- that's in digital imaging, what I've talked about before. And then -- but we have a whole bunch of Defense programs in our Aerospace and Defense portfolio, which are doing really well. So overall, I think we're, okay.Joe Giordano:
Just one quick clarification. I know the DI margins were up year-on-year but sequentially, they were down on higher revenue. So was there like a mix change going on there? And then I have a quick question on Test & Measurement.Robert Mehrabian:
I don't know. They were down sequentially what, about 20 basis points. I'm not so concerned about that. There's so many moving parts in there that it just balances itself out. That's not something that worries me. That's all I'll say about that. Go ahead with your other area, please.Joe Giordano:
Just curious on -- if you have any color on like the order -- the order intake for things like oscilloscopes versus the revenue delivery now? Like I know the revenue is strong, are orders starting to slow there? I'm just curious like what that revenue trend looks like? Like how much backlog do you have? How fast is that kind of coming out? And is it being replenished at the same pace?Robert Mehrabian:
Yes. As you know, on the Test and Measurement, we have 2 distinct product lines. One is oscilloscopes, the other is protocols. And both of those are relatively short-term revenue. So big backlog, which doesn't make a whole lot of difference. Our oscilloscopes revenue in Q2 was outstanding, really good. Our protocol revenue was relatively flat and partially, that's because new protocols are coming out in September and we expect that revenue to pick up. If you look at the whole year, we think that we're going to have something like 3.5% to 4% growth in our oscilloscope and protocol products. We think third and fourth quarter are going to be all right. They may not expand as much as the first quarter but year-over-year, we're going to be fine. In terms of just answering your question on backlog, book-to-bill in that Test and Measurement is very close to 1, it's 0.98. So I would say it's 1. So again, it's not something that concerns me right now.Operator:
Our next question will be from the line of Greg Konrad with Jefferies.Greg Konrad:
Maybe just one clarification. I mean it seems like you brought down -- you didn't change guidance for the year but brought down digital imaging. You talked about the strength in A&D. Has there been any change to the overall company margin guidance for the year just given it seems like A&D is tracking ahead and instrumentation continues to be maybe slightly above expectations?Robert Mehrabian:
Yes. I'd say, if you went back to April guidance versus today, probably margin is going down 10 basis points. Again, nothing significant. For the full year, we expect margin to go up about 26 to 30 basis points year-over-year. So overall, it's a -- that's not something that concerns me because as I've mentioned several times, because of our diversity of our products, for example, Instruments margin will go up 80 basis points year-over-year. Aerospace and Defense, similarly, 80 basis points. Even Engineered Systems will go up about 38 to 40 basis points. So a flat digital imaging doesn't change anything at this time.Greg Konrad:
And then, I mean, you talked about FLIR Defense and kind of what you're seeing on the order front and A&D performance top line was really strong in the quarter. I mean, what are you seeing across Teledyne as it relates to Defense? And how are you kind of thinking about runway just given orders and some of the '23 budget money coming through?Robert Mehrabian:
Yes. As you mentioned, there has been a change in the budget for a long time. The budgets look healthy but money wasn't coming through and it started to come through more recently. Overall, I would say we are fairly comfortable with our Defense businesses, probably across everything, mid-single and single digits growth year-over-year. We are enjoying actually pretty good margins and orders in our legacy Defense businesses. And as I mentioned, our fleece defense businesses are turning around and had a good book-to-bill in Q2. It's not just the U.S. Defense. If you look at Defense also in NATO countries, that expenditures are increasing and we have a significant amount of sales overseas, in both our Defense as well as Defense, including things like traveling wave tubes for missile defense products in places like South Korea. So it's a pretty healthy environment right now.Operator:
[Operator Instructions] And let's go to the line of Jordan Manosh with BOA [ph].Unidentified Analyst:
This is [indiscernible] Bank of America. So I just had a quick question on the backlog for Defense. Are you guys seeing any specific constraints that could put the deliveries at risk? And also, too, for those wins, should we expect the majority of them to come through for '23 or extend that into the out years?Robert Mehrabian:
Some will come to in '23 and some will come through in -- starting in Q4. For example, let me just give you one example or two. We do have some counter drone products that are going to Europe, probably about $25 million, $26 million. Most of that would come in '23. On the other hand, the Black Hornet 3 that we just announced for the U.S. Army is $94 million, only about 10% of it will come this year, the rest will come in future years. So it's a balance. I think we'll get some of it this year and a lot of it in future years.Operator:
And we'll go to the line of Guy Hardwick with Credit Suisse.Guy Hardwick:
Robert, I think you said in your prepared remarks that digital imaging margins should grow considerably over time. Could you a little bit flesh that out a little bit for us, what is over time? And could this mean that digital imaging margins exceed the sort of 24% levels I think that delivered in 2021?Robert Mehrabian:
Yes. The answer is, yes. And the reason I say that is the margins in our legacy businesses are already around that and even higher than that. And I think FLIR margins will increase as we -- especially as we take the cost out that I just mentioned. And overall margins for Digital Imaging this year, we're projecting to be 22.3%. So to go to '24, 170 basis point expansion. Yes, we can do that.Guy Hardwick:
I think last quarter, you had pointed out negative mix, lag of price increases, I think, in the Medical business. So was there any other mix effects other than Defense that you talked about in Q2? Is there anything else that we should be aware of, which may have held back margins? Because I think 3 months ago, you did expect sequential improvement and 30 basis points up for the full year?Robert Mehrabian:
Yes. I think in the health care business, things are really good for us. We've had significant expansion, both in our X-ray products, that is our panels as well as components that we put out for X-ray systems. And as I said before, there is some slowdown in China. If you look at China as a whole, they have had some contraction even though you don't hear about it, there has been some contraction there. On the other hand, less than 10% of our portfolio is sold to China. So again, our balanced portfolio helps us. The flip side also is that we've gotten some really good higher-margin products development programs that are helping overall Digital Imaging. Shipments have been a little slower but I think bookings are okay. So again, it's not something that worries me, where we don't have, let's say, a commercial imaging system that somebody would buy in China. On the flip side, we have custom products that we're developing, which are very profitable. Actually, more profitable than commercial. I sit here today and I'm just looking at our portfolio and I wouldn't change it with anybody else's considering all the uncertainty around the world. One area may go down a little bit but we'll pick it up somewhere else. And that's the resilience of our earnings year-over-year, quarter-over-quarter.Guy Hardwick:
Just one last one for me. In Aerospace and Defense Electronics, I think previously, you had mentioned that you benefited from a particularly good mix there. Is that -- presumably, that has continued in Q2 and assume that continues in the second half given your guidance for the margin?Robert Mehrabian:
Yes. We think we may have a little lower revenue in the second half. On the other hand, the products that we make in Aerospace go primarily in commercial aircraft. And that market has expanded, as you well know, very close to pre-COVID. Q3, Q4 margins for Aerospace and Defense might be a little lower than Q2 but it will be higher than Q1. So again, I don't see major inflections in that area.Operator:
We'll go the line of Jim Ricchiuti with a follow-up from Needham.Jim Ricchiuti:
You gave us some book-to-bills and I'm just wondering if you could perhaps provide us the book-to-bill in the different segments. I feel like I've got pieces of it.Robert Mehrabian:
Sure. Jim, in Instruments, our book-to-bill is about 1.05, so over 1, led by our Marine businesses, which are doing really well, both -- in underwater vehicles as well as oil discovery and production. In the Digital Imaging as a whole, the book-to-bill is about 1.07. In Aerospace and Defense, that's a little more =- and Engineered Systems, those are much more lumpy orders. So quarter-over-quarter book-to-bill may change but it's not affecting the revenue that much because we expect both -- revenue in both segments to grow. Overall, across the company, our book-to-bill is about 1.Jim Ricchiuti:
Okay. And last question for me. Just given the debt pay down, I'm wondering how -- if anything has changed with respect to thinking about acquisitions, including any change in areas that you might be pursuing? And I know you can't be specific but I'm just wondering, just in general, what your appetite is for M&A as you look out over the next several quarters?Robert Mehrabian:
Well, as I mentioned earlier, Jim, we paid on $620 million this year effective today, let's say. That's taken our net debt-to-EBITDA ratio to 2.1%. We have about $60 million of debt left that's variable, which we pay 6%, out of the $3 billion that -- $3 billion plus that Sue mentioned, the rest of our debt is on fixed. So other than that $60 million, our interest payments are 2.1% in future years, which is a very healthy place to be because we haven't really touched our line of credit. So we have a lot of capability to acquisitions. Last year, even as we were paying our debt down, last year, we did 3 bolt-on acquisitions and spent about $160 million. We expect to continue that bolt-on acquisitions. On the flip side is that because if we don't do anything else, if we don't make acquisitions, if we don't -- doing anything, our debt-to-EBITDA ratio is going to go less than 1 in about a year and 1.5 years. So we're bullish about acquisitions, including larger ones, if we can find them. And of course, we are continuously looking at that. The last question was, what areas. Right now, I would say in the general instrumentation area is what's very attractive. We have done some digital imaging acquisitions. As you know, we made the ETM acquisition. We made acquisition for our acquisition. But I think it'd be nice if we could find some things in our Instrumentation area.Operator:
And we have no other participants queued up at this time.Robert Mehrabian:
Thank you, operator. I now ask Jason to conclude our conference call.Jason VanWees:
Thanks, Robert. And thanks, Thomas. To give the replay information to the audience, I would appreciate it. And again, all our news releases are available and for those who want to talk to me, please feel free to call me the number in the earnings release. Thanks, everyone. Bye.Operator:
Absolutely. Thank you, ladies and gentlemen. To dial in to the replay, it will be available this morning and starting today at or 10 a.m. in the Pacific Time Zone and lasting through August 25 at midnight and you may access the AT&T playback service at any time by dialing, please me get that number for you, goes by dialing 1-800 or excuse me, 866-207-1041. And please enter the access code of 2597973 and that will be available for 1 month through August 25 at midnight. And we thank you for your patience in using the AT&T Event Services. You may now disconnect.Operator:
Ladies and gentlemen, thank you for standing by. And welcome to the Teledyne First Quarter Earnings Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. Instructions will be given at that time. [Operator Instructions] As a reminder, this conference is being recorded. I’d now like to turn the call over to our host, Mr. Jason VanWees. Please go ahead, sir.Jason VanWees:
Thanks, Brad, and good morning, everyone. This is Jason VanWees, Vice Chairman. And I’d like to welcome everyone to Teledyne’s first quarter 2023 earnings release conference call. We released our earnings earlier this morning before the market opened. Joining me today are Teledyne’s Chairman, President and CEO, Robert Mehrabian; SVP and CFO, Sue Main; SVP, General Counsel, Chief Compliance Officer and Secretary, Melanie Cibik; and also Edwin Roks, Executive VP of Teledyne. After remarks by Robert and Sue, we will ask for your questions. Of course though, before we get started, please be aware that all forward-looking statements made this morning are subject to various assumptions, risks, and caveats as noted in the earnings release and our periodic SEC filings and actual results may differ materially. In order to avoid potential selective disclosures, this call is simultaneously being webcast and a replay both via webcast and dial-in will be available for approximately one month. Here is Robert.Robert Mehrabian:
Thank you, Jason. Good morning, everyone, and thank you for joining our earnings call. We began 2023 with record first quarter sales, operating margin, non-GAAP earnings and free cash flow. Overall, sales increased 4.7%, with revenue and operating profit growing in every segment. Excluding foreign currency headwinds, which negatively impacted first quarter sales growth by approximately 1.4%, growth in local currency would have been 6.1%. Excluding acquisitions, core growth in local currency would have been approximately 4.2%. GAAP operating margin of 17.5% and non-GAAP operating margin of 21.1% were also first quarter record. First quarter GAAP earnings per share were $3.73 and non-GAAP earnings of $4.53 were also first quarter record. Given record first quarter cash flow, our consolidated leverage ratio declined to 2.3 even after completing the ChartWorld acquisition at the beginning of the quarter. We also repaid $300 million of debt which matured on April 3rd on the first day of the second quarter. Turning to our 2023 full year outlook, we are reaffirming our prior sales and non-GAAP earnings per share outlook. As supply chain challenges improved modestly, we were able to exceed our original first quarter sales and earnings outlook by pulling forward some revenue from the second quarter. Consequently, by maintaining the full year guidance, we have also modestly derisked the quarterly sequential revenue and earnings slopes. While our short-cycle businesses are more economically sensitive, they were resilient in the first quarter. We are now a little more cautious. On the other hand, we are more positive in our longer-cycle medical, aerospace, defense and marine businesses. On revenue, specifically we will continue to see total 2023 growth of approximately 5% or sales of approximately $5.73 billion with the second quarter being roughly $1.4 billion. Regarding margins, our earnings outlook now implies approximately 40 basis points of margin improvement for the full year 2023. Currently, we think the Instrumentation segment will be above average contributor to this, while margins in the other segments may increase more modestly. I will now further comment on the performance of our four business segments. Our Digital Imaging segment was founded on our first acquisition in 2006 of Teledyne Scientific, our research laboratories, and Imaging, which provides high-end infrared sensors for space and astronomy. Since then, this segment has grown organically and through acquisitions such as DALSA, e2v, Scientific Cameras, FLIR and most recently ETM and ChartWorld to contribute almost 56% of Teledyne’s revenue today. First quarter sales in this segment increased 4.7% on a constant currency basis with foreign currency translation contributing negative 1.8%. Sales increased year-over-year for industrial and scientific vision systems, as well as for our low-dose high-resolution digital X-ray detectors. But were offset by lower sales of unmanned ground systems for defense applications. Our product families increased or decreased more modestly with higher sales of surveillance, unmanned air systems and especially -- specialty semiconductor devices, offset by some lower sales of certain commercial infrared imaging and marine’s products. GAAP segment operating margin increased 40 basis-points to 15.8% and adjusted for a reduced intangible asset amortization, non-GAAP margin decreased 13 basis points and it was lower at 21.75%. Turning to our Instrumentation segment, it is comprised of marine, test and measurement and environmental instruments, and contributes about 24% to Teledyne’s revenue. Overall, first quarter sales increased 8% versus last years with sales growing in all fields noted above. Sales of marine instruments increased a healthy 14.6% in the quarter, primarily due to strong marine defense sales, especially autonomous underwater vehicles, as well as ongoing recovery in offshore energy markets. Sales of electronic test and measurement systems, which includes oscilloscopes, digitizes and protocol analyzers collectively increased 5.3% year-over-year despite a tough comparison with the first quarter of last year. Some softness in sales of analyzers and electronic storage and high speed networking applications was more than offset by devices for wireless and video protocols, as well as very strong sales of oscilloscopes and related accessories. Sales of environmental instruments increased 3.4% compared with last year, with greater sales of air quality, process gas and safety analyzers, partially offset by drug discovery and laboratory instruments. The other two segments of Teledyne are Aerospace and Defense Electronics and Engineered Systems that together contributes 20% of Teledyne’s revenue. In the Aerospace and Defense Electronics segment, first quarter sales increased 4.2%, driven by growth of both defense and commercial aerospace products. GAAP and non-GAAP segment operating profit increased approximately 9.6%, with margins 132 basis points greater than last year. In the Engineered Systems segment, first quarter revenue increased 9.1% and operating profit increased 6.4%, resulting in a modest 25 basis points decline in margin from last year. Finally, first, because of our unwavering focus on improving on all aspects of Teledyne’s operations, and second, prudent capital allocation, and third, the broad geographic and end markets that we serve from short-cycle to long-cycle commercial to defense, I am optimistic that Teledyne will successfully navigate through today’s uncertain economic times as we have consistently done so in the past. Our record also shows that we have successfully dealt with multiple economic turmoils and during the ensuing recoveries have been able to acquire complementary enterprises for compounded growth. I will now turn the call over to Sue.Sue Main:
Thank you, Robert, and good morning, everyone. I will first discuss some additional financials for the quarter not covered by Robert and then I will discuss our second quarter and full year 2023 outlook. In the first quarter, cash flow from operating activities was $203 million and primarily reflected higher accounts receivable collections compared with the first quarter of 2022. Free cash flow that is cash from operating activities less capital expenditures was $178.6 million in the first quarter of 2023, compared with adjusted free cash flow of $58.7 million in 2022. The 2022 adjusted value excluded by $296.4 million payment to the Swedish Tax Authority related to a FLIR pre-acquisition tax reassessment. Capital expenditures were $24.4 million in the first quarter of 2023, compared with $21 million in 2022. Depreciation and amortization expense was $82.1 million for the first quarter of 2023, compared with $86.9 million. We ended the quarter with approximately $3.16 billion of net debt that is approximately $3.82 billion of debt less cash of $665.2 million. Stock-based compensation expense was $7.9 million in the first quarter of 2023, compared with $9 million in 2022. Turning to our outlook, management currently believes that GAAP earnings per share in the second quarter of 2023 will be in the range of $3.76 per share to $3.88 per share with non-GAAP earnings in the range of $4.56 to $4.66. And for the full year 2023, our GAAP earnings per share outlook is $15.80 to $16.05. And on a non-GAAP basis, we are maintaining our prior outlook of $19 to $19.20. The 2023 full year estimated tax rate excluding discrete items is expected to be 23%. I will now pass the call back to Robert.Robert Mehrabian:
Thank you, Sue. We would now like to take your questions. Brad, if you are ready to proceed with the question-and-answers, please go ahead.Operator:
Thank you. [Operator Instructions] We can first go to Jim Ricchiuti with Needham & Company. Please go ahead.Jim Ricchiuti:
Hi. Thank you. Good morning. Robert, I am wondering if you could talk a little bit about the shorter-cycle areas of the Instrumentation business. I think you gave some color about the Digital Imaging short-cycle business, but if you look at Instrumentation, any changes that you are seeing in that shorter-cycle business?Robert Mehrabian:
Not much. There is a little bit of -- in one of our businesses, like, which is our test and measurement, we make a protocol solutions -- provide protocol solutions to the electronics industry. There we have some new product protocols coming out. So people are little waiting for the new ones and maybe not buying the old loans. Other than that, where the book-to-bill is almost 1, oscilloscopes are doing well and in the T&Ms we feel alright. On the environmental, the only thing that there is a little softness that we are experiencing in the pharmaceutical market, where we supply a whole range of products. There -- but we are making that up by some of our air quality and other products that are doing well in this environment. So, overall, I think, we are doing okay.Jim Ricchiuti:
Got it. Since you were good enough to give us a book-to-bill, which I think was for the entire Instrumentation business. I am wondering if you could provide some book-to-bill color on Digital Imaging and the Aerospace and Defense and maybe the company as a whole? Thank you.Robert Mehrabian:
Yeah. Jim on the Instrumentation, if you put marine in, which we didn’t talk about. Marine has got a book-to-bill of 1.12. So, it’s very healthy. So because of that, it pulls Instrumentation as a whole above 1 to 1.04. Going to Digital Imaging, book-to-bill is less than 1, not substantially, but less than 1, primarily I think, because of some of the ground-based defense systems that we have which is about a little over 0.9. But having said that, we have some really large orders coming and we have also post-quarter had a large order for our Black Hornet, small air UAVs. When we had right after the quarter, as an example, we had $94 million award for those, and by the way, those are also in high demand in the Ukraine conflict. So, overall, I am encouraged with what’s happening in Digital Imaging. There has been a little lag in the defense part, but that’s coming up as the backlog is filling in and it’s -- we have better orders this quarter, first quarter than we did last year. And then on the AD&E side, I think, book-to-bill is 1.05. Engineered Systems is close to 1, but that’s lumpy. So, I think, we are going to be fine there. Overall for the company, I’d say when you add all those numbers up, it’s slightly less than 1, maybe 0.96, 0.97, but that’s not a great concern at this time. We are just being cautious as we always are, because of the uncertain times that everybody is facing. Other than that, I feel pretty good about our portfolio and its resilience.Jim Ricchiuti:
Got it. And just final question if I may, just in light of that -- the some of the uncertainty that’s out there. I think you have talked about M&A. Should we still think mainly about M&A this year is more tuck-in related and then potentially as we come out of this, there might be some opportunities for larger deals in 2024. Is that better way to think about M&A, again without being specific which I know you can’t be?Robert Mehrabian:
No. I understand, Jim. I think that’s a good analysis. There might -- we are obviously chasing some, what we call, string of pearls M&As. We -- it’s possible that we might end up with something more mid-size near the end of the year, but definitely with our balance sheet. We have right now -- we have drawn down on our line of credit, which is about 1.15 billion. We have only drawn down $25 million and it’s sitting there. We have paid all of our debt that’s coming due. We don’t have any debt payments until 2024. And we have a lot of capacity for to do larger deals, as opportunity comes, and of course, we are looking at things. But you are right, larger deals take time and it would probably be more like early 2024 or sometime in 2024.Jim Ricchiuti:
Got it. Thanks very much.Robert Mehrabian:
Thanks, Jim.Operator:
And next we can go to Greg Konrad with Jefferies. Please go ahead.Greg Konrad:
Good morning.Robert Mehrabian:
Good morning, Greg.Greg Konrad:
Maybe just to revisit Digital Imaging, is there any way to kind of decompose the organic growth, just given your short-cycle commentary, when you think about health care, machine vision, space and maybe the legacy FLIR business, just kind of what trends you are seeing and you mentioned being more cautious on short-cycle, like, how are you thinking about Digital Imaging for the year?Robert Mehrabian:
Well, first, let’s start with Q1. Organic -- and let’s also do what you suggested, which is stay with the first, what we would call our historical Digital Imaging, which is DALSA, e2v and associated companies. There we had a healthy organic growth in Q1 of 6.2%, healthcare grew 9.2% and MEMS grew 8.8%. So, overall, we are very happy with that and some of those like smaller cycle vision systems had a healthy growth rate there. On the FLIR side of the equation, which would be the newer digital imaging, we had both positives or negatives. Overall, we had a contraction of about 4.8%. But that was primarily driven by our unmanned systems and primarily in the unmanned drone vehicle systems. As I said, after the quarter, we have had some very healthy awards in our UAVs, which are unmanned air vehicles. Surveillance declined and was plus 5%. Tomography was down a little bit -- a little under 4%, but uncooled and cooled cores, which are infrared cores, they were up 3%. And industrial vision system was up almost 19% -- over 19%. So it was a mixed bag. The drag down for that business was primarily in the defense and primarily on ground -- on unmanned ground systems. Now we had a little softness in tomography and maritime, which is our marine -- Raymarine businesses. But, overall, I think, we were okay. We just have to fill out the backlog for our unmanned vehicles, ground vehicles and we will be fine.Greg Konrad:
And this might just be miss-modeling on my part, but I mean margin seemed a little late in Digital Imaging in the quarter. Can you maybe talk about price-mix going forward and how you are expecting margins to trend for the year, given your commentary? I think, you still expect them to be up, just a lesser degree than the total 40 for the company?Robert Mehrabian:
Well, right now what I’d say is, I expect the margins to be up about 30 basis points for the year, let’s start with the year and this is the overall Digital Imaging margin. So that would be pushed out on one side. I think, in Q2, we will improve sequentially on our margins and we should be fine and we are also going to take some price actions to make sure that we get there. On the overall for the company, we think the margins now would increase 40 basis points for the year and if we can have better price increases going forward, we should improve on that. So when I look at it, I’d say, look in our instruments businesses, we are going to have margin improvement for the year of almost 80 basis points, Digital Imaging about 30 basis points, Aerospace and Defense is so healthy that I will be happy to just keep our 27.1% operating margin. Engineered Systems will probably increase in 50 basis points, and overall, the segment’s 40 basis points and the company about 40 basis points. That -- I hope that helps you.Greg Konrad:
That was perfect. I will leave it to you. Thank you.Robert Mehrabian:
Thank you.Operator:
And next we have Elizabeth Grenfell with Bank of America. Please go ahead.Elizabeth Grenfell:
Hi. Good morning.Robert Mehrabian:
Good morning, Elizabeth.Elizabeth Grenfell:
Could you give us -- could you give us some color on defense on a consolidated basis for the quarter and then what your expectations are for defense growth on a consolidated basis for the year? Thank you.Robert Mehrabian:
Yeah. Sure. I think, overall, in Q1, defense was flat year-over-year and we think for the year, it will be probably low-to-mid single-digit growth in our defense businesses. The primary reason, again, I am saying the U.S. Government programs were flat, primarily driven, as I said, but the on ground vehicles -- unmanned ground vehicles. We think for the year we are probably growing in the mid-single-digits in our defense.Elizabeth Grenfell:
Great. Thank you very much.Robert Mehrabian:
For sure your excellence.Operator:
And next we will go to Joe Giordano with TD Cowen. Please go ahead.Joe Giordano:
Hey. Good morning, guys.Robert Mehrabian:
Good morning, Joe.Joe Giordano:
You talked about pulling forward some revenue from 2Q into 1Q. Can you give some detail there as to like where it was and what that means for that business from here?Robert Mehrabian:
I think, basically, we have pulled in about $10 million and most of that was in Instruments, most of that was in our marine businesses. We shipped more underwater vehicles in Q1 that we had anticipated. We have some really good orders -- we actually have good orders for Q2 also. So that’s -- that was just to ensure that we hit what we expected to. And also, as I said, that was affected by the fact that we are having improvements in our supply chain. We are seeing improvement, significant improvement and I expect that to continue the rest of the year based on what we are seeing and based on what the Chief of our Procurement is doing with various companies. So that’s why we pulled it forward, we felt we could and did.Joe Giordano:
No. That makes sense. Now when I think about the full year guide, I mean, so you come in, it’s clearly at the high end of your guide here. You are guiding the second quarter high end is basically in line with consensus. You guys tend to be -- you are holding the full year, understanding that the macro is uncertain, like, are you trying to give the impression that the second half is weaker than you thought three months ago or are you kind of like derisking that full year guide, like, how should we think about the -- what the -- between the lines there?Robert Mehrabian:
Between the lines, I don’t think it’s going to be weaker, except that something terrible happens. It’s -- I feel good about, look, as you know, we are always more conservative. I can go out and say we are going to make a lot more in our earnings per share and we probably could. On the other hand, with the uncertain environment that we are facing, with semiconductors being down, everybody is projecting semiconductors will recover in 2024, not this year, both equipment and supply. We grow -- we -- which obviously we serve those markets. I am being cautious as we always are. But I don’t think the second -- right now I don’t think the second half is going to be weaker. I think it’s going to be actually stronger. If you look at earnings per share, they have to improve in the second half of the year for us to make the $19.10 that we projected or $19.20, if you want to take the high-end.Joe Giordano:
Yeah. Okay. Two more quick ones from me. You started off the year, free cash flow is pretty high, like what are your expectations for the year now, does that go up, higher than what you thought before? And then just curious on the supply chain improvement and the lack of having to pay as much gray market, like, how much benefit is that -- of that 40 bps, like, how much you are getting from there and where is it getting offset from in other elements of costs? Thank you.Robert Mehrabian:
Let me start with the free cash flow. We are going to beat last year’s free cash flow by a couple of $100 million, let’s just say, $850 million is our current estimate. I hope we can do better than that and we have just continued deleveraging the company, get ready for -- when all of this is uncertainty is behind us and use our capability and ability to buy things that have not there, perhaps, done as well in this environment. Coming back to the supply chain, we have seen improvement in Q1. Last year, in Q1, we -- our brokerage, we bought about $23 million of goods from brokerage and that does repay 70% premium let’s say. This year first quarter, it’s the same type of thing, cost us about half as much as that and so that’s a savings, obviously. But more importantly, if you look at revenue that’s being affected by the shortages. That is improving, which is much more comforting to me, because it makes our revenue projections a little more predictable, because we don’t have -- we are not missing a lot of revenue, because we don’t have parts. So there is improvement in the supply chain. We are seeing that. There is improvement in the premium that we are paying and also the fact that we are not going to miss as much revenue, because we can ship products, because they are sitting on the shelf, waiting for one or two parts. That’s it.Joe Giordano:
Thanks very much.Robert Mehrabian:
For sure.Operator:
And next we have got Guy Hardwick with Credit Suisse. Please go ahead.Guy Hardwick:
Hi. Good morning.Robert Mehrabian:
Good morning, Guy.Guy Hardwick:
I think the previous -- good morning, all. I think the previous guidance for at Group level was a 50 basis points improvement in the adjusted margin, so you are now guiding to 40s. So what are the kind of the main parts of the change and is it bias towards Digital Imaging?Robert Mehrabian:
Actually, what we have is a mixture. January, you are perfectly correct. We guided 50 basis points and now we are guiding 40 basis points. We are taking some guidance down in Instrumentation from January to today. We had over 100 basis points, we are closer to 80 basis points. Digital imaging, we are taking down about 10 basis points, all in. Aerospace and Defense, we are actually guiding -- we are guiding flat and we had it going down and so that’s good. And then in Engineered Systems, we have a moderate up, which are smaller business, but we still have a moderate 45 basis points or so up. So, overall, I think, we will be up 40 basis points. Again, we hope to do better than that and the way to do better than that is if we can stick some more price increases in our portfolio, because inflation is moderating. Nevertheless, our wages are going up 4.5% to 5%. Our purchasing of direct and indirect goods is going up with inflation and so we have to catch-up a little more with price increases to make-up for those in order to keep or be able to increase our margins. That’s the kind of uncertain part. How much can we gain from price increases? First quarter, we were okay. We made up what we paid out and we are a little positive actually. So, rest of the year, can we keep that pace of reasonable price increases to make up for inflation in both goods, as well as wages.Guy Hardwick:
And is the intention to be price/cost neutral or do a little bit better than that and then on the second...Robert Mehrabian:
I’d like to do better than that. I’d like to do better than that. For sure.Guy Hardwick:
Okay.Robert Mehrabian:
Last year…Guy Hardwick:
All right.Robert Mehrabian:
… we were negatively by 60 basis points. This year I hope to be positive.Guy Hardwick:
And just to follow-up on the broker purchase, I believe that you said that it was $70 million incremental last year. What does your guidance imply in terms of lowering that $70 million in 2023?Robert Mehrabian:
It’s hard to tell at this point, but if I were to take the first quarter and project it out, I’d say half.Guy Hardwick:
So potentially $35 million…Robert Mehrabian:
So it will…Guy Hardwick:
… $30 million to $40 million lower.Robert Mehrabian:
Yeah. $35 million.Guy Hardwick:
$35 million lower broker purchases.Robert Mehrabian:
Yeah. Yeah.Guy Hardwick:
Broker, okay.Robert Mehrabian:
Approximately.Guy Hardwick:
Okay.Robert Mehrabian:
Again, that’s a moving target. So, so far, we have been successful. As the semiconductor industry has gone down, as you can expect, the parts that were in shortage, some of them have become available. Some of them are at the harder parts to get. The FPGAs, et cetera are still harder to get. So it’s a mixture. But things are improving, which makes me feel positive.Guy Hardwick:
And just one final one for me, is there any sort of mix effect either positive or negative in Digital Imaging in terms of the margin?Robert Mehrabian:
No. I don’t believe so.Guy Hardwick:
Okay. Thank you.Robert Mehrabian:
For sure.Operator:
[Operator Instructions] We will go now to Kristine Liwag with Morgan Stanley.Kristine Liwag:
Hey. Good morning, everyone.Robert Mehrabian:
Good morning, Kristine.Kristine Liwag:
Robert, on the supply chain, just want to follow-up on the premiums paid to brokers for component sourcing. So you have talked about how that’s declined. And is that because traditional sources have reopened and therefore you are now sourcing less parts from these brokers or are you seeing more availability of parts and there’s not as much of a scarcity and therefore their premiums have declined? Can you provide more color on what’s driving the dynamic there?Robert Mehrabian:
Yeah. The big picture is that we are able to buy more from the OEMs than from brokers. We obviously prefer to buy from OEMs, because the prices are stable or it might be price increases versus last year. But brokers, you -- there you end up paying premiums of 70% to them. So that’s the big picture. And the availability is improving, it’s very interesting just anecdotally, there have been a few brokers that have called us asking us if we want some of their parts. Last year, we were out there begging for parts, and obviously, if that were to happen, I look at that as they have some obsolete or some excess supply and we are buying, but we buy them at a discount to what we paid to the OEMs. So the market is improving. I like that.Kristine Liwag:
Great. And then, Rob, you mentioned that you anticipate that you can pass on whatever inflation costs that you have into pricing. So that should be a net positive for you. But can you talk about the demand environment? What’s been the customer sensitivity to pricing and right now, if you look at the financial markets, we have had two regional bank failures last month and there is more uncertainty today. Is that macro environment affecting your customer’s decision for capital purchases or to have some sort of pricing sensitivity?Robert Mehrabian:
Yes. The answer to it is, yes. On the other hand, because we are in such a diverse market, if you look at some of our longer-cycle businesses, as I mentioned, like marine with energy dependent. Some of our defense businesses or others, they are not as price sensitive to what’s happening in the financial market. Some of our shorter-cycle businesses, yes, we have to be careful that we don’t increase prices and lose to the competition, lose market share to the competition. But in some areas, like healthcare, where we make X-ray panels that are very high resolution, very low dosage, there we have pricing power and so it’s a mixture. Overall, when I say uncertainty, about economic uncertainty, I am speaking exactly to what you pointed out, some of the uncertainty in the financial market that’s shipping out into other markets as well.Kristine Liwag:
Great. Thank you for the color. And if I could sneak a last one in, when you look at your overall portfolio, what percent of it would you say, you have more pricing power versus what percent would have more pricing sensitivity?Robert Mehrabian:
I think about 40% of our portfolio, we have more pricing power and 60% is more sensitive, because the 60% in some ways, it depends on the global macro environment. As you may know, the way our portfolio has evolved, today we sell about 22% to the government, 28% U.S. commercial and 50% commercial and defense outside the U.S. So the macro -- global macro environment is what we are more sensitive to a 40% not so.Kristine Liwag:
Great. Thank you very much.Robert Mehrabian:
For sure.Operator:
And currently we have no further questions in queue.Robert Mehrabian:
Thank you, Brad. I appreciate that. I will now ask Jason to conclude our conference call.Jason VanWees:
Thanks, Robert, and thanks everyone for joining us this morning. Of course, if you have follow-up questions, please feel free to call me at the number on the earnings release or e-mail me for those who have my contact information. Brad, if you could give the replay information, we would greatly appreciate it. Thank you.Operator:
Certainly. Thank you. Ladies and gentlemen, the conference will be available for replay after 10 o’clock today and running through May 26th at midnight. You can access the AT&T replay system at any time by dialing 1-866-207-1041 and entering the access code 8989973. International parties may dial 402-970-0847. Those numbers again 1-866-207-1041, international parties 402-970-0847, with the access code 8989973. That does conclude our call for today. Thanks for participation and for using AT&A Teleconference. You may now disconnect.Operator:
Ladies and gentlemen, good morning. Thank you for standing by, and welcome to the Teledyne Fourth Quarter Earnings Call. At this time, all lines are in a listen-only mode. Later, there will be an opportunity for your questions and instructions will be given at that time. [Operator Instructions]. And as a reminder, today's conference is being recorded. At this time, it's my pleasure to turn the conference over to our host, Mr. Jason VanWees. Please go ahead.Jason VanWees:
Thank you, Tom, and good morning, everyone. This is Jason VanWees, Vice Chairman of Teledyne, and I'd like to welcome everyone to Teledyne's Fourth Quarter and Full Year 2022 Earnings Release Conference Call. We released our earnings earlier this morning before the market opened. Joining me today are Teledyne's Chairman, President and CEO, Robert Mehrabian; Senior Vice President and CFO, Sue Main; Senior Vice President, General Counsel, Chief Compliance Officer and Secretary, Melanie Cibik. Also joining today is Edwin Roks, EVP of Teledyne. After remarks by Robert and Sue, we will ask for your questions. Of course though, before we get started, attorneys have reminded me to tell you that all forward-looking statements made this morning are subject to various, risks, assumptions and caveats as noted in the earnings release and our periodic SEC filings and of course, actual results may differ materially. In order to avoid potential selective disclosures, this call is simultaneously being webcast and a replay both via webcast and dial-in will be available for approximately one month. Here is Robert.Robert Mehrabian:
Thank you, Jason. Good morning, and thank you for joining our earnings call. 2022 ended up being an excellent year. We concluded it with all-time record quarterly and full year sales and earnings per share. During 2022, Teledyne, as with many other companies, found itself faced with external forces beyond our control. These were inflation, strong dollar and part shortages. Nevertheless, with continued -- we continued our long history of navigating difficult market environment and we ultimately delivered earnings in excess of our own expectations. Excluding foreign currency headwinds, which negatively impacted fourth quarter sales growth by approximately 2.6%, growth in local currency would have been 5.7%. Excluding ETM acquisition, core growth in local currency would have been approximately 5%. GAAP operating margin of 19.3% was an all-time record and non-GAAP operating margin of 22.4% increased 95 basis points from last year. GAAP and non-GAAP earnings of $4.74 and $4.94, respectively, were also records for Teledyne. Fourth quarter free cash flow was reasonably healthy, but included interest payments of approximately $30 million, which last year were made in the third quarter of 2021. While we completed the acquisition of ETM, our leverage ratio continued to decline from 3.8 times in May of 2021 when we acquired FLIR to 2.4 times at the end of 2022. Finally, our acquisition pipeline remains healthy as evidenced by the recent addition of ChartWorld, whose maritime navigation software and hardware tools bridge a product and technology gap between our Teledyne Marine and Raymarine businesses. Turning to our 2023 full year outlook. While still very early in 2023 and with many unknowns, including projections of a recession, we're inclined to offer an initial revenue and earnings outlook in line with consensus expectations. On revenue, we see total 2023 sales growth of approximately 5%, including incremental sales from recent bolt-on acquisitions. For our backlog-driven long-cycle businesses, we expect growth to be higher than average. For the majority of our short-cycle commercial businesses, foreign currency headwinds will impact the first quarter of 2023 where comparisons are tough and economic uncertainty and export regulations remain fluid. We continue to see overall growth, not contraction in these businesses, but expect that growth will be less than the total company average. On the other hand, supply chain constraints are improving, albeit modestly. There are a few minors other non puts and takes such as increased scope on our NASA contract at Engineered Systems equally offset by the 2022 completion of our OneWeb contract in the Aerospace and Electronics segments, but no other significant items to highlight this early in the year. Our earnings outlook approximately 50 basis points of margin improvement in 2023 and we currently think instrumentation and digital imaging will be above-average contributors to this, while margins at Aerospace and Defense Electronics may be flat or declined slightly, given especially tough comps as a greater mix in 2023 of Defense Electronics relative to commercial aerospace aftermarket sales. I will now further comment on the performance of our four segments. In our Digital Imaging segment, fourth quarter sales were relatively flat despite currency translation headwind of approximately 3.5%. Sales increased year-over-year for our industrial and scientific vision systems, as well as our low-dose high-resolution digital x-ray detectors. Sales of commercial infrared imaging cameras and components also increased and were at record levels since closing the FLIR acquisition in May of 2021. While total FLIR-related sales increased sequentially from the third quarter, sales of some surveillance and unmanned ground systems declined from last year on especially tough comparison. On the other hand, sales of unmanned air systems increased considerably year-over-year. GAAP segment operating margin was 18.8% and adjusted for intangible asset amortization only, segment margin was 23.8%, approximately 50 basis points greater than the fourth quarter of last year. In our Instrumentation segment, overall fourth quarter sales increased 7.9% versus last year, despite approximately 2.4% of FX translation headwind. Sales of electronic test and measurement systems, which include oscilloscopes, digitizers and protocol analyzers increased 3.8% year-over-year despite a tough comparison with the fourth quarter of last year's. Sales of motor oscilloscopes and protocol analyzers remained healthy with continued strength in products for industry standards such as peripheral component, Interconnect Express or PCI Express and Universal Serial Bus or USB. Sales of environmental instruments increased 9%, compared with last year with greater sales of both drug discovery and laboratory instruments, as well as air monitoring and process gas analyzers. Sales of marine instrumentation increased 9.8% in the quarter, primarily due to a strong marine defense sales and the ongoing recovery in offshore energy markets. Overall, Instrumentation segment operating profit increased 18.4% in the fourth quarter with GAAP operating margin increasing 215 basis points to 24.2% and 162 basis points on a non-GAAP basis excluding intangible asset amortization, which brought the non-GAAP margins to 25.3%. In Aerospace and Defense Electronics segment, fourth quarter sales increased 8.9%, driven by broad-based growth of both defense and commercial aerospace products. GAAP and non-GAAP segment operating profit increased approximately 30% with margins over 480 basis points greater than last year. In the Engineered Systems segment, Fourth quarter revenue increased 6.7%, but operating profit declined given lower margins for some of our electronic manufacturing service products. Before I turn the call over to Sue, I want to make a couple of concluding remarks. First, I was very pleased that Teledyne was able to overcome issues faced by most companies in 2022. Despite the macroeconomic and supply chain challenges noted earlier, our results exceeded the top end of our earnings outlook issued at any point during the year. While difficult to predict outcomes in 2023, we are reasonably confident that a number of our long-cycle businesses serving defense, medical, energy and aerospace markets will grow. While demand is more difficult to predict in our short-cycle instrumentation and imaging businesses, supply chain constraints and the previous premiums for gray market electronic components have begun to ease modestly. Given the strength of our balanced business portfolio and our management's long history of navigating challenging markets, I am optimistic that Teledyne will continue on its successful path in 2023. I will now turn the call over to Sue.Susan Main:
Thank you, Robert, and good morning, everyone. I will first discuss some additional financials for the quarter not covered by Robert and then I will discuss our first quarter and full year 2023 outlook. In the fourth quarter, cash flow from operating activities was $237.7 million, compared with cash flow of $295.6 million for the same period of 2021. The fourth quarter of 2022 reflected greater interest payments due to the timing of fixed rate bond interest and increased inventory purchases, compared with the fourth quarter of 2021. Free cash flow, that is cash from operating activities less capital expenditures was $203.6 million in the fourth quarter of 2022, compared with $261.6 million in 2021. Capital expenditures were $34.1 million in the fourth quarter of 2022, compared with $34 million in 2021. Depreciation and amortization expense was $81.8 million for the fourth quarter of 2022, compared with $86.2 million. In addition, non-cash inventory step-up expense for the fourth quarter of 2021 was $47.8 million with no comparable amount recorded in the fourth quarter of 2022. We ended the quarter with approximately $3.28 billion of net debt, that is approximately $3.92 billion of debt less cash of $638.1 million. Our stock option compensation expense was $6.2 million in the fourth quarter of 2022, compared with $6.4 million in 2021. Turning to our outlook. Management currently believes that GAAP earnings per share in the first quarter of 2023 will be in the range of $3.57 to $3.69 per share with non-GAAP earnings in the range of $4.37 to $4.47 and for the full year 2023, our GAAP earnings per share outlook is $15.80 to $16.10 and on a non-GAAP basis, $19 to $19.20. The 2023 full year estimated tax rate, excluding discrete items is expected to be 23%. I will now pass the call to Robert.Robert Mehrabian:
Thank you, Sue. We would now like to take your questions. Operator, if you are ready to proceed with the questions and answers, please go ahead.Operator:
[Operator Instructions] We'll begin today with a question from Greg Konrad representing Jefferies. Please go ahead.Greg Konrad:
Good morning.Robert Mehrabian:
Good morning, Greg.Greg Konrad:
Good quarter. And then, I mean, maybe just to start, given your commentary around supply chain and long cycle outperforming in 2023, can you maybe just update us on your expectations for defense across the businesses? I mean, it seems like peers have called out somewhat underperformance on supply chain this year. What are you seeing just in terms of the supply side and also in terms of demand?A - Robert Mehrabian:
Frankly, we think defense, while the growth was relatively modest in 2022 was 2% to 3%, that's our generally our U.S. government businesses. We think in 2023, it'll be about 5% organic growth. So we are relatively optimistic. And then…Greg Konrad:
And then, I mean, I was pleasantly surprised with just margins in the commentary. I mean, some of them seem very outside across the segment. Just in terms of your margin commentary for this year, what are some of the assumptions around price and inflation, add backs and just looking at that Q4 outperformance, anything unusual in that just let me think about the opportunities for 2023.Robert Mehrabian:
Well, I think basically in 2022, we hit just about every cylinder at the end of the quarter, especially the last month, month-and-a-half that we stand out very favorably. Of 2023, we think Q1 is going to be softer just like we had in 2022. Mostly, we have some headwinds from FX in the first quarter. We think there will be a decline in our revenue, maybe as much as 10%, but we don't know. It's too early. Maybe 1% of headwind, maybe 1% of revenue decline, I would say that. On the other hand, I think, we will pick up in Q2, Q3, Q4, just like we did this year. Right now, early in the year, the first two weeks, we had some slower orders in some of our short-cycle businesses, but the last two weeks they seem to be picking up. So overall, Greg, I am optimistic about 2023 altogether.Greg Konrad:
And then, maybe just sneaking one last one in. I mean, how are you thinking about free cash flow in 2023, just given top line growth, margin expansion and any working capital needs? I mean, in the past, you talked about a target, how are you thinking about 2023 in terms of free cash flow?Robert Mehrabian:
Yes, I think just pausing for a second because this would be asked. In 2022, we were a little short on cash. Well, a little $200 million, to be exact, and we think that's not going to happen in 2023. We think our cash in 2023 is going to be higher, approximately $900 million in cash, whereas in 2022, we really have to be very careful. We build a little more inventory than we wanted to primarily because of the shortages. We fell about $30 million short on revenue in the fourth quarter because of shortages. Also in 2022, there was that lack of R&D deductibility, which everybody has referred to, that costs us about $40 million. And we had about $60 million of more cash taxes, which brings us to just $400 million [ph]. We don't think that's going to repeat itself in 2023. So, we're optimistic.Greg Konrad:
Thank you.Operator:
And next, we're going to go to the line of Elizabeth Grenfell, representing Bank of America. Your line is open.Elizabeth Grenfell:
Just a couple of questions. One, in the 5% revenue growth guidance, could you just break out what is price and what is volume in that?Robert Mehrabian:
I think it’s a little too early to do both, but I’ll tell you that’s about 3.5% of organic growth and then 1.5% from our acquisitions that we made including the most recent one that we announced. If you look at projections from GDP and inflation at the current time, I am one of those people that doesn’t really believe in these projections at this point. But the projections are that pre-GDP in the U.S. will only grow 1.4% in 2023 and inflation will drop to about 2.7%, overall developed markets probably GDP will grow 1.1%. That's where the projections are maybe a little higher in inflation. But Elizabeth, it's a little too early for me. I don't think the economies know either. So, I'll just say that we expect to have an organic growth of 3.5% at this time. If things move like they did in 2022, hopefully, we'll increase that and of course, we'll make more acquisitions, too.Elizabeth Grenfell:
Okay. And then, can you give us a little more detail on your outlook by segment and where you see the most opportunity for upside?Robert Mehrabian:
Sure. First, I think in the instrumentation, which includes marine, environmental and test and measurement, we expect growth to be about 5% or average of the company. Of course, that doesn't have acquisitions in it. In the Digital Imaging segment as a whole, we again expect a 5% growth, maybe 5.1%; aerospace and defense, maybe 4%; and Engineered Systems, maybe a little over 5%. Part of the reason for aerospace and defense being a little less than the average, last year, we had that OneWeb program that we ended successfully, which contributed about $20 million in revenue. On the other hand, in Engineered Systems, we think we'll be a little above the average, because we won that very successfully won the NASA MOSSI contract, which adds about $20 million. So, that's - at this point, that's all I can say about that.Elizabeth Grenfell:
Thank you very much.Robert Mehrabian:
Sure, Elizabeth.Operator:
And we'll go to the line of Jim Ricchiuti with Needham & Company. Please go ahead.Jim Ricchiuti:
Hi, thank you. So is it the short-cycle commercial business where if you looked at 2023, Robert, where there might be some upside or are there some parts of the long-cycle business that could drive the upside versus the 5% that you are talking about for the company as a whole?Robert Mehrabian:
I think if I broke it down, the marine businesses have a little longer look at them. We think marine as a whole also because the energy -- offshore energy markets are improving and our projections for that are over 7%, maybe as much as 7.5% in marine. And in the short-cycle businesses, which is environmental and test and measurement, we think that will be about 3.5% together. We think that I have already talked about some of the others. In digital imaging, where we did have a really good year and a really good fourth quarter which was in DALSA and e2v. We think we are going to be relatively flat organically, but we made some acquisitions, so that should give us about with the acquisitions maybe 3.8%. We think FLIR would do better last next year, maybe a little over 5%, 6%. So -- and the -- it's built between defense and aerospace, defense is longer cycle than aerospace. If you discount the $20 million that we don't have in web, we think defense will grow some, Aerospace may be flat, more short cycle and I've already talked about Engineered Systems and the MOSSO, which we won which are longer-cycle businesses. We feel comfortable there.Jim Ricchiuti:
So, Robert, it sounds like you are relatively positive on constructive on what you are seeing out in the market. If I look at your commercial businesses, you alluded to some variability in bookings trends in some parts of the business and maybe you can provide a little bit more color on that. But is there anything that you are seeing in the commercial areas, whether it's test and measurement or machine vision that might be consistent with a slowing economy?Robert Mehrabian:
Yes, a little bit. I think you hit it on the head. Just a sliver, I'd say in -- if you look at Marine, our book-to-bill in the fourth quarter was 1.15. That's why I said it's longer cycle, we feel good about it. We're just going to specifically what you said, environmental and test and measurement, while for the whole year, our book-to-bill is about 1 in the fourth quarter, it dropped down to 0.96. To me, that's a sliver lower. So we are a little cautious about that. So DALSA, e2v dropped even further a little bit and I think FLIR would be okay, but some of our vision systems and scientific cameras, we just hit it out of the park in the fourth quarter and we think we're a little cautious about predicting. On the other side, I mean, just to cut to the chase, the other side is that it's very early. Everybody is predicting one thing or another. All we're doing is we are kind of hunker down and we are going to do what we always do. If we have to cut, we have cut and if we have to hire, we’ll hire and we’ll do what we have to do to make our numbers.Jim Ricchiuti:
Was the book-to-bill, last question, was the book-to-bill around 1 for the company as a whole?Robert Mehrabian:
Yes, just under 1, about 0.96, 0.97, but that has Engineered Systems in it, which was 0.9%, but that's but it's very lumpy. For the year, Engineered System was 1.12, which is a long-cycle business. For the year, the company was closer to 1.Jim Ricchiuti:
Got it. Thanks very much.Robert Mehrabian:
For sure.Operator:
And our next question will come from the line of Joe Giordano with Cowen. Please go ahead.Joe Giordano:
Hey guys. How are you?Robert Mehrabian:
Good morning, Joe. Very well.Joe Giordano:
I've been hearing more people talk about risks, what may be in the second half of the year from prices actually going down just given some of the deflationary characteristics you're seeing in prices paid and things like that. Is that something that you're seeing, like how do you think about price and your ability to continue to raise or is it more about supporting where they are now?Robert Mehrabian:
Well, in 2022, we added, Joe, we added about 4% in pricing. And then, if you hold against that, what we ended up spending, we had wages go up 4.5, overall buying stuff about $2.5 billion of direct and indirect materials, that went up overall, about 6.7%. Of course, that's on the cost of goods sold. I am only saying this because I want to put this in perspective. So, we increased prices across the board, 4%. Our materials inflation was 3.7% negative. Our wages were 1% negative to sales. So when you add those two, sales, materials inflation was and wage inflation was 4.7% negative. We increased prices 4%. So, net-net, we suffered about 60 basis points of determent between the two. Now, going forward, we expect to increase prices. How much? It's difficult to predict because as you said, some people are talking about decreasing prices in the second half. But we have to increase prices somewhat because we are going to have more inflation that we inherited and we are going to have to -- we are giving our employees about 4% raises across the board. So, to make up for that we have to increase prices somewhat. It depends on how the market behaves itself. We are right now saying our overall margins are going to improve 50 basis points versus last year and that's pretty good. So, we'll have less broker premiums. Last year, we paid $90 million excess fees to our brokers for parts. We think in 2023, that will maybe be half. So, I mean, it's a long answer to a short question. There is a lot of unknowns, but I feel we'll maintain our crisis and maybe increase on that level.Joseph Giordano:
If I think about your -- the bottom-end of your guide, I mean it's a pretty narrow guide, but if I think about the bottom-end of that guide, how protected do you think you are if there is like, what kind of recessionary outlook does that have? If we do -- some of these macro indicators are pretty bad. If we do go into a recession, do you feel like you have coverage there at the bottom-end of the guide and like which businesses? Like do you -- are you anticipating declines at certain businesses at the bottom-end?Robert Mehrabian:
Well, the longer cycle businesses are less cyclical which would be our government defense about 25%, medical, scientific, energy, aerospace in overall, which constitutes about 40% of our portfolio, I don’t think those are going to be affected. On the flip side, the short cycle businesses will constitute 60% of our overall portfolio. If the world macroeconomic really suffers, obviously, we are going to have to take some hits. As you said, we have a very narrow range that we came out with, primarily because we're not sure what's going to happen. We could have probably had a larger range, but coming out of 2020 as strongly as we did, we feel okay about that.Joseph Giordano:
Just the last one for me. Have you internally started adding things like, have you started to be a little bit more judicious on expenses and travel and things like that in anticipation of things weakening? Or is that you'll adjust as necessary?Robert Mehrabian:
Oh no, that's a mode of our operation. It's something we do day in and day out regardless of what the macroeconomics are. We control everything. We controlled expenses in travel, we eliminate square footage of our manufacturing facilities. Everything we do we're vigilant and that's the only way we made it through 2022 as well as we did and we're going to continue that.Joseph Giordano:
Thanks, guys.Robert Mehrabian:
For sure.Operator:
[Operator Instructions] And we’ll go to the line of Guy Hardwick representing Credit Suisse. Please go ahead.Guy Hardwick:
Hi, good morning. So it's been about 20 months since Teledyne closed on FLIR. Can you give us a bit of insight as to how to combine the portfolios is progressing, whether there is any -- if we've seen some revenue benefits from combining the two technology platforms? I mean in the past, you've done the same with DALSA and e2v. I'm just wondering if there is any comparable success stories or potential success stories to come from that?Robert Mehrabian:
Thank you, Guy. Good question. The answer is yes. We have some new products. We are -- we have some new markets, especially in machine vision and for example, also mapping or FLIR has this Raymarine business and we've had this geospatial business, where we do a lot of hydrographic mapping and the most recent acquisition that we made ChartWorld bridges the gap between those two. I don't know if we would have bought ChartWorld if we didn’t have FLIR, we were just hold geospatial. So, those are really good. The other thing is that, FLIR has really exceptional products in the unmanned air vehicle domain. And we have had historically good products at Teledyne legacy in the underwater domain. FLIR also brings now ground-based vehicles. So now, if you look at the combination of the two companies, we have about $450 million or so of revenue in unmanned vehicles, unmanned air vehicles, unmanned ground vehicles, unmanned underwater vehicles. And there is a lot of common technologies between those three in terms of control, because of software in terms of digitization and imaging. So, those are some examples, GUY, after 20 months. But that will, of course, grow as a function of time.Guy Hardwick:
Okay. Thank you. And just a quick follow-up. I am just trying to understand the FX guidance implied in your guidance, because it looks like at current rates that FX actually could be a tailwind in the second half?Robert Mehrabian:
It could be. As we think in the first half, certainly, first quarter, we think it's going to be a 1% headwind versus 2.1% to 2.5% last year. Having said that, I don't think anybody knows. I don't think the economies know, they might say, but they don't know. I don't think anybody knows what's going to happen. I certainly don't ever put it that way.Guy Hardwick:
Okay. But can you just clarify what rates you perhaps think about dollar euro rate you have currently?Robert Mehrabian:
Well, currently, it's 1.09.Guy Hardwick:
That's not what you're using in guidance, though, right?Robert Mehrabian:
We're using about 1.06.Guy Hardwick:
Okay. Thank you.Operator:
And there are no other questions queued up at this time.Robert Mehrabian:
Thank you very much. Operator, I will now ask Jason to conclude our conference call.Jason VanWees:
Thanks, Tom, and thanks, everyone, for joining, of course, if you have follow-up questions, certainly feel free to call me or email me. My phone number on the earnings release. And Tom, if you could give the replay information on the call and conclude we'd appreciate it. Thanks you.Operator:
Absolutely. Thank you. Ladies and gentlemen, this conference will be available for replay starting at 10 AM Pacific and running through February 25 at midnight. You may access the AT&T playback service at any time by dialing 866-207-1041 and entering the access code of 347-2355. International participants, you can dial 402-970-0847. Those numbers again are 866-207-1041. International participants please dial 402-970-0847 and enter the access code of 347-2355. And that does conclude our conference for today. We thank you for your participation and using the AT&T Event Services. You may now disconnect.Operator:
Ladies and gentlemen, thank you for standing by. Welcome to the Teledyne Technologies Third Quarter Earnings Conference call. [Operator Instructions] And as a reminder, this call is being recorded. I’d now like to turn the call over to our host, Mr. Jason VanWees. Please go ahead.Jason VanWees:
Good morning, everyone. This is Jason VanWees, Vice Chairman of Teledyne and I’d like to welcome everyone to Teledyne’s third quarter 2022 earnings release conference call. We released our earnings earlier this morning before the market opened. Joining me today are Teledyne’s Chairman, President and CEO, Robert Mehrabian; Senior Vice President and CFO, Sue Main; SVP, General Counsel, Chief Compliance Officer and Secretary, Melanie Cibik; and also Edwin Roks, Executive VP of Teledyne. After remarks by Robert and Sue, we will ask for your questions. Of course though, before we get started, attorneys have reminded me to tell you that all forward-looking statements made this morning are subject to various assumptions, risks and caveats as noted in the earnings release and our periodic SEC filings. And of course, actual results may differ materially. In order to avoid potential selective disclosures, this call is simultaneously being webcast and a replay both via webcast and dial-in will be available for approximately 1 month. Here is Robert.Robert Mehrabian:
Thank you, Jason. Good morning and thank you for joining our earnings call. I am very pleased with our performance this quarter as well as Teledyne’s long history of navigating challenging markets. Despite the strong dollar, supply chain constraints and inflation, we achieved record third quarter sales, earnings, operating margin and free cash flow. Excluding foreign currency headwind, which negatively impacted third quarter sales growth by approximately 3% or $39 million, core growth in local currency would have been 6.9%. In addition, year-over-year reported sales increased in all segments despite the FX headwind. Non-GAAP earnings of $4.54, was a third quarter record and just shy of our all-time record. And our earnings quality was also very high given our largest effective tax rate in several years. Overall, orders and demand remained strong, which is a testament to the strength of our balanced business portfolio. Total company book-to-bill was 1.06x and while orders remained reasonably healthy in our short-cycle commercial businesses that were particularly strong in our longer cycle government, marine and aviation businesses and quarter end external backlog of approximately $3.2 billion was also a record. Record third quarter free cash flow of $252 million improved for the second consecutive quarter and was 116% of adjusted net income. Our acquisition pipeline is growing and we are pleased to announce – we were pleased to announce the pending acquisition of ETM earlier this morning. Turning to our 2022 full year outlook, with our strong operating performance in the third quarter, we were able to increase our full year earnings outlook while derisking the prior heavily weighed Q4 forecast. On revenue, given our current exchange rate and the U.S. government’s continuing resolution as well as the evolving semiconductor and technology export controls, we are a bit cautious at this time and now project full year sales of roughly $5.45 billion. In the third quarter, we also took the opportunity to refocus Teledyne FLIR by eliminating some smaller money-losing products to help improve our margins. And as a result, we had some cost towards our revenue. Finally, while supply chain constraints continue to limit shipments, we have seen a modest – very modest improvement in recent weeks at least with regard to availability of certain printed circuit boards as well as electronic components. I will now further comment on the performance of our four segments. Starting with our Digital Imaging segment, third quarter sales increased 2.3% despite currency translation headwind of nearly 4%. Sales growth was strongest for industrial and scientific vision sensors and systems as well as for our low-dose high-resolution digital X-ray detectors. Sales of commercial infrared imaging cameras and components also increased. GAAP segment operating margin was 17.2%, but adjusted for intangible asset amortization, segment margin was 22.9%, a 170 basis point improvement from the second quarter of this year. In our Instrumentation segment, overall third quarter sales increased 6.7% versus last year. Sales of electronic test and measurement systems, which include oscilloscopes, digitizers and protocol analyzers, remained strong and increased 9.7% year-over-year with growth in all major geographies and product categories. Sales of protocol analyzers across numerous industry standards such as Peripheral Component Interconnect Express or PCI Express, Universal Serial Bus or USB, and high-definition multimedia interface, HDMI, remains strong as well as sales of oscilloscopes and our unique crossing product, which combine oscilloscopes and protocol analyzers together. Sales of environmental instruments increased 6.3% compared with last year with greater sales of both drug discovery and laboratory instruments as well as air monitoring and process gas analyzers. Sales of marine instrumentation increased 5.1% in the quarter, primarily due to new record sales of autonomous underwater vehicles for both defense and commercial oceanography applications. Overall, Instrumentation segment profit increased 12.9% in the third quarter with GAAP operating margin increasing 126 basis points to 23.2% and 83 basis points on a non-GAAP basis. Excluding intangible asset amortization, the margins increased to 24.5%. In the Aerospace and Defense Electronics segment, third quarter sales increased 4.8%, primarily driven by a 20.7% increase in sales of commercial aerospace products. GAAP segment operating profit increased 23.4%, with margin 349 basis points greater than last year. And finally, in our Engineered Systems segment, third quarter revenue increased 7.2% and operating profit also increased slightly. Before turning the call over to Sue, I wanted to make a couple of concluding remarks. Over the last 18 months, we have endured the same challenges as most companies, that is record inflation, supply chain constraints and now strong U.S. dollar. At the same time, we completed the integration of Teledyne FLIR, our largest acquisition and then we rapidly deleveraged. While the operating environment remains challenging, we are glad to be back to doing what we do best, investing in our businesses to drive organic growth, being vigilant on costs and simplifying our operations to increase margins and finally, acquiring and integrating complementary businesses. And now I’ll turn the call over to Sue.Sue Main:
Thank you, Robert and good morning everyone. I will first discuss some additional financials for the quarter not covered by Robert and then I will discuss our fourth quarter and full year 2022 outlook. In the third quarter, cash flow from operating activities was $268.9 million compared with cash flow of $192.8 million for the same period of 2021. The third quarter of 2022 reflected stronger trade receivable collections compared with the third quarter of 2021. Free cash flow that is cash from operating activities less capital expenditures was $252.2 million in the third quarter of 2022 compared with $163.6 million in 2021 which included $2.1 million of after cash – cash payments related to the FLIR transaction. Capital expenditures were $16.7 million in the third quarter of 2022 compared with $29.2 million in 2021. Depreciation and amortization expense was $80.8 million for the third quarter of 2022 compared with $90.2 million. In addition, non-cash inventory step-up expense for the third quarter of 2021 was $35.2 million with no comparable amount recorded in the third quarter of 2022. We ended the quarter with approximately $3.44 billion of net debt. That is approximately $3.9 billion of debt less cash of $479.3 million. Stock option compensation expense was $3.7 million in the third quarter of 2022 compared with $5.8 million in 2021. Turning to our outlook. Management currently believes that GAAP earnings per share in the fourth quarter of 2022 will be in the range of $3.67 to $3.80 per share with non-GAAP earnings in the range of $4.46 to $4.56. And for the full year 2022, our GAAP earnings per share outlook is $15.46 to $15.60, and on a non-GAAP basis, $17.70 to $17.80. The 2022 full year estimated tax rate excluding discrete items is expected to be 23.1%. I will now pass the call back to Robert.Robert Mehrabian:
Thank you very much, Sue. We would now like to take your questions. Operator, if you are ready to proceed with the questions and answers. Please go ahead.Operator:
Thank you. [Operator Instructions] We will go first to Greg Konrad with Jefferies. Please go ahead.Greg Konrad:
Good morning.Robert Mehrabian:
Good morning, Greg.Greg Konrad:
Maybe just to start, Digital Imaging had a nice margin pickup and recovery from kind of H1. Can you maybe talk about the margin dynamics around price mix and how you think about the recovery there or maybe expectations for the year?Robert Mehrabian:
Well, let me start with expectations for the year and then see if I can answer the rest. Actually, if you look at the year, we have net pricing improvement across all of our businesses of about 3.6% of sales, but that includes Digital Imaging. On the other hand, we have also against that, we have inflation, Greg, and price increases in the products that we buy. The price increases in the products that we buy have been about 3.4%. We also have salary increases of about 4%. So our net pricing increases have kind of offset the headwind that I have – that we have from price increases to us, that is inflation. The flipside of that is that we have had to pay a little extra for scarce products like complex FPGAs and others that we could not build into our price. So that we have had a headwind there, I am going to say about 2%, about $50 million. So fundamentally, Digital Imaging has done well. They have improved their margins, but it’s been a relatively tight year up to now.Greg Konrad:
And then can you maybe comment on just the Defense business more broadly? I mean it seems like you’re getting quite a few of contracts, some at FLIR, some in the broader business. I mean broader market commentary seems to think that demand outstrips supply right now. I mean how do you think about the timing of some of these new defense opportunities and kind of the outlook there?Robert Mehrabian:
I think the – in general, what we’re finding is that in our Defense businesses, our book-to-bill has improved significantly. Now for the third quarter, actually, our government businesses were down slightly, but the book-to-bill, which is an important part for us, has improved both in FLIR, it’s close to 1x, but in our Aerospace and Defense Electronics is closer to 1.5x and in Engineered Systems to 1.35x. The – what we’re finding is that the demand for electronic components and systems, including parts that are going to Javelin and other weapons that are being depleted, those are coming back strong. We also have really good orders in systems that are being developed like a wide field of new tracking layer, which is for missile tracking basically. We’ve had orders – good orders, and we will have programs of about 60 million over 2 years. And that goes across a lot of our products. So in general, you’re right. We’ve had – we’ve seen strength in our Defense businesses and some moderation in our commercial businesses as time has gone on.Greg Konrad:
And then just last one, kind of a clarification question. I mean you called out the 3% headwind from FX. Just want to clarify, is that only a translation headwind? Or are you seeing any changes to competition just when you’re competing with maybe a local currency competitor?Robert Mehrabian:
No. It’s really a headwind from FX. It’s a translation only. It started the year at about 1%, went to 2% in Q2, 3% in Q3, and we’re estimating about 2% in Q4, for a total, Greg, of $110 million hit that we’re taking to our revenue for the full year. So if we didn’t have this translation only, we would have revenues – another $110 million in revenues.Greg Konrad:
Thank you.Robert Mehrabian:
Thank you, Greg.Operator:
And next, we can go to Joe Giordano with Cowen. Please go ahead.Joe Giordano:
Hey, guys. Good morning.Robert Mehrabian:
Good morning, Joe.Joe Giordano:
Last quarter, very modest cut, I think, took some people by surprise. Now a bit of a raise here. We’re kind of in the same zone at the end of the day, despite all of that. So kind of like what are the big changes? Did some kind of key risks that you were thinking about next – last quarter maybe not materialize to the same extent? Because it was kind of like a lot of movement to get to the same place, I guess, at the end of the day.Robert Mehrabian:
Yes. Well, when we started the last quarter, we weren’t sure how much prices we could – of our price increases would stick. And obviously, we were also concerned whether we could manage our margins that take cost out to improve our margins. All of those coupled with the fact that our commercial orders held up pretty well, like in the Imaging businesses, helped us along the way. So in a way, yes, we were looking at – we weren’t in trouble in any way. We were just kind of very cautious because the headwinds were unpredictable. But as we took some cost out and increased prices, and we had good cash flow, by the way, it’s given us a lot more confidence. So we raised our outlook and de-risked Q4 at the same time.Joe Giordano:
Yes. No, that’s fair. I think when we spoke last quarter, your view for Digital Imaging margins was something like 22% ish for this quarter and then maybe 23% for next quarter. It looks like you’re 3 months ahead of that, so you’re at 23% now. Should we expect Digital Imaging margins to increase further in the fourth quarter?Robert Mehrabian:
A little bit, yes. I think overall in the fourth quarter – well, let me go talk to the year, which is easier for me to do. For the year, we think we will be at 22.2%, which would be about 20 bps better than last year. So I think Q4 is going to be better about 22.9%, 22.7% of that range. Again, I’m a little cautious here because there is some softness in the commercial market. But again, our Defense businesses are picking up.Joe Giordano:
Yes. That makes sense. And then just last for me. I mean I know it’s early and we don’t want to talk about ‘23, but I know that there was this bogey out there for a while now about the potential for you guys to do, give or take, around $1 billion of free cash flow in 2023. Is that still in this world like a reasonable target to shoot for? Or is it – is that kind of not achievable given FX and all these other things we’ve talked about for the last 6 months?Robert Mehrabian:
Let me say, I think $1 billion for ‘23 is a little too high because we have capitalized R&D that we have to worry about. But having said that, if you look at the big picture, which is the way I approached this, we started the year – we started after the FLIR acquisition with a net debt-to-EBITDA of 3.7x. We’re down to about 2.5x now. By the end of the year, everything else going along, we will be down to 2.4x. If all goes well by the end of next year and then by the end of ‘24, we will be down to 0.9x. But that gives us a lot of cash to do acquisitions. And that includes making maybe $500 million of acquisitions in the interim. So the way I look at cash flow is a longer-term view. We probably won’t make the full $1 billion. We will come close, but most importantly, we will be levered and be able to make acquisitions. At the same time, put us in a position where we can do something bigger if we want to later on.Joe Giordano:
Thank you.Operator:
And next, we will go to Elizabeth Grenfell with Bank of America. Please go ahead.Elizabeth Grenfell:
Hi, good morning. Can you give us a few details around the acquisition that you announced this morning?Robert Mehrabian:
Yes. I’d be happy to. It’s really, it’s a – while we didn’t disclose the terms, it’s got about 112 employees. It’s in Northern California. What it does is really it gives us two very important components to our – ads to our products that we don’t have. First, in the microwave area, we make traveling-wave tubes. But in order to drive these tubes, you need a power supply. So far, we’ve had to go to other people to buy the power supplies for our tubes. And we’ve been looking for that, and there is a scarcity of suppliers in that domain. With this acquisition, now we can essentially supply a system of both tubes and power supplies. For example, in a given application, we were studying, we sell the tubes and they add up to about $300,000 for that application. When we put the power supply with the tubes together, we can sell it over $2 million. So that’s in the Defense area. The second area is in our Medical field where we supply products that go into cancer therapy, radiotherapy, X-ray systems to kill cancer. We basically have a product that makes microwave – high energy pulsed microwave that are used in that system. And we’ve added to that – we seriously sell that for about $10,000. We’ve added to that more components, and we’ve gotten to where we sell about $40,000, $50,000 of products in a system. But again, what we didn’t have is the power supply, cooling system, the whole system that you can use in developing the high-energy X-rays. And that, again, is something that ETM brings to us. So what happens is a content that used to be $10,000, we have grown it to maybe $40,000, now can grow over $100,000 per radiotherapy system. And they have really good customer contacts and they have been accepted by the customers as have we with our own products. So that’s why we’re making this acquisition. It’s complementary to both our Defense as well as our radiotherapy businesses.Elizabeth Grenfell:
Okay. Great. And then the impact of the portfolio shaping you did within Teledyne FLIR this quarter, how much of an impact did that have on margins?Robert Mehrabian:
It improved margins slightly, but more importantly, what we’re doing is we took the costs out by reducing the workforce. It was a product line, for example, that they bought just before our acquisition in December of 2020. We bought them in May of 2021. It was a product where they were trying to produce basically commercial – industrial, commercial UAVs, unsuccessful, difficult business to be in. We have – in FLIR, we have really good products in the defense domain that we sell substantial amounts of. But to compete in the industrial domain, that was a product that we had to kill.Elizabeth Grenfell:
Okay. And then if I could shift – speak one more in, please. How are you thinking about the supply chain headwinds now? And when, if you think they’ll abate? And then the sales that are being lost because of challenges are those continuing to shift to the right or are they starting to disappear, any way to think about that?Robert Mehrabian:
Elizabeth, let me answer the second part of the question first. What’s happening to us is that we have about a $60 million shortfall in sales that rolls over quarter over quarter. So it’s not cumulative. It’s not like you have four quarters of $60 million loss in sales that adds to $240 million, just $60 million. What happens, it gets delayed, we get parts. The next quarter, we ship what we couldn’t ship, then we get delayed again. So we may start the quarter looking, saying, it’s going to hurt us by $100 million, but we recover from that, so it’s a $60 million problem for us right now. The flipside, the first part of your question, we are seeing some improvement especially in the more simpler printed circuit board assemblies. For example, to sell our cameras from Teledyne, DALSA and e2v, we need about 1,000 circuit boards a day on occasion. And that was drying up for various reasons. We’ve managed to address that problem. So that’s good. We also have some improvement in components. Having said that, we still have really tight market for more complex systems like field-programmable gate arrays, which – gate arrays, which are FPGAs. And there, what’s happening is the supply shortages are such that people are allocating certain number to each company. We have a very effective effort underway to combine all of our needs across Teledyne, prioritize them and give our priority numbers to our suppliers. Having said that, that is not improving. Some of our suppliers are asking for non-cancelable orders that go out a year from now. And so you have to make choices there, obviously. And we’re also doing that. So part of it is relaxing the PCBAs, but part of it with the field-programmable gate arrays, that’s not. So it’s a mixture. But I’d say, overall, there is improvement.Elizabeth Grenfell:
Great. Thank you very much.Robert Mehrabian:
Sure.Operator:
And next, we go to Jim Ricchiuti with Needham & Company. Please go ahead.Jim Ricchiuti:
Thank you. Good morning. Robert, you alluded to the short-cycle business holding up reasonably well. And I’m just wondering, as you think about that area of your business in a mild recessionary environment, which areas do you see the business beginning to soften the first? And are you seeing any signs of that in your bookings in any of that short-cycle business?Robert Mehrabian:
Yes. In some of the products that we make – I’ll start with Digital Imaging. In some of the products that we make, for example, that go into warehouses, as the demand is softening in that domain, then obviously, they don’t need as much of our products for automation and improvement of delivery of their products. On the other hand, we – because we have such a broad portfolio of products that range from security to traffic to firefighting, not all of them are kind of getting impacted simultaneously. That’s why we think it’s – the downward pressure is not as great for us because of the diversity of our products. Now if you went outside Digital Imaging, for example, in our Instruments domain where we have environmental instruments, we have oscilloscopes, protocols, we have marine instruments, we have marine vehicles. There, things are a lot better. We think it might soften but it hasn’t softened much yet. We are getting in the Instruments our book-to-bill is still 1.05x. So what happens is that’s the thing that Jason and I always talk about is the breadth of our products and both in terms of who we supply to and what people buy our products for, but also the diversity of our – geographic diversity of our products, where that’s protecting us. So we might have softness in some areas. But overall, I think we’re doing okay.Jim Ricchiuti:
Okay. And just on the comment that you made about M&A and certainly you could see the net leverage really coming down fairly meaningfully over the next 1 to 2 years. You alluded to 2024 potentially giving you the opportunity to do a big deal. Are you averse to doing a larger deal in ‘23? Or is it a case of – there are a lot of – there are smaller deals that you could do and you’ll just maybe gauge how the macro environment is and whether valuations potentially come down for certain larger assets?Robert Mehrabian:
Good point. Right now, if you look at the market for public companies as Jason often says, people always look in the rearview mirror, right? So everybody is looking in the rearview mirror, including us, and you’re seeing 52-week highs, right, in the back. It might be 9 months ago, nevertheless, it’s there. So expectations are what you see in your rearview mirror. If we go forward and things persist the way they are and people see lower numbers looking backwards, then I think we will have more opportunities. Right now, what our focus is to see if we can do more bolt-ons as we have done historically. When we acquired e2v in 2017, our ratio, net debt-to-EBITDA ratio went up almost to 3x. What we did – it came down by the end of ‘20. 2.5 years later or so, it came down to essentially zero. And we in the interim, made another $500 million of acquisitions during that period. So, the number I quoted for 2024 includes us being able to spend maybe $600 million of smaller acquisitions. As to the bigger acquisitions, I think we are waiting a little – obviously, we have some things in mind, but we ought to wait a little bit before people’s – people are not so effervescent about their evaluations.Jim Ricchiuti:
And is your interest mainly in the commercial area, or has anything changed with respect to how the defense environment looks?Robert Mehrabian:
Right now, we still like our commercial businesses. But we are also seeing, as you saw, we also bought something at least a bolt-on in the defense domain, partially bolt-on – partially defense in the bolt-on. We will do some bolt-ons in the defense, especially if they fit our portfolio. But on the larger stuff, it would be either commercial or a mixture of the two, like FLIR was. FLIR was 60% commercial, 40% defense. And so we will look at that, whether it’s 70%-30% or 60%-40%. We look at the combo.Jim Ricchiuti:
Alright. Thanks very much and congratulations on the quarter.Robert Mehrabian:
Thank you.Operator:
Next, we will go to Andrew Buscaglia with Berenberg. Please go ahead.Andrew Buscaglia:
Hey. Good morning guys.Robert Mehrabian:
Good morning Andrew.Andrew Buscaglia:
Along the lines of the short cycle discussion, specifically, can you just comment on FLIR – FLIR’s more industrial assets, which can be pretty volatile and can move pretty quickly, especially to the downside in a downturn? I guess what are you seeing with pace of orders or anything, any indication how that’s trending in that business? And then generally, how are FLIR margins settling? And I know they have been kind of volatile during this integration process. So, can you update us on how you feel about that?Robert Mehrabian:
Sure. Let me start with the products. Generally, I would say because of the breadth of the products, while there are some softness in some areas, just like our – rest of our digital imaging, FLIR’s book-to-bill right now is close to 1x, 0.98x, which is in some ways better than DALSA, e2v. From – because of the – again, because of the breadth of the products that they have from tomography instruments to infrared detectors to maritime systems, security, traffic, I don’t think we are going to get hit on all of those all at once, and we are not. The only problem that we have at FLIR, if I may call it that, is that historically, their revenues have been more skewed to the end of the quarter rather than evenly paced during the quarter like the rest of our digital imaging is. So, the only risk there is you get closer to the end of the quarter and something unforeseen happens. And then it can hurt you. We are working very hard to flatten that out. It will take us – we have the same problem in every acquisition we have made, large acquisitions, whether it was DALSA or e2v or others. And so we are working very hard to flatten that curve, the shipment curve. Having said that, coming back to margins, I think margins are settling in. They – from a non-GAAP perspective, while there has been some volatility, as you appropriately noted, I think will settle by the end of the year, we will settle to about overall in digital imaging to 22.2%. FLIR will be a little bit down from that. But generally, we should be okay. We are looking forward to really – last year was an odd year because we bought FLIR in the middle of the second quarter, and we essentially shipped 12 weeks of product with 8 weeks of cost. Again, because of that, end of the quarter shipment that I mentioned. So, that skewed the numbers. But things are fairly well stabilized now. And I think what we are looking for is make sure we get to our 22.2% by the end of the year for all of our digital imaging and then hunker down and improve that next year.Andrew Buscaglia:
Okay. That’s helpful. And then you gave some nice color on the ETM deal. I might have missed this, but how big is this company? And maybe any information you can provide on their margin profile, where you expect those to go?Robert Mehrabian:
Alright. Obviously, we have been hesitant to talk about it, but it’s going to be probably in our Q anyways in a few days, maybe later on. But it’s got about 112 people. The reason I am a little hesitant about the sales, which are about $50 million, is that they also buy products from us. So, they buy our traveling-wave tubes, including with their power supplies and they sell them. So, the deal is going to be accretive. How many cents depends on how you look at the cost of borrowing. Could be accretive $0.02, $0.03, $0.04, if we say the cost of borrowing is 4%, 5%. On the other hand, our cost of borrowing is not 4%, 5% because our average cost of borrowing with our fixed borrowing and cash is more like 2%. So, it’s going to be accretive, revenue a little shy around $50 million, with some pass-through of our own products. I don’t know if that’s helpful.Andrew Buscaglia:
Okay. Yes, very helpful. Just trying to get an idea of the size. Okay. Thank you, guys. Thanks Robert.Robert Mehrabian:
Sure.Operator:
Next, we will go to Kristine Liwag with Morgan Stanley. Please go ahead.Kristine Liwag:
Hey. Good morning everyone.Robert Mehrabian:
Good morning.Kristine Liwag:
Robert, on the supply chain, it really sounds like it’s starting to ease for you and your mitigating actions have been paying off. But can you provide a quantitative update? Last quarter, you had mentioned that the 800 of 900 missing components were resolved. Where are we at this quarter? And how does that trend from here?Robert Mehrabian:
It’s getting better. Last – and you are correct. But we started the year, this year, Kristine, by having about 36% of our missing components. Of course, the components were a lower number when we started the year. There were more like 500 components and we are at 35% that we couldn’t get at that time. We are now over 1,000 components, 1,100 components. But the missing percentage has gone down to about 6%, 7%. So, you are absolutely right. There is the improvement. The flip side is that of the 1,100 components, where we are missing maybe 65 or as I said, 60 open parts, the delay in those are kind of getting longer. And the demand on us is, okay, we are going to allocate so many to you, and you will get it next April. The flip side is it’s a non-cancelable order. I wish I had products like that. I would love to be in that business myself. So, it’s getting better, but still a challenge.Kristine Liwag:
I see. And then in terms of – maybe back to digital imaging, you had mentioned a return to portfolio simplification activities. Now, you have pruned a very small loss-making product line. But as you assess that portfolio having owned FLIR now for a few quarters, are you evaluating a potentially larger cost-cutting initiative or a divestiture, or is this kind of insulated and minimal?Robert Mehrabian:
Yes. I think it’s the latter. No, we are – in all of our products, I know in all of our businesses, we do 80-20, which means we take some products that are unique and they don’t make money. We take the product lines out and then increase our products that are making us a lot of money. We are doing that at FLIR like we do at Teledyne. But no, we are not going to divest any large part of FLIR. We are happy with what we have and we are actually probably going to add some to certain areas.Kristine Liwag:
Very helpful color. And if I could sneak in one more. Back to your comment on the supply chain, you mentioned that for some of the missing items, the lead times are getting longer. What’s driving those incremental headwinds? I mean I would think with some of the demand in other parts of semiconductors, for example, we are seeing rolling consumer demand, shouldn’t that free up capacity for your orders? And I guess I am just surprised that we are seeing some things continue to lengthen instead of really get resolved sooner.Robert Mehrabian:
Yes. In some of the discrete components like using commercial domain, things are okay. They are improving. On the other hand, in some of the memory stuff it’s – the length is getting longer. The lead times are longer. But depends on the complexity. Let me just kind of go through it. If you look at memory devices, lead times are getting lower. On the other hand, if you look at more complex devices, like microcontrollers, processors, the lead times are still 4 weeks to 60 weeks. So, it’s kind of a mixture and depends on what device we are looking for. For the simpler components and as I have said, printed circuit boards, we are making some real improvements there, and we feel very good about that. But some of those also require our people to go into the suppliers’ factory and schedule our products on a daily basis to get them out. So, it’s a mixture.Kristine Liwag:
Great. Thank you very much.Robert Mehrabian:
Sure.Operator:
And next, we will go to Noah Poponak with Goldman Sachs. Please go ahead.Noah Poponak:
Hey. Good morning everybody.Robert Mehrabian:
Good Noah.Noah Poponak:
Robert, I just wanted to go back to your commentary around the bid-ask spread in the M&A process. Some other companies that have a similar strategy to yours have pointed to that, but it pretty recently suggesting that, that hasn’t really broken yet. You have a deal this morning. You are saying the pipeline looks good. You are quantifying what you could potentially spend in the immediate-term. So, I guess maybe in some ways, you have already answered this, but I am just really curious to put a finer point, like has – now that public markets peaked almost a year ago, has that bid-ask spread challenge cracked and that spread has narrowed, or are you just saying that it hasn’t yet, but it eventually has to?Robert Mehrabian:
I think in the private deals it’s probably cracked a little bit. And the reason for that is private entrepreneurs are looking at things – they are looking at the world, Noah, the way it is evolving, right. The uncertainty in the future is becoming much more pronounced at this time. So, entrepreneurs that have built a business like the one we just bought, that – those people have been in business since 1973, they are becoming more reasonable because they see things are not going to get better in the short-term. So, on the smaller deals like that, I think you are right. We are seeing some better pricing. Having said that, on the bigger deals and public companies, they are still seeing 52-week highs in the background. Until we get beyond that, which is going to be another six months, four months, where people are not looking at, look my high was $500. And I am now trading at $350, they look in the mirror and say, well, my high was more like $400 and now we are at $350. Then I think it’s going to be more actionable.Noah Poponak:
Okay. That’s helpful. You have referenced reducing cost and also price increases. Can you just provide a little bit more detail on where in the business you have done that? And how sizable are we talking on each side?Robert Mehrabian:
Yes. It depends on the business. Some businesses, we have a hard time increasing prices because of the programs that we have, long-term programs. But let me just give you an example. In digital imaging, DALSA, e2v, for example, we have been able to increase prices about 4.7%. In marine, where we supply unmanned vehicle, but also a lot of connectivity products for oil and gas, we have also been able to increase prices about 4.7%. On the other hand, in some of our defense products, we have hardly cracked price or gotten about 1% or 2%. Having said that, on the average across the company, our price increases have been about 3.6% year-to-date. And against that, we have wage increases that are 4%. And then products, material that we buy that have been about 3.4%. That’s excluding the extra 2% that we pay for scarce materials. So, that’s been a wash between the price increases and the inflation. Where we hurt is, of course, we are spending $50-plus million extra on getting our scarce products. So, I think over time, that will go away too.Noah Poponak:
Okay. And lastly, which products or segments did you allow to roll off of FLIR?Robert Mehrabian:
Just really, there was just an Altavian product that they bought in December of 2020, about four months, five months before we bought them. Actually, we were already in discussions with them, and they picked that up. And it was – I think it’s basically an industrial, commercial drone business, not in a very difficult market. There are 20 companies that – of that ilk that are competing with one another. Me on that domain, I would rather buy the truck and put in our very really advanced imaging systems on somebody else’s truck. I don’t want to build those inexpensive trucks. So, that’s the one.Noah Poponak:
Okay. Thank you.Robert Mehrabian:
Sure Noah.Operator:
And currently, no further questions in queue.Robert Mehrabian:
Thank you very much. We would – if you would be kind enough operator, I am going to ask Jason to conclude our conference call, and then we will stop.Jason VanWees:
Thanks Robert. And again thanks everyone for joining us this morning. Brad, if you could give the replay information at the end of the call that would be great. And if you have follow-up questions, certainly do feel free to call me as well. Bye-bye.Operator:
Thank you. Ladies and gentlemen, the call will be available for replay after 10 o’clock Pacific Time today and running through November 6th at midnight. You can access the AT&T replay system at any time by dialing 1-866-207-1041 and entering the access code 1148115. International parties may dial 402-970-0847 with the access code 1148115. That does conclude our call for today. Thanks for your participation and for using AT&T Teleconference. You may now disconnect.
Greg Konrad - Jefferies:Joe Giordano - Cowen:Elizabeth Grenfell - Bank of America:Jim Ricchiuti - Needham & Company:Andrew Buscaglia - Berenberg:Kristine Liwag - Morgan Stanley: